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Abstract.
This thesis describes a series of studies examining the fibronectin-binding 
proteins (FnBPs) of the pathogenic bacteria Staphylococcus aureus and 
Staphylococcus schleiferi. The firs t two results chapters explore the role of FnBPs 
in the interaction between S. aureus and human endothelial cells in vitro. The 
Impetus for studying this area was the iikely importance of this interaction in 
vivo during the process of bacterial seeding from the bloodstream to distant 
sites, a common accompaniment to bacteraemia and invasive disease. Having 
demonstrated a central role for FnBPs in adherence to, and invasion of 
endothelial cells, the third results chapter describes phenotypic and genotypic 
variation in fnb genes and the proteins they encode in a large population of 
ciinical S. aureus isolates. The fourth results chapter examines whether 
proteases, and in particular serine (V8) protease, influence S. aureus FnBP 
function, potentially modelling the bacterial cell surface and controlling the 
presence or absence of a functional adhesin. The fifth  results chapter 
demonstrates that S. schleiferi, a coagulase-negative staphylococcus and a 
nosocomial pathogen, expresses a FnBP. In the final results chapter, the 
presence of fnbA encoding S. aureus FnBPA is compared between isolates 
associated with carriage and invasive disease, together w ith 32 other bacterial 
factors. The aims of this study were to identify virulence-associated genes (one 
of which was fnbA)', to assess the cumulative effect of viruience-associated 
genes on virulence; and to identify gene combinations and determ ine if some 
combinations have a greater pathogenic potential than others.
X V lll
Chapter 1. Introduction.
1.1 General background.
1.1.1 The genus Staphy/ococcus.
Staphylococci are gram-positive cocci of ~ lp m  in diameter which on 
direct gram-stained smears from clinical specimens may appear singly, in pairs 
or short chains but have a strong tendency to form clusters. Staphylococci grow 
under both aerobic and anaerobic conditions on blood agar and other non- 
selective media. Most staphylococcal species grow rapidly, forming colonies on 
solid agar of > l-2 m m  in diameter by 24 hours incubation. Colonies are usually 
smooth with a low convex profile and an entire edge, the colour of which varies 
between species and ranges from yellow pigmented (some strains of 
Staphylococcus aureus), through white to gray. Staphylococci are differentiated 
from streptococci by a positive catalase test in which hydrogen peroxide is 
converted into water and oxygen on contact with a colony, giving rise to the 
appearance of bubbles.
S. aureus is by far the most im portant pathogen among the 
staphylococci. This species is differentiated from others in the genus by a 
combination of tests, including mannitol fermentation, production o f coagulase 
and deoxyribonuclease, and the expression o f a cell wall-associated fibrinogen- 
binding protein (Collee e t al., 1996). Thirty-two species of coagulase-negative 
staphylococci (CoNS) have been described to date, o f which 15 are indigenous to 
man (Kloos, 1997). Differentiation of CoNS species was originally based on a 
scheme devised by Kloos and Schleifer which relied on biochemical 
characteristics, while more recent species differentiation has used molecular 
methods based on DNA -  DNA hybridization (reviewed in Kloos, 1997).
1.1.2 S. at/reus carriage.
S. aureus is a common member of the normal human commensal flora. 
Colonization often occurs shortly after birth and appears to be a dynamic 
process. The umbilical stump is the first site to be colonized (Simpson et a!., 
1960), but within a few days the reservoir of S. aureus shifts to the vestibule of 
the anterior nares (Simpson et a/., 1960). Other sites including the axilla, 
perineum and pharynx may also be colonized (Williams, 1963), but elim ination 
of nasal carriage by topical antibiotics leads to loss o f carriage elsewhere 
(Reagan et a/., 1991), indicating that the nares represent the dominant 
ecological niche. The epithelium in the anterior nares is stratified, keratinized, 
non-ciliated epithelium, setting it apart from the rest of the nasal cavity and 
respiratory tract which is lined with ciliated columnar epithelium. Some healthy 
children and adults carry S. aureus in the pharynx as detected by throat swab, 
but scanning electron microscopy using human nasal tissue obtained from 
surgical specimens has demonstrated that adherence of S. aureus to ciliated 
epithelium is poor (Shuter e t a!., 1996). I t  is unclear, therefore, whether throat 
carriers are a subgroup of the population who can maintain S. aureus in this 
anatomical site, or whether organisms are temporary residents.
Longitudinal studies have reported that three carriage patterns can be 
distinguished in the healthy adult population, w ith approximately 20% of 
individuals being persistent S. aureus carriers, about 60% in term itten t carriers, 
and 20% persistent non-carriers (reviewed in Kluytmans e t a!., 1997). This is 
likely to be an over-simplification, not least because the duration of follow-up is 
often lim ited. In addition, comparison of results between studies is made difficu lt 
by the lack of conform ity in the methods of ascertainment and carriage 
definitions as well as the absence of information on antib iotic exposure, an 
important confounding variable. Despite these reservations, there is sufficient 
data to support the idea that some individuals w ithin the population are never.
or hardly ever positive for S. aureus, others are infrequent carriers, and the 
remainder are usually carriers.
1.1.3 The relationship between carriage and disease.
Three strands of evidence support the view that nasal carriage of S. 
aureus and the development of staphylococcal infection are linked. First, rates of 
infection are higher in carriers than non-carriers. This has been demonstrated in 
a range of clinical settings studied to date, including the development of post­
operative wound infections (Weinstein, 1959), in patients undergoing continuous 
ambulatory peritoneal dialysis and haemodialysis (Luzar et a!., 1990; Yu e t a!., 
1986), and in those infected with the human immunodeficiency virus (Weinke et 
a!., 1992). Second, studies comparing carriage and infecting isolates of S. 
aureus have demonstrated that individuals are usually infected w ith the ir own 
carriage isolate (Luzar e t al., 1990; Nguyen et a!., 1999; Yu et a!., 1986). This 
has recently been validated in a large study conducted by von Eiff e t al. in which 
greater than 80% of isolates from S. aureus bactaeremic infections were 
identical to strains carried in the patients nares (von Eiff et al., 2001). Third, the 
temporary eradication of carriage by the use of topical mupirocin has been 
shown to result in a reduction in nosocomial infection in dialysis patients and in 
those undergoing surgery (Boelaert e t al., 1993; Yu et al., 1986; Perez-Fontan 
e ta l.,  1993; Kluytmans, 1998).
1.1.4 S. aureus infection in man.
Considering the frequency of carriage in the population and the 
association between carriage and disease, attack rates for invasive S. aureus 
infection are comparatively low (estimated incidence 10/100,000 in Oxfordshire, 
personal communication Dr N. Day). Nonetheless, S. aureus is a m ajor cause of 
community-acquired and nosocomial infection (Emori & Gaynes, 1993; Steinberg 
et al., 1996). S. aureus is the second most common blood culture isolate in the
UK after Escherichia coli according to figures from the Public Health Laboratory 
Service, and is by far the commonest hospital-acquired infection (CDSC, 1998). 
I t  is also a common tropical pathogen; for example, it has recently been 
identified as the firs t or second commonest cause of community-acquired 
bacteraemia (depending on the year studied) in Vientiane, the capitol city of 
Laos (Mahosot Hospital, personal communication. Dr Paul Newton).
Clinical manifestations of S. aureus infection are diverse, and include 
superficial infections (for example, carbuncles, furuncles, cellulitis, lymphangitis 
and lymphadenitis), bacteraemia, endocarditis, pneumonia, osteomyelitis, septic 
arthritis, post-operative wound infection, and infections of medical devices 
including intravenous devices, prosthetic jo in ts and peritoneal dialysis catheters 
(Waldvogel, 2000). S. aureus also causes toxin-mediated disease through the 
production of epidermolytic toxins (the cause of staphylococcal scalded skin 
syndrome), enterotoxins (a cause of food poisoning), and toxic shock syndrome 
toxin 1 (Bohach e ta l. ,  1997).
1.2. Determinants of S. aureus infection.
1.2.1 Host factors.
Nasal carriage is an important determ inant of invasive disease, but host 
factors tha t are associated with carriage and/or invasive disease are poorly 
understood. Host genetic factors are known to be an im portant determ inant of 
early death due to sepsis in general (Sorensen e t al., 1988), but there are no 
data in the published literature defining the existence o f susceptibility loci in S. 
aureus disease. Specific immune defects such as chronic granulomatous disease 
and Job's syndrome are known to predispose individuals to infection w ith S. 
aureus (Donabedian & Gallin, 1983), but the pathways (and variations thereof) 
which influence whether disease develops in the normal host are not known.
1.2.2 Bacterial factors.
Although the pathogenesis underiying many of the ciinical manifestations 
of human S. aureus disease are pooriy understood, it is widely held tha t bacterial 
factors including toxins, cell wall-associated adhesins and secreted exoproteins 
are involved in the disease process (Projan & Novick, 1997). The evidence for 
this is strongest in the case of toxin-mediated S. aureus diseases such as toxic 
shock syndrome, scalded skin syndrome and food poisoning (Bohach e t a!., 
1997). However, the vast m ajority of cases of severe S. aureus disease cannot 
be explained by the action of a single virulence determ inant, and it is likely that 
a number o f factors act in combination during the infective process. Support for 
this comes from animal models where outcome has been compared following 
infection with isogenic mutants deficient in a single putative virulence 
determ inant, in which infection was attenuated but not prevented (Hienz e t a/., 
1996; Moreillon e t al., 1995). In addition, clinical isolates associated w ith human 
infection may be naturally deficient in a range of putative virulence 
determinants. I t  seems likely that S. aureus strains associated w ith human 
infection have variable combinations of pathogenic determinants. I t  is also 
possible tha t the presence or expression of given combinations varies depending 
on the type o f infection and genetic susceptibility of the affected host. The 
capacity to examine multiple bacterial factors are only ju s t emerging, and the 
current understanding of putative virulence determinants is mainly derived from 
the experimental evaluation of individual bacterial components.
1.2.3 S. aureus adhesins.
A range of S. aureus cell wall-associated proteins have been 
characterised and shown to promote adherence to extraceliular m atrix proteins 
and/or soluble plasma components (Patti e ta l. ,  1994a). Such adhesins may play 
a key role in colonization and invasive disease. The best characterised o f these 
are protein A (Spa) (Uhlen et al., 1984), collagen-binding protein Cna (Patti et
a i ,  1992), the fibrinogen-binding proteins ClfA, ClfB and Efb (form ally fib) 
(Boden & Flock, 1994; McDevitt e ta l. ,  1994; Ni Eidhin e ta l. ,  1998), and the two 
fibronectin-binding proteins FnBPA and FnBPB (Greene et al., 1995; Jonsson e t 
al., 1991; Signas e t al., 1989). Additional staphylococcal proteins include three 
members of the serine-aspartate multigene fam ily (SdrC, SdrD and SdrE) of 
unknown function (Josefsson e ta l. ,  1998); the bone sialoprotein-binding protein 
Bbp, (Tung e t al., 2000); the elastin-binding protein EbpS (Park e t al., 1996); 
the major histocompatibility complex class I I  analog Map and the highly sim ilar 
extracellular adhesin protein Eap (McGavin et al., 1993a; Palma e t al., 1999); 
the plasmin-sensitive Pis (Savolainen et al., 2001), and biofilm-associated 
protein (Bap) (Cucarelia e ta l.,  2002).
With the exception of Efb, EbpS and Map/Eap, these proteins have 
features that are characteristic of Gram-positive bacterial surface-expressed 
proteins, including a secretory signal sequence at the N-term inus, and at the C- 
term inus a positively charged ta il, a hydrophobic transmembrane domain and a 
wali-spanning region containing an LPXTG m otif (Foster & Hook, 1998). The 
latter represents the target of a specific enzyme (sortase) which cleaves the 
m otif between the threonine and glycine residues. The protein is then covalently 
anchored to the peptidoglycan cell wall (Mazmanian e t al., 1999; Schneewind e t 
al., 1995; Ton-That e ta l. ,  1997).
1.3 S. aureus fibronectin-binding proteins.
1.3.1 Description of S. aureus fibronectin-binding proteins.
S. aureus was first reported to bind fibronectin in 1978 (Kuusela, 1978); 
labelled fibronectin bound to the bacteria, while unlabelled Fn was inhibitory. 
Four years later Espersen and Clemmensen isolated a FnBP from sonicated S. 
aureus strain Newman using affin ity chromatography (Espersen & Clemmensen, 
1982). Two bands were identified with relative molecular masses of 197,000 and 
60,000 kDa. A complex could be demonstrated between purified S. aureus
protein and flbronectin using crossed immunoeiectrophoresis. Froman et al 
reproduced these data, and in addition reported that degradation of FnBP by V8 
protease generated a iarge number o f peptides tha t retained fibronectin binding 
activity. This was interpreted to mean that FnBP contained several binding sites 
for fibronectin (Froman e ta !.,  1987).
The m ajority of the early work defining S. aureus FnBPs was conducted 
by Martin Lind berg and colleagues, Sweden. A gene encoding a FnBP was 
identified from S. aureus 8325-4, genomic DNA from which had been cloned into 
Escherichia coii (Flock e t ai., 1987). Although not an idea cloning vector for a 
Gram-positive cell wall-anchored adhesin, the relevant clone was Identified by 
defining secretion of a product into the periplasm of E. coii which inhibited the 
binding of radiolabelled fibronectin to S. aureus Cowan. The region encoding 
fibronectin-binding activity was identified by sub-cloning, and was reported to be 
in a region tha t was later termed the D (repeat) region. The nucleotide sequence 
of S. aureus fnbA was subsequently defined for S. aureus 8325-4 (Signas e t ai., 
1989). The entire gene sequence was annotated based on regions o f repetition 
using computer analysis, defining from N-terminus to C- term inus, the A region, 
two B repeats (each of 30 amino acids), the C region and three D repeats of 38 
amino acids plus a partial fourth (Signas et ai., 1989).
A second gene termed fnbB located 682bp downstream of fnbA in S. 
aureus 8325-4 was reported two years later (Jonsson et ai., 1991). The gene 
was sequenced, and the amino acid sequence deduced and compared to tha t for 
the deduced sequence of fnbA. The two genes showed sequence homology In 
large parts. In FnBPB a stretch of 66 amino acids downstream to the signal 
peptide had 75% identity with the corresponding region of FnBPA. At the C- 
term inal site another 394 amino acid stretch was almost identical in both gene 
products. This stretch contained the D repeats, the wall spanning region and the 
hydrophobic membrane spanning region. The D repeats in FnBPB were noted to 
be highly conserved.
The two fnb genes were further characterised by Professor T. Foster, 
Dublin. Insertion mutations were constructed In fnbA and fnbB. Single mutants 
did not show a significant reduction In adherence to immobilized fibronectin, but 
the double m utant was completely defective (Greene e ta !., 1995).
1.3.2 Fibronectin.
Fibronectin is a ubiquitous glycoprotein that exists in body fluids and the 
extracellular m atrix (reviewed in Potts & Campbell, 1994). I t  plays a m ajor role 
in many im portant physiological processes, promoting cell adhesion and affecting 
cell morphology, m igration, differentiation and cytoskeletal organisation via 
interactions w ith integrins. A host ligand for FnBP, fibronectin was the first 
extracellular m atrix protein shown to act as a substrate for microbial adhesion 
(Kuusela, 1978). Each subunit of fibronectin is a mosaic protein made up of 
repeating modules of three types (I, I I,  I I I ) .  There are 12 type I repeats each 
around 45 amino acids long and clustered Into 3 groups, two adjacent type I I  
repeats and 15-17 type I I I  repeats. The Initial secreted form Is a dim er of two 
subunits held together by a pair of disulphide bonds near the ir C-term ini. 
Dimeric fibronectins are soluble molecules but become insoluble in extracellular 
m atrix fibrils where they are further disulphide-bonded into high molecular 
weight polymers. The modular proteins often correspond to the exon structure of 
the gene, and are organised into functional domains that contain binding sites 
for extraceliular m atrix proteins such as collagen and thrombospondin, cell 
surface receptors such as integrins, circulating blood proteins such as fibrin , and 
g lycosaminoglycans such as heparin and chondroitin sulphate.
1.3.3 Interactions between S. aureus FnBPs and fibronectin.
Investigation of the interaction between fibronectin and S. aureus 
commenced at around the time tha t FnBPs were firs t identified. Binding was 
demonstrated to be non-covalent and saturable, and was dependent on tim e and 
fibronectin concentration (Maxe et a!., 1986; Proctor e t a!., 1982). Adherence 
was affected by bacterial growth phase; S. aureus harvested in logarlthim ic 
growth phase had a higher number o f binding sites compared w ith stationary 
phase organisms (Proctor et al., 1982), and there was a decrease in adherence 
to immobilized fibronectin as the duration of incubation increased (Maxe e t a!., 
1986).
1.3.3.1 Binding sites for FnBPs on fibronectin molecule.
Using fibronectin fragments, S. aureus was found to adhere to both the 
NH2 term inal (Kuusela et a!., 1984; Kuusela e t a!., 1985; Mosher & Proctor, 
1980; Sakata et a!., 1994; Bozzini e t a!., 1992), and to a 120-140kDa COOH 
term inal fragment (Kuusela e t a!., 1984; Kuusela e t a!., 1985). Bacterial 
adherence to immobilized fibronectin was inhibited by the presence o f soluble 
fibronectin or a 29kDa NH2 term inal fragment, and by pre-incubating substrate 
w ith purified FnBP (Maxe et a!., 1986). The N-terminus of fibronectin is now 
recognised as the domain primarily recognised by FNBPs. This region contains 
five type I 'finger' modules. Investigation using recombinant truncated 
fibronectin molecules generated with deletions or mutations in the N-term inal 
type I modules suggested that binding of S. aureus required all five type I 
modules (Sottile e t a!., 1991), evaluation using recombinant FnBP D region 
peptides indicating that binding occurs prim arily to fingers 4 and 5 (Huff e t a!., 
1994).
1.3.3.2 Ligand binding sites on FnBP.
Sequencing of fnbA perm itted the construction of synthetic FnBP peptides, 
an im portant step towards detailed analysis of FnBP-ligand binding. The original 
cloning experiments of fnbA suggested that binding to fibronectin occurred via 
the D repeat region. Three peptides mimicking the structure o f each 38 amino 
acid unit of FnBPA were constructed, all of which were found to Inhibit binding of 
soluble fibronectin (intact or 29kDa N-terminal fragment) to staphylococcal cells 
(Signas e t al., 1989). Synthetic peptides D l,  D2 and D3 or D l-3  were also 
reported to Inhibit the attachment of S. aureus to immolilized intact fibronectin 
or N-terminal 29kDa fragment (Raja e t al., 1990).
The region of the D peptide involved in fibronectin binding was then 
mapped using digested fragments of recombinant protein. An active peptide 
encompassing residues 15-36 of a 37 amino acid D3 synthetic peptide analog 
was isolated following typsin digest. This had activ ity comparable w ith intact D3, 
suggesting tha t the FnBP binding region was w ithin the C-terminal portion of the 
D repeat. Scrambling the amino acid sequence of th is peptide or replacing the 
aspartic and glutamic residues resulted In loss of activ ity, while reduction in size 
from either the N- or C-terminal end resulted in peptides w ith greatly diminished 
activity (McGavin e t al., 1991). Synthetic peptides corresponding to the C- 
term inal 20 to 21 amino acids of each D repeat (D l,  D2 and D3) demonstrated 
that each were Independently capable of binding fibronectin, the D3 repeat 
binding with 5- to 10- fold greater affin ity than either D l or D2 (Huff e t al., 
1994). The interaction between the D repeats and intact fibronectin or the N- 
term inal fragment is common to several Gram-positive bacteria able to recognise 
fibronectin, and recombinant ligand binding region proteins (equivalent to D 
repeat region) from S. aureus. Streptococcus dysgalactlae and Streptococcus 
pyogenes effectively inhibit the binding of each other to radiolabelled fibronectin 
(Job e ta l.,  1994).
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Further assays of chemically modified peptides and peptide fragments 
derived from chemical or proteolytic cleavage suggested tha t a core conserved 
sequence, defined as ED(T?S) (X9,10)GG(X3,4)(I/V)DF, w ith in a 30-amino acid 
segment was present. ED(T?S) was reported to be non-essential, whereas the 
GG and the (I/V)DF together with acidic residues in the C-term inal half of the 
peptide were required for activity (McGavIn e t al., 1993b).
The presence of additional FnBP binding sites was firs t suggested during 
cloning and sequencing of fnbB, when a sub-clone lacking the coding region for 
the D repeats was found to have fibronectin binding activity (Jonsson e t al., 
1991). Evaluation of a series of truncates spanning FnBPA also demonstrated a 
second ligand binding region located outside the D repeat which appeared to be 
w ithin the B region (Joh e t al., 1998). Using a phage display library o f S. aureus 
genomic DNA constructed and panned against immobilized fibronectin and 
cultured osteoblasts, binding activity has also been located to the A region 
(Williams e t al., 2002). Thus, FnBP appears to have the ability to interact w ith 
fibronectin at several sites throughout the length of the protein.
1.3.3.3 Interaction between FnBPs and fibronectin.
Biophysical characterisation of recombinant FnBP suggested that this 
protein had iittle  or no regular secondary structure in phosphate buffer at neutral 
pH. Binding to fibronectin led to the Induction of a predominantly p-sheet 
structure in the recombinant adhesin (House-Pompeo e t al., 1996; Speziale e t 
al., 1996). Nuclear magnetic resonance techniques were used to study 
conformationai properties of D1-D4; these provided further evidence tha t th is 
protein was largely unstructured in aqueous solution at pH 6 (Penkett e t al., 
1998; Penkett e t al., 1997). Examination of the interaction between D3 and D l-  
4 of FnBPA with a fibronectin module pair C^Fl^Fl) using heteronuclear NMR 
spectroscopy showed tha t part of D3 converted from a disordered to a more
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ordered, extended conformation on binding to D l-4  also appeared to go
from a disordered to a more ordered conformation (Penkett e ta !., 2000).
1.3.4 FnBPs and other ligands.
The recombinant form of the A region of FnBPA has also been shown to 
recognise fibrinogen (Wann e t a!., 2000). Binding occurred to the gamma chain 
of fibrinogen, the chain recognised by the S. aureus fibrinogen-binding protein 
ClfA. Recombinant FnBPA competed w ith ClfA for binding to both immobilised 
and soluble fibrinogen, and over-expression of FnBPA in a bacterial mutant 
defective in ClfA and ClfB led to Its adherence to soluble fibrinogen.
1.3.5 Regulation of FnBPs.
S. aureus is known to have at least two major regulatory systems, 
termed the accessory global regulator (Agr) and staphylococcal accessory 
regulator (Sar). Both have been examined in relation to fnb expression, agr 
mutants were found to bind more fibronectin than wild type (Abdelnour e t al., 
1993; Cheung e t al., 1992; Cheung e t al., 1994; Saravia-Otten e t al., 1997). 
Analysis of transcription and translation of fnb genes demonstrated that 
synthesis of FnBPA and FnBPB in both an agr m utant and wild type took place 
preferentially during the firs t hour of growth and rapidiy decreased after the 
second hour. The concentration of fnb mRNAs and proteins differed by a factor of 
16 between different strains but the difference in fibronectin binding was only 
twofold, indicating that binding of fibronectin to the bacteria was not directly 
proportional to the amount of FnBPs on the ir surface, fnb genes were negatively 
regulated by agr and also by an agr-independent mechanism tha t restricted fnb 
mRNA synthesis to the early exponential phase of growth (Saravia-Otten e t al.,
1997).
The regulation of fnbA and fnbB by sar and agr was examined fu rther 
using single or double mutants of S. aureus Newman. Expression o f FnBPA was
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enhanced in the agr m utant but inhibited in the sar and the sar-agr double 
mutant. The same regulatory pattern was observed by Northern blot analysis 
using fnbA specific probes. Introduction o f sar on a multicopy plasmid increased 
the already enhanced fnbA transcription of the agr mutant. Thus, agr negatively 
regulates fnb gene, while sar upregulates fnb genes during exponential growth 
phase. Gel shift assays showed that SarA bound to the fnbA promoter 
fragments. Regulation of FnBPA and FnBPB was not a shared process; FnBPB 
was not detectable by ligand blotting and the FnBPB promoter activ ity  was not 
affected by either sar or agr w ith only minor amounts of /h66 -specific transcripts 
by Northern blot analysis (Wolz et al., 2000).
An im portant caveat to such findings is that these experiments represent 
regulation In vitro  during growth in broth media. I t  is becoming increasingly clear 
that this may not reflect events In vivo. Sub-genomic m icroarray analysis 
(covering 68 genes) was used to compare gene expression during growth of S. 
aureus in vitro  in standard laboratory medium, in rabbit serum In vitro, and in 
chambers implanted into the subcutaneous tissues of rabbits. Expression of 
RNAIII, the effector molecule of the agr locus, was dramatically repressed in 
serum and In vivo, despite the increased expression of secreted virulence factors 
previously considered to be under negative regulation. A positive correlation 
between the expression of agr and virulence factors was not found, disruption of 
the agr locus resulting in a minimal effect on the expression In vivo o f those 
virulence factors examined (Yarwood et al., 2002). Thus, it appears tha t 
regulatory circuits in vivo override agr activity, sar promoters have also been 
shown to be differentially expressed in differing m icro-environments. Using 
green fluorescent protein transcriptional fusions as a detection system for sar 
activation, promoters were found to be differentiaily expressed In vitro  and in 
vivo, and to differ depending on the position of the bacteria w ith in an 
experimental vegetation formed on rabbit heart valve in vivo (Cheung e t al.,
1998).
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1.3.6 Factors influencing surface expression of functional FnBPs.
There are several possible explanations for the observation that the 
amount of cell surface FnBP expressed on the bacterial cell surface is maximal 
during exponential growth but disappears rapidly as the culture progresses Into 
stationary phase. In addition to the process of regulation discussed above, it is 
also possible tha t proteins are either masked by a second protein that is 
secreted during late exponential phase, or tha t FnBPs are cleaved from the 
bacterial cell surface after expression has occurred.
1.3.6.1 Masking of FnBPs.
Capsuie is well placed to affect adhesion function, especially given the 
proxim ity of the D repeats to the bacterial cell wall. Strain M encapsulated 
(heavily encapsulated) has been shown to bind fibronectin poorly while M 
unencapsulated bound well. However, Smith diffuse (profuse capsule) and 
compact (no capsule) had sim ilar binding activ ity (Switalski e t al., 1983). 
Futhermore, most strains of S. aureus produce a microcapsule (at least, under In 
vitro  conditions). These observations suggest that capsule may not have a m ajor 
influence on adhesin function.
Biofilm is another contender as a masking protein. Two genes/gene 
clusters have so far been implicated in biofilm formation. These are the IcaADBC 
operon encoding intercellular adhesion, and bap encoding a biofilm-associated 
protein (Bap), a large protein consisting of 2,276 amino acids (Cucarella e t al., 
2002). A Bap positive strain was shown to have lower adherence to immobilized 
fibronectin and fibrinogen than an isogenic deficient strain. The effect o f lea on 
adherence to fibronectin is unclear.
Study of FnBPs and ClfA expression by S. aureus 8325-4 and Newman 
genetically altered to carry a chromosomal copy of the mec element (encoding 
methicillin resistance) demonstrated tha t the presence of mec ied to defective 
adherence to fibronectin and fibrinogen. Western blotting showed sim ilar
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amounts o f protein between m utant and wild type. I t  was considered possible 
that the mec element also carried a gene encoding a surface protein that 
masked or interfered with the function of other surface proteins (Vaudaux e t al.,
1998). This was consistent with previous reports that a higher proportion of 
methicillin resistant strains failed to agglutinate in the presence o f fibrinogen, (a 
reflection of ClfA function), compared w ith methicillinj^strains. Purification of a 
plasmin sensitive protein from a clinical methicillin resistant S. aureus strain 
(Hilden et a i ,  1996), was followed by identification of the gene termed p/s and 
characterisation of the cell wall anchored protein which had a serine-aspartate 
repeat region characteristic of the Clf-Sdr fam iiy (Savolainen e t al., 2001). A p/s 
m utant constructed by allelic replacement adhered well to Immobilized 
fibronectin (and IgG), in contrast to poor adherence of the parental strain.
1.3.6.2 Proteolytic cleavage of FnBPs.
McGavin et al. investigated the cause o f poor adherence o f one clinical 
isolate to fibronectin, the results of which suggest that FnBPs are cleaved by 
serine (V8 ) protease (McGavin e t al., 1997). A culture of a clinical Isolate with 
good fibronectin binding was supplemented at the time of inoculation with 
concentrated stationary phase supernatant from a second strain w ith poor 
binding to fibronectin. The resulting exponential phase cells were devoid of FnBP, 
but this was prevented by the addition of the universal protease inhib itor «2 
macroglobulin. V8 protease was purified from the supernatant o f the poor 
binder; its addition to a culture of the good binder led to loss o f cell surface FnBP 
and adherence to immobilized fibronectin. V8 protease cleaves on the carboxyl 
side of glutamic acid (Drapeau e t al., 1972), the most abundant amino acid of S. 
aureus FnBP (Signas et al., 1989), and one that is essential for fibronectin 
binding (McGavin e ta l.,  1991).
The relevance of these observations to in vivo events during the course of 
S. aureus infection is not understood. I t  has been hypothesized tha t modelling of
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the bacterial cell surface may be required during the transition between 
colonizing and invasive phases of infection with a shift from an adhesive to a 
relatively non-adhesive phenotype (McGavin et al., 1997), but this is likely to be 
a gross over-simplificatlon. I t  is also unclear whether V8 protease-mediated 
cleavage is common to other strains of S. aureus.
1.3.7 Interactions between FnBPs and host immunity.
1.3.7.1 Ceiiuiar response.
Interactions between recombinant FnBP, plasma fibronectin, anti-FnBP 
antibodies and phagocytic cells (polymorphonuclear cells and macrophages) has 
been examined (Rozalska & Wadstrom, 1992). Antibodies opsonized and 
promoted phagocytosis In vitro. FnBPs appeared to have chemoattractant 
activity in the mouse peritoneal cavity, leading to the accumulation of 
polymorphonuclear cells (PMNs) and macrophages. Phagocytosis o f bacteria in 
the presence of FnBP in vitro  was the same as tha t for the control, but the 
addition of plasma fibronectin led to an increased uptake by macrophages and to 
a lesser extent PMNs.
Little is known of the effect of FnBPs on other cell types o f the Immune 
system, although one study suggests tha t other interactions may occur; 
truncated forms of recombinant FnBPA protein have been shown to in terac^w ith  
integrin asPi via a fibronectin bridge to mediate adhesion and co-stim u^atory 
signals to T lymphocytes (Miyamoto e t al., 2001).
1.3.7.2 Antibody response.
One published study has examined the humoral response to FnBPs 
(Casolini et al., 1998). This was performed using samples from 33 patients with 
a 'variety' o f S. aureus infections. Timing of blood samples varied from 2 days - 
3 weeks, and the age range of the study group was 21-86 years. Samples from 
2 year old children were used as controls. Infected individuals had higher
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antibody levels than controls. The antibodies raised preferentially reacted with 
recombinant D l-4 , (regions A, B C and D were tested). Anti-D region antibodies 
preferentially recognized epitopes in the C-terminal 20 amino acids o f the D3 
motif, but only once complexed w ith fibronectin. There was little  interaction with 
recombinant proteins spanning A, B and C regions. All patients had antibodies 
tha t specifically recognised the fibronectin-FnBP complex, w ith epitopes 
recognized by these ligand induced binding site (LIBS) antibodies in each D 
repeat o f FnBP. Thus, antibodies recognised the antigenic epitope o f FnBP after it 
had undergone a conformational change upon ligand binding. This is consistent 
w ith the observation tha t antibodies did not inhibit fibronectin binding (Casolini 
e ta l.,  1998).
1.3.8 Effect of antibiotics on FnBPs.
Nearly 20 years ago, Richard Proctor reported tha t sub-inhib itory 
concentrations of antibiotics altered fibronectin binding to S. aureus (Proctor et 
al., 1983). This received little  further attention at the time but there has been 
renewed interest in this phenomenon in recent years, principally w ith respect to 
fluoroquinolones and the macrollde clindamycin.
Bacterial resistance to fluoroquinolones is mediated through DNA 
mutation of genes encoding DNA gyrase and topoisomerase IV. A S. aureus 
m utant defective in both grIA (topoisomerase IV, A sub-uinit) and gyrA (DNA 
gyrase, A subunit) grown in the presence of sub-inhibitory concentrations of 
ciprofloxacin expressed increased levels of FnBPs and had significantly higher 
attachment to fibronectin-coated polymer surfaces. This was seen w ith the 
double mutant, but not the strains with a single mutation or In the susceptible 
parent (Bisognano e t al., 1997). Fluoroquinolone-resistant clinical isolates were 
subsequently examined; 8/10 m ethiciiiin-resistant and 4 /6  m ethicillin- 
susceptible strains exhibited a significant increase in attachment to fibronectin- 
coated surfaces after growth in the presence of one-quarter the MIC of
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ciprofloxacin (Bisognano e t al., 2000). Enhanced adherence also occurred to 
explanted coverslips that had been removed from the subcutaneous tissues of 
guinea pigs, (these become coated w ith host protein including 
fibronectin)(Bisognano et al., 2000). Ciprofloxacin increased fnbB but not fnbA 
promoter activ ity of a fluoroquinolone-resistant deriviative of 8325 but not its 
susceptible parent. This was abolished by pre-treatm ent w ith rifampicin, 
indicating an effect at the level of transcription. Activation of the fnbB promoter 
was not due to an indirect effect on growth rate, and still occurred In an agr 
mutant.
Sub-inhibitory clindamycin was reported to elim inate production of nearly 
all exoproteins but had virtua lly no effect on cytoplasmic proteins (Herbert e t al.,
2001). The effect was abolished by a gene conferring resistance to macrolides- 
lincosamides-streptogramin B, showing that differential inhibition of protein 
synthesis was responsible. Sub-Inhibitory clindamycin stimulated synthesis of 
FnBPB at the level of transcription, and blocked production o f several of the 
Individual exproteIn genes, including spa, hla and sspA (encoding protein A, 
alpha toxin and serine protease, respectively). This pattern is suggestive of 
differential inhibition of one or more regulatory proteins, but agr and sar were 
m inimally effected by the antibiotic and did not appear to be responsible.
1.3.9 FnBPs and anti-staphylococcal vaccines.
Much prelim inary work has been undertaken towards the development of 
an anti-staphylococcal vaccine using FnBP as the target. The ideal would be to 
generate antibodies that block adherence while maintaining the ability to 
opsonize bacteria and enhance phagocytosis. Whether this is achievable is a 
topic for debate, reasons for which will become apparent from the discussion 
below.
Work using experimental animal models started more than a decade ago. 
D repeats of S. aureus FnBPA fused w ith E. coll p-galactosidase (gal-FnBP) was
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found to stim ulate antibodies in mice which partially blocked the binding of 
fibronectin to gal-FnBP in vitro  (CIborowski et a!., 1992). Vaccine efficacy was 
subsequently examined using several animal models. Rats were immunized with 
gal-FnBP, after which experimental endocarditis was induced and the outcome 
compared w ith unvaccinated controls (Schennlngs e t a!., 1993). The bacterial 
count on the injured heart valve was significantly reduced In the immunized 
group, and again the antibodies generated partiaily blocked adherence of S. 
aureus to immobilized fibronectin. Antibodies raised in rabbits to Gal-FnBPA and 
ZZ-FnBPB and injected into the mouse peritoneum led to a more rapid clearance 
of S. aureus from the peritoneal cavity and liver compared w ith controls. 
Clearance of opsonized S. aureus from the mouse bloodstream following 
intravenous injection was also more rapid than tha t for non-opsonized bacteria 
(Rozalska & Wadstrom, 1993). Similarly, rabbits immunized w ith recombinant 
FnBP had a lower bacterial count in blood and excised organs compared w ith 
controls following intravenous inoculation (Park e t a!., 1999). The protective 
potential of immunization with fusion proteins encompassing the D repeat region 
of FnBPA was also evaluated in a mouse mastitis model. Vaccinated mice showed 
a decreased number of bacteria recovered from mammary glands and 
significantly reduced cases of severe mastitis (Mamo e ta l. ,  1994). These studies 
suggested that anti-FnBP antibodies were opsonic, but the question remained as 
to the ir potential to block the interaction between FnBP and its host ligand.
Antibodies were then analysed in more detail with respect to the ir ability 
to block the interaction between FnBP and its ligand, and the epitopes which 
they recognised. Polyclonal antibodies against recombinant FnBP D repeat (gal- 
FnBPA and ZZ-FnBPB) were reported to recognize native FnBP on the cell surface 
(Rozalska e t al., 1994). The m ajority of antibodies in this study recognised a 
fibronectin-binding D1-D2 sequence of FnBPA, while anti-FnBPA Fab failed to 
bind the D3 sequence. Anti-FnBPA antibodies blocked fibronectin binding to S. 
aureus by about 50%, the investigators suggested that this m ight be explained
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by the presence of FnBP binding regions outside the D region (Rozalska e t al., 
1994). In a second study, affin ity purified antibodies from rabbits immunized 
w ith recombinant D1-D3 were poor inhibitors o f fibronectin binding to S. aureus) 
these recognised several different epitopes w ith a preference fo r clusters of 
acidic amino acids that do not contribute to fibronectin binding. A further round 
of antibodies generated using a GSTDl-3 did not promote more than 50% 
inhibition. These antibodies were found to be specific for amino acids essential 
for binding in D l;  none recognised the region containing a m otif critical for the 
binding site of D3. Antibodies specific for the binding region of D l and D3 (raised 
by immunising w ith synthetic peptides corresponding to D l24.34 and D320-33 
caused the now fam iliar 40-50%  inhibition of binding o f S. aureus to fibronectin 
(Sun et al., 1997).
One explanation for the poor ability of antibodies to block the interaction 
between FnBPs and fibronectin is that antibodies raised In vivo are 
predominantly to ligand-induced binding sites, that is, those tha t exist only after 
the FnBP-Fn Interaction has occurred. Such antibodies would be expected to 
have poor or no adherence-blocking activity, and may even enhance enhance 
ligand binding by stabilizing ligand-FnBP complexes. Furthermore, if anti-LIBS 
antibodies were present in high concentrations, they could potentia lly mask 
inhibiting antibodies, if present. Such thinking has dominated recent work which 
has aimed to generate antibodies using recombinant FnBP protein w ith preserved 
antigenic activ ity but reduced ligand-binding activity.
D2 peptide of FnBP (amino acids 1-30 of D2 which is unable to bind to 
fibronectin) was expressed on the surface of the cowpea mosaic virus or potato 
virus (Rennermalm e t al., 2001). High titres of antibodies were obtained from 
mice and rats immunized with cowpea virus, despite the fact tha t disordered 
proteins have been reported to be poor immunogens (Foster & Hook, 1998). 
Truncated D2 domain of FnBP displayed on a cowpea mosaic virus carrier 
induced protection against endocarditis in mice, afforded protection from  weight
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loss due to bacteraemla, and were opsonic in vitro  (Rennermalm e t a!., 2001). 
However, such antibodies were still only capable of partially blocking adherence 
of S. aureus to fibronectin In vitro  (Brennan e t al., 1999).
A sim ilar approach was taken by Huesca and colleagues who set out to 
elim inate the influence of fibronectin binding on antibody development (Huesca 
et al., 2000). This was achieved using synthetic peptide immunogens D I21-34 and 
D320-33 which contain a conserved pattern o f amino acids that is essential for 
fibronectin binding but which cannot bind fibronectin w ithout N- or C-terminai 
extensions. The D320-33 immunogen promoted the production o f polyclonal 
antibodies tha t were 10-fold more effective as inhibitors of fibronectin binding to 
the D3 m otif than antibodies obtained by immunizing with an extended peptide 
D3i6-36 which exhibits functional fibronectin binding. The D320-33 Immunogen also 
facilitated the production of a monoclonal antibody which was highly specific for 
the epitope SVDFEED (essential for binding), and which abolished binding by the 
D3 motif. These investigators concluded tha t by Immunizing w ith short synthetic 
peptides that are unable to bind fibronectin, antibodies were raised to epitopes 
comprised of amino acids tha t are essential for fibronectin binding. Further work 
is clearly needed since FnBP contains several ligand binding sites, and blocking 
antibodies would have to Inhibit the binding of ligand to all of these sites if 
blocking was considered to be an essential property o f an antibody response.
1.4 Evaluating the role of FnBPs in disease.
1.4.1 Experimental animal models.
Experimental endocarditis is one of the models commonly used to study 
S. aureus virulence. The aortic valve is damaged by the placement o f a catheter 
via the carotid artery. This stays in situ  for 24 hours and may be removed or 
remain in piace when a bacterial inoculum is given into a vein. Animals are then 
sacrificed and the valve examined using bacteriai counts. This model has been 
used to examine the role of FnBPs (Kuypers & Proctor, 1989). Rats inoculated
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with a transposon m utant of S. aureus 879R4S defective in fibronectin binding 
were examined after 1 hour by culturing the heart, liver and spleen. Culture of 
heart valves from catheterised rats had 250 fold fewer organisms after challenge 
with the m utant, while the number of organisms in other sites was no different. 
This was repeated using an isogenic mutant of 8325-4 defective in FnBPs (Flock 
e t al., 1996). Adherence of haematogenously spread bacteria to traumatized 
heart valves at 1 hour was not different between the m utant and wild type. 
Bacterial counts at 24 hours were comparable, and clearance o f the two strains 
did not differ. I t  is unclear why these results differ, but a later study using the 
non-pathogenic Lactococcus lactis as a bacterial expression vehicle found that 
bacteria expressing FnBPA required a lower infective dose to induce valve 
infection in the rat (Que et al., 2001).
The role of FnBPs in lung Infection has been examined using two modeis. 
In the first, the trachea of Wistar rats were removed and then frozen and thawed 
to remove surface epithelium (Mongodin e t al., 2002). Primary cultures of 
human airway epithelial cells were collected from human nasal polyps, cultured 
In vitro  and then seeded Into the rat tracheas, thereby making a humanized 
bronchiai xenograph. These were implanted into the subcutaneous tissue of the 
flanks of female nude mice for a variable period before bacteria were inoculated 
into them, left for one hour, harvested and examined using computer-assisted 
scanning eiectron microscopy. Adherence of an FnBP-defective m utant was 
compared w ith tha t of wild type to cells grown to a monlayer In vitro, and to the 
cells lining the implants. Adherence of wild type to non-ciliated and ciliated 
differentiated epithelial cells was weak In vitro, while wild type adhered to 
undifferentated cells In a FnBP-dependent manner. This pattern was reproduced 
using the implants. No bacteria bound to ciliated (differentiated) epithelium , and 
bacteria were seen to be trapped in mucus. This may have implications for 
individuals who have damaged epithelium lining the bronchiai tree, but it is 
unclear whether It has relevance to the normal host.
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The second lung model used rats Inoculated via the respiratory tract, lung 
in jury and bacterial survival being assayed at 24 and 96 hours (McElroy et al.,
2002). Growth of S. aureus and the extent of lung in jury were both increased in 
rats inoculated with S. aureus 8325-4 defective in FnBPs compared w ith rats 
inoculated w ith wild type or the m utant strain re-complemented w ith fnb  carried 
on a multicopy plasmid. FnBP positive bacteria were associated w ith increased 
elim ination at 24 hours, and reduced damage at 24 hours as defined by protein 
concentration (as a marker for damage to the air-blood barrier), and RTI40 (a 
biochemical marker o f type I cell damage). FnBP had no effect on neutrophil 
recruitment or bacterial uptake by these cells. Thus, FnBP appeared to decrease 
the virulence of S. aureus in pneumonia.
A guinea pig wound abscess model has also been used to study FnBPs, in 
which the ID50 did not differ between S. aureus 8325-4 and an isogenic m utant 
defective in FnBPs (Menzies et al., 2002).
1.4.2 in vitro models.
1.4.2.1 Libraries of ciinicai isolates.
Previous studies of FnBPs in clinical isolates encompass a relatively 
limited number of isolates (Proctor e t al., 1982; Proctor et al., 1984; Switalski et 
al., 1983). One study reported adherence of radiolabelled fibronectin to 22 of 23 
isolates (Switalski e t al., 1983). Isolates from invasive disease have also been 
reported to agglutinate more readily in fibronectin compared w ith non-invasive 
strains, although there were only 11 strains,in each group in this study (Proctor 
e t al., 1984). The presence o f at least one fnb gene has been confirmed for 25 
isolates using Southern blot analysis, but whether these possessed one or two 
fnb genes was not determined (Smeltzer et al., 1997). The finding tha t S. aureus 
879R4S possesses a single fnb gene which is homologous to fnbA (Greene et al.,
1996), suggests the presence of genetic diversity, but the extent o f th is is 
unclear.
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1.4.2.2 Interaction with prosthetic material.
Study of the adherence of S. aureus to prosthetic material has principally 
relied on the use of either segments of intravenous catheter used in an in vitro  
model, or polymethylmethacrylate coverslips implanted Into the subcutaneous 
tissues o f guinea pigs and explanted four weeks later. Adherence to explanted 
coverslips has been reported to be related to fibronectin deposits on the foreign 
body surface (Vaudaux e t a!., 1984). S. aureus also adhere to unlmplanted 
coverslips coated in fibronectin (Herrmann e t a/., 1988), or in the presence of 
serum (Vaudaux e t a/., 1984). Coating prosthetic catheters in vitro  w ith 
fibronectin or fibrinogen led to increased S. aureus adherence (Vaudaux e t a/.,
1993). S. aureus also adhered to intravenous catheters collected from adult 
hospital in-patients. Fibrinogen was found to be present on the surface of these 
catheters in a degraded form and had poor adherence-promoting properties, 
while Intact or fragmented fibronectin, although in much lower amounts, could 
actively promote adherence to catheters In vitro  (Vaudaux e t al., 1993). This 
contrasted w ith the results of a short term  model in which clean catheters were 
exposed to canine blood for up to 60 minutes. S. aureus defective in ClfA 
(fibrinogen-binding protein) but not FnBPs showed a large decrease In adherence 
(Vaudaux e f a/., 1995).
1.4.2.3 Interaction with endothelial cells.
The mechanism ieading to infection of superficial tissues is likely to be 
through local Inoculation. Similarly, the route of entry for organisms causing 
nosocomial infection occurs primarily via breaches in the normal host defences, 
for example because of surgery or the presence of an intravenous device. The 
process by which bacteria gain access to the intravascular com partm ent to cause 
community-acquired bacteraemia is unclear, as Is the reverse process by which 
S. aureus exit the intravascular compartment to seed deep sites such as bones 
and jo ints. This is a common clinical problem; bacterial metastasis from blood to
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tissues such as bones, jo in ts  and solid organs is clinically apparent in 1-53% of 
individuals with staphylococcal bacteraemia (reviewed by Ing e t a!., 1997). I t  
seems likely that bacterial metastasis involves interactions between circulating 
bacteria and vascular endothelial cells.
S. aureus has been shown to adhere to human endothelial cells in vitro  
(Ogawa e t a!., 1985; Vercellotti e t a!., 1984). This process was found to be time 
dependent (Vercellotti et al., 1984), greater for bacteria in exponential versus 
stationary growth phase (Pohlmann-Dietze et al., 2000; Tompkins e t al., 1990; 
Vriesema e t al., 2000), and markedly decreased for bacteria treated with 
proteases to remove surface proteins (Verceilotti et al., 1984). The heavily 
encapsulated M strain was reported to adhere poorly, perhaps because of surface 
masking (Vercellotti et al., 1984), evidence for which was provided by the report 
that Newman defective in capsuie adhered more to endothelial cells tha t the 
capsule positive wild type (Pohlmann-Dietze et al., 2000).
Once adhesion has occurred, S. aureus cells undergo a process akin to 
phagocytosis (Lowy e t al., 1988; Yao e t al., 1995; Vriesema e t al., 2000); 
uptake was blocked by cytochalasin B which interferes w ith m icrofilament 
function (Hamill et al., 1986). Transmission electron microscopy demonstrated 
tha t adherence was followed by formation and elongation o f surface extensions 
from the endothelial cell which surrounded and completely enclosed the bacteria 
during the uptake process (Hamill e t al., 1986). Bacterial internalization elicited 
release of the cytokines IL-6, IL-8 and IL - ip  (Yao e ta l. ,  1996; Yao e t al., 1995). 
Cytochalasin D, an inhibitor of endocytosis, prevented IL-1 and IL-6 induction 
(Yao e t al., 1995).
Uptake has also been reported to induce surface expression of 
intracellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 
and monocyte chemotactic protein-1 (MCP-1) (Veltrop e t al., 2001; Tekstra et 
al., 1999), and hyper-adhesiveness for monocytes and granulocytes (Beekhuizen 
et al., 1997; Veltrop e t al., 2001). Endothelial cells expressed tissue factor (TF)-
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dependent procoagulant activ ity (TFA) in response to ingestion o f S. aureus 
(Drake & Pang, 1988; Veltrop e t a!., 1999). Endothelial cells also expressed TFA 
after exposure to IL-1, but TFA production by S. aureus was not prevented by 
IL-1 receptor antagonist (Veltrop e t al., 1999). TF is an obligate co-factor for 
coagulation factor V ll/V IIa  and may be im portant in the development o f heart 
valve vegetations. Supernatants of p-lactam-exposed cultures o f S. aureus 
containing cell wall fragments enhanced the adhesiveness o f endothelial cells for 
granulocytes. This coincided w ith higher ICAM-1 expression, and secretion of IL- 
8 and MCP-1. These changes may have been due to the action of lipoteichoic 
acid and peptidoglycan.
Following endothelial cell uptake, S. aureus has been demonstrated both 
within vacuoles and free in the cytoplasm (Menzies & Kourteva, 1998; Ogawa et 
al., 1985). Intracellu lar bacteria do not appear to m ultipiy (Vann & Proctor, 
1987) although bacterial gene expression studies four hours a fte r internalization 
have demonstrated activation of genes involved in transport, catabolism, 
biosynthesis and DNA repair (Vriesema et al., 2000). Internalized bacteria may 
remain viable for 72 hours (Menzies & Kourteva, 1998). The subsequent fate o f 
the endothelial cell varies between studies. Cells become damaged over tim e, 
this depending on the size of bacterial inoculum, length of tim e after exposure 
and the strain of S. aureus (Vann & Proctor, 1987). Variability in cell damage 
between bacterial strains may relate to secretion of a-toxin, a haemolysin which 
is cidal to endothelial cells (Vann & Proctor, 1988). Lack of a-toxIn production 
by small colony variants may explain why these can persist in the intracellular 
niche w ithout causing endothelial cell death (Balwit e t al., 1994; von Eiff e t al.,
1997). Endothelial cell death has been reported to occur by apoptosis, a process 
dependent on Internalization of live bacteria (Menzies & Kourteva, 1998). 
Whether S. aureus can subsequently be released from the basal surface o f such 
an "infected" endothelial monolayer has not been determined. I f  the endothelial 
cells are killed before the bacteria, the la tter are released and the in tegrity  of the
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monolayer is breached. I f  either mechanism operated in vivo, bacteria would 
gain access to the sub-endothelium.
The m ajority o f clinical isolates produce capsular polysaccharide serotype 
5 or 8 (Karakawa & Vann, 1982), which when purified has been shown to bind to 
endothelial cells and result in release of IL-6 and IL-8 (Soell e t a/., 1995). 
However, this is inhibited by the presence o f pooled human serum from healthy 
blood donors (Soell e ta /., 1995). Endothelial cell activation by IL-1 or endotoxin 
had no affect on adherence (Blumberg e t a/., 1988), while human tum our 
necrosis factor was shown to enhance adhesion to glutaraldehyde-fixed 
endothelial cells in the presence of plasma (Cheung e ta /., 1991b).
Attempts to define the endothelial receptor for S. aureus adherence have 
yielded a 50kDa membrane glycoprotein on human cells (Tompkins e t a/., 
1990), and a 130kDa membrane glycoprotein on bovine cardiac endothelial cells 
(Johnson, 1993). Neither has been characterized further. Fibrinogen had been 
reported to act as a bridging molecule in adherence to glutaraldehyde fixed 
endothelial cells (Cheung e ta l. ,  1991a), w ithout definition of the cognate ligands 
for it on either cell type. The bacterial determinants tha t promote adhesion of S. 
aureus to endothelium had not been elucidated prior to the sta rt of th is thesis.
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1.5 Fibronectin-binding proteins and S. schleiferi.
1.5.1 Ciinicai manifestations of S. scb/eiferi infection.
Following the description of Staphylococcus schleiferi subsp. schleiferi in 
1988 (Freney e t al., 1988), this coagulase-negative staphylococcus has been 
identified from in-patient microbiological specimens, skin flora, and the hospital 
environment. A proportion of positive cultures arising from patient specimens 
appear to have no clinical significance (Fleurette e t al., 1989; Vandenesch e t al.,
1994). However, S. schleiferi has been clearly implicated as the causative 
pathogen in a range of nosocomial Infections including bacteraemia (Jean-Pierre 
et al., 1989; Latorre et al., 1993), brain abscess (Grattard e t al., 1993), 
pacemaker and other intravenous device-related infections (Celard e t al., 1997; 
Da Costa e t a l . ,  1998; Grattard e t a l . ,  1993), orthopaedic implant-associated 
infection (Jean-Pierre e ta l . ,  1989), wound infection (Grattard e t al., 1993), and 
urinary tract infections (Ozturkeri et al., 1994). This organism has aiso been 
associated w ith an outbreak of surgical wound Infections in 6 patients 
undergoing cardiac surgery (Kluytmans et al., 1998).
1.5.2 Pathogenic mechanisms associated with S. schleiferi infection.
The processes leading to S. schleiferi infection are unknown, but given 
the degree o f sim ilarity between the spectrum of infections caused by this 
microorganism, and those associated w ith S. aureus (Waldvogel, 2000), it is 
possible tha t the two species express one or more common virulence 
determinants. S. aureus fibronectin- and fibrinogen binding proteins may play a 
central role in the pathogenesis of colonization of medical devices through the 
interaction w ith fibrinogen and fibronectin tha t rapidly coats prosthetic material 
following insertion in vivo (Vaudaux et al., 1989; Vaudaux e t al., 1993; Vaudaux 
e t al., 1995). The clinical observation that S. schleiferi has been isolated from 
cultures of prosthetic material (Celard e t al., 1997; Grattard e t al., 1993; Jean- 
Pierre e t al., 1989; Vandenesch e t al., 1994), suggests the presence o f one or
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more bacterial cell surface-expressed adhesins w ith a sim ilar host protein 
specificity. S. schleiferi has been reported to bind fibrinogen as assessed by 
commercial agglutination kits (Hebert, 1990; Personne eta l . ,  1997; Vandenesch 
et al., 1994), but adherence to fibronectin and the identification o f cell wall- 
associated adhesins have not previously been described for this organism.
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1.6  Aims of this dissertation.
-U \ésis
The work contained in this "dissertation describes a series o f studies that
explore the role of fibronectin-binding proteins (FnBPs) in human staphylococcal
disease. Specifically, these projects:
1. Examine the role of S. aureus FnBP in adherence to, and invasion of human 
endothelial cells in vitro.
2. Examine the role of each domain of FnBPA in the interaction w ith endothelial 
cells.
3. Determine whether endothelial cell expressed integrins are involved in S. 
aureus uptake.
4. Examine whether proteases, and in particular serine (V8) protease, influence 
FnBP function, potentially modelling the bacterial cell surface and controlling 
the presence or absence of a functional adhesin.
5. Demonstrate the presence of a functional FnBP by the nosocomial pathogen 
Staphylococcus schleiferi.
6. Study phenotypic and genotypic variation In fnb genes In a large population 
of clinical isolates.
7. Determine the presence o f fnbA encoding S. aureus FnBPA, together w ith 32 
other bacterial factors, in a second bacterial population associated carriage 
and invasive disease. This was undertaken to identify virulence-associated 
genes (one of which was fnbA)) to assess the cumulative effect of virulence- 
associated genes on virulence; to Identify gene combinations, and determine 
if some combinations have a greater pathogenic potential than others; and to 
study the horizontal transfer of putative virulence determinants.
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Chapter 2. Materials and Methods.
2.1 Chemicals and reagents.
All chemicals and reagents were obtained from the Sigma-Aldrich 
Company Ltd., unless otherwise indicated. Culture media (Medium M199, 
phosphate-buffered saline and fetal calf serum) were from Gibco Life 
technologies Ltd. Falcon tissue culture plasticware was obtained from Becton 
Dickinson Ltd.
2.2 Bacterial culture and storage conditions.
(a) Liquid media: S. aureus and coagulase-negative staphylococci were 
grown in Todd Hewitt broth (THB) or Trypticase soy broth (TSB) under constant 
rotation at 37°C in air. Escherichia coii was cultured in Luria-Bertani (LB) broth 
under constant rotation at 37°C in air. L. iactis MG1363 was grown in M17 broth 
containing glucose (0.5% , w /v) static at 30°C in air. Cultures were routinely 
grown in 10ml of media contained in 35ml glass universal containers. Bacteria 
cultured prior to harvest of cell wall-associated proteins were grown in 25mi 
brain heart infusion (BHI) in 100ml flasks.
(b) Solid media: S. aureus and coagulase-negative staphylococci were grown 
on either trypticase soy agar (TSA) or 5% horse blood agar. E. coii was grown on 
Luria agar, and L. iactis dn  M17 agar. Agar plates were Incubated at 37°C in air. 
Antibiotics were incorporated into media, where appropriate, at the following 
concentrations: chloramphenicol lOpg/m l; ampicillin/50pg; tetracycline 2pg/m l; 
and erythromycin 5pg/mi. Phage base plates and phage agar were used for 
bacterial transduction.
(c) Bacteriai storage: L. iactis was suspended in M17 broth containing glucose 
(0.5%, w /v) and glycerol (15%, v /v ). S. aureus and coagulase-negative
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staphylococci were suspended in TSB containing glycerol (15%, v /v ), and E. coli 
in LB broth containing glycerol (15%, v /v ). All isolates were stored at -80°C.
Media was from obtained from Difco Laboratories and prepared by the 
Department of Microbiology, John Radcliffe Hospital who undertook weekly 
quality control.
2.3 Methodology used in studies of bacterial adherence to host proteins.
2.3.1 Adherence of staphylococci to purified human fibronectin.
Previous investigators have studied adherence of staphylococci to plasma 
and m atrix proteins in vitro using one of two methods: (i) adhesion to protein in 
solution, adherence being detected by the use of radiolabelled bacteria; or (ii) 
adherence of bacteria to host proteins absorbed onto a plastic surface, adhesion 
being measured either visually or by optical density after bacterial staining with 
Crystal violet. These methods are not directly comparable since adherence of a 
given isolate may be inconsistent between the two types of assay, (for example, 
the laboratory isolate S. aureus Newman adheres to soluble fibronectin but 
adhesion to immobilised fibronectin is poor) (Vaudaux e t ai., 1995). There is no 
consensus as to which assay should be adopted for the study of staphylococci. I t  
was decided to use adherence to immobilised proteins throughout this study, 
thereby avoiding the used of radioisotopes and providing a permanent record of 
the result.
2.3.2 Growth of bacteria for use in adherence assays.
Staphylococci normally form microscopic clumps during growth in vitro. 
This makes visual counting of bacterial adherence to proteins or host cells 
difficult. I t  could also give misleadingly high results for the number of adherent 
bacteria as assessed by either visual or indirect enumeration methods, since a 
proportion may simply be part of a clump. Could the clump size be reduced by 
gentle washing of a bacterial suspension? To answer this, the laboratory strain S.
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aureus 8325-4 was inoculated from frozen stocks into 10ml THB and incubated 
for 18 hours under constant rotation at 37°C in air. Following centrifugation at 
3,000 rpm for 10 minutes, the bacterial pellet was placed into a 1.5ml eppendorf 
and washed four times in phosphate-buffered saline (PBS) by gently pipetting up 
and down using a Gilson pipette. Bacteria from the unwashed overnight culture 
and each o f the washing steps were Gram stained. Bacteria from the overnight 
culture were clumped as expected. Each wash reduced the average size of the 
clump until bacteria washed four times were in singles, pairs or small clumps. All 
bacterial preparations used in adherence assays (to both host proteins and 
endothelial cells), subsequently underwent four washes in PBS prior to use.
2.3.3 Solid-phase fibronectin bacterial adherence assay.
The firs t objective was to standardise the adherence assay in such a way 
tha t made it robust and reproducible, and able to detect differences in adherence 
between bacterial strains. The following variable parameters were considered: 
(1) duration and conditions of bacterial culture prior to adherence assay; (2) 
incubation conditions and duration of adherence assay; (3) size of bacterial 
inoculum used in adherence assay; and (4) concentration of fibronectin. 
Parameters (1) and (2) were set at this point, growth of bacteria used in the 
assay being standardised to 15-18 hours shaking at 37°C in air, and incubation 
conditions for the adherence assay itself fixed at 1 hour static at 37°C in air. 
Parameters (3) and (4) were evaluated in pilot studies in which adherence to 
fibronectin was examined using variable inocula and a range of protein 
concentrations, as follows.
(a) Standardising the inocuium: 5. aureus 8325-4 was grown in 10ml THB for 18 
hours under constant rotation at 37°C in air, collected by centrifugation, washed 
four times in PBS and resuspended to give a series of suspensions w ith a range 
of spectrophotometer readings at ODeso- Aliquots of 100|il from each sample
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were spread over a blood agar plate (in trip licate), and incubated overnight at 
37°C in air. The number of colonies were counted and the weighted mean count 
calculated (British Standards Institu tion, 1981). Figure 2.1 shows the results for 
colony forming units per ml (cfu/m l) versus ODeso of bacterial suspension. This 
provided the basis for resuspending washed staphylococci to a known 
concentration.
Human fibronectin lO ^g/m l in PBS was spotted onto tissue culture grade 
60 X 15mm plastic petri dishes. These were incubated at 37°C in air for 1 hour, 
then flooded with bovine serum albumin (BSA, 1%, v /v ) in PBS and maintained 
overnight at 4°C. The dishes were rinsed twice in PBS immediately prior to use. 
Bacterial suspensions of overnight, washed cultures of S. aureus 8325-4 were 
adjusted by optical density (ODeso) followed where necessary by serial dilution to 
a final concentration of 1 x 10^, 1 x 10^, 5 x 10^ or 1 x 10® cfu/m l in PBS with 
BSA (1%, v /v ). A fter adding 1.5ml of a given suspension, dishes were incubated 
at 37°C in air for 1 hour, rinsed four times with PBS, fixed with glutaraldehyde 
(2%, v /v ) in PBS for 2 hours and stained with Crystal violet (0.5% , v /v ) for 5 
minutes. Adhesion was then quantitated using a visual method. The purified 
fibronectin spots were examined using a calibrated graticule under oil immersion 
with a XlOO magnification lens. The number of bacteria adherent to an area of 
Im m ^ of purified protein was enumerated by a standardised counting procedure. 
W ithout prior visual inspection, 5 high power fields were selected for counting as 
follows: (1) the centre of the protein spot; (2) two points between the centre 
and left edge; and (3) two points between the centre and right edge. Each spot 
was performed in quadruplicate in a given experiment, and independent 
experiments were performed three times, the results for which are shown in 
Figure 2.2.
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Figure 2.1 Colony forming units/mi of S. aureus 8325-4 in PBS versus ODeso of 
bacterial suspension.
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Figure 2.2 Bacterial inoculum versus number of bacteria (S. aureus 8325-4) 
adherent to 1 mm  ^of petri dish base coated with purified fibronectin 1 0 pg/ml.
Results represent the mean of triplicate experiments.
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(b) Standardising the concentration o f fibronectin: Human fibronectin l^ g /m l, 
5pg/ml or lO ^g/m l in PBS was spotted onto tissue culture grade 60 x 15mm 
plastic petri dishes. Plates were incubated and rinsed as described in (a) above. 
A bacterial suspension of an overnight, washed culture of S, aureus 8325-4 at 5 
X 10^ cfu/m l in PBS with BSA (1%, v /v ) was added to the dish, incubated, 
rinsed, fixed and counted as described in (a) above. Each spot was performed in 
quadruplicate in a given experiment, and independent experiments were 
performed three times, the results for which are shown in Figure 2.3.
Subsequent use of this type of adherence assay used a bacterial 
suspension of 5x l0^cfu /m l and fibronectin lOpg/m l. The reasons for this were 
that: (i) this gave countable numbers of bacteria in the range of approxim ately 
1000 bacteria per Im m ^ of protein for wild type bacteria; and (ii) results lay on 
the steep part of the dose response curve. Differences in adhesion (e ither up or 
down) between the controi and other bacterial strains should, therefore, be 
detectable.
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Figure 2.3 Number of bacteria (S. aureus 8325-4) adherent to 1mm  ^ of petri 
dish base versus fibronectin concentration (bacterial concentration 5 x 10^  
cfu/ml). Results represent mean ± standard error of the mean (SEM) o f trip licate 
experiments.
38
2.3.4 Microtitre plate fibronectin adherence assay using a non-visual method 
to determine bacterial adhesion.
The adherence assay above was applicable to small numbers of bacterial 
isolates (and is used for work in chapter 3), but was not tim e efficient when 
testing adherence of large numbers of bacterial isolates to fibronectin. A method 
was subsequently used for the remainder of the work based on adherence to 
protein coating the base of 96 well m icrotitre plates, in which adherence was 
assessed by optical density after staining of bacteria with Crystal violet.
Pilot studies were performed to determine working concentrations of 
bacteria and fibronectin. Growth of bacteria used in the assay was standardised 
from the outset to 15-18 hours shaking at 37°C in air, and incubation conditions 
for the adherence assay itself were fixed at 1 hour static at 37°C in air. Ninety- 
six well flat-bottom ed polystyrene m icrotitre plates (Corning Costar, NY) were 
coated for 1 hour at 37°C with lOOfxl of purified fibronectin at a concentration 
ranging from O.OOlpg/ml to lOOpg/ml. Remaining sites were blocked by 
overnight incubation at 4°C with 200pl BSA (1%, v /v ) in PBS. The plates were 
washed three times w ith PBS prior to inoculation of lOOjil washed bacterial 
suspension at a concentration of 10®, 10^, 10® or 10^ cfu/m l. A fter incubation at 
37°C in air for 1 hour, the wells were rinsed three times w ith PBS and bound 
cells were fixed w ith 200pl glutaraldehyde (2% , v /v  in PBS) for 60 minutes and 
stained w ith Crystal violet (0.5% , v /v ) for 5 minutes. The plates were rinsed w ith 
water, air-dried, and the absorbance measured at OD405 using an ELISA plate 
reader. Each fibronectin/bacterial concentration combination was performed in 
quadruplicate in a given experiment, and independent experiments were 
performed three times. All assay plates Included PBS w ithout bacteria as a 
negative control. The OD405 was taken as the mean value for a given isolate after 
subtraction of the background, (defined by the OD405 of the negative control on 
the same plate). The results are shown in Figure 2.4. Therafter, th is assay used 
lOOpI of bacterial suspension at 1 x 10^ cfu/m l and fibronectin lO fig /m l.
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Figure 2.4 Microtitre plate adherence assay: optical density (OD450) versus 
bacterial inocula (S. aureus 8325-4) and fibronectin concentration. Results 
represent mean ± SEM of triplicate experiments.
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2.3.5 Relationship between OD405 in the microtitre assay and the number of 
adherent bacteria.
Making sense of different optical density resuits between bacterial isolates 
examined using a non-visual m icrotitre plate adherence assay depends on an 
understanding of the relationship between OD405 and the actual number of 
adherent bacteria. This was evaluated as follows. Adhesion of S. aureus 8325-4 
to fibronectin lOpg/m l was performed for a range of bacterial inocula (10^, 10^, 
10^ 5 X 10^ and 10® cfu per well in lOOpI volumes) using a modification of the 
assay described above. Fibronectin was adsorbed onto 13mm Thermanox 
covers lips (Gibco) which were trimmed to f it  the bottom of 96-well assay plates. 
After the OD405 were read the covers lips were mounted onto glass slides, and the 
number of bacteria adherent to a surface area of Im m ^ counted using a 
calibrated graticule under oil immersion at XlOO magnification. Quadruplicate 
covers lips were used per assay at each bacterial concentration, and independent 
assays were performed in triplicate. The results obtained demonstrated a linear 
relationship between OD405 and adherence to fibronectin over the range of OD405 
values obtained for clinical isolates (Fig. 2.5).
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Figure 2.5 Number of bacteria (S. aureus 8325-4) adherent to 1mm  ^ of 
Thermanox coverslip coated with purified fibronectin 10pig/ml versus optical 
density (OD405). Results represent mean ± SEM o f triplicate experiments.
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2.4 Endothelial cell assays.
2.4.1 Endothelial cell culture.
Endothelial cells were obtained from human newborn umbilical vein using 
an adaptation of a previously described method (Jaffe & Mosher, 1978). Both 
ends of the cord vein were cannulated using a Portex luerlock adaptor (Southern 
Syringe Ltd.), after which the vessel was flushed with PBS. Cells were released 
by instilling M199 supplemented with penicillin 50U/ml (Gibco), streptomycin 
50pg/ml (Gibco) and collagenase type lA  0.5m g/m l into the vessel lumen. After 
incubation for 20 minutes at 37°C in 5% COzthe cell suspension was collected by 
centrifugation, resuspended in M199 supplemented with fetal calf serum (20%, 
v /v ), heparin 90^g/m l, recombinant fibroblast growth factor 5ng/m l, penicillin 
50U/ml and streptomycin 50U/ml and seeded into a 25cm^ tissue culture flask. 
Cells were maintained at 37°C in 5% CO2 and passaged twice on reaching 
confluence using a 1:3 split, before subculture onto 13mm Thermanox covers lips 
in 24-well tissue culture plates. All flasks and covers lips used in cell culture were 
pre-coated w ith gelatin (0.2% , v /v ) overnight at 37°C.
The identity of the cells was confirmed as endothelial by the ir cobblestone 
appearance at confluency, and positive staining for von Willebrand factor (vWF) 
(Jaffe et a!., 1973). In brief, confluent endothelial cells were lifted from the 
tissue culture flask by Incubating with 2mM EDTA in PBS, resuspended in growth 
media and spun onto a glass slide using a cytospin. After drying for 8 hours at 
room temperature, cells were fixed with acetone and incubated w ith mouse 
antibody to vWF (1:250, Dako) for 30 minutes. After rinsing, horseradish 
peroxidase-conjugated goat anti-mouse antibody was added (1:200, Dako) for 
30 minutes followed by DAB (peroxide substrate, 3-3 diaminobenzidine). A 
negative control (no mouse antibody to vWF) was performed in parallel. Slides 
were dipped in haematoxylin to give background staining of the cells, then 
covered w ith coverslips using aquamount. Representative views of the results 
are shown in Figure 2.6.
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Figure 2.6 Staining of human endothelial cells for von Willebrand factor. Top
view, negative control; bottom view, cytoplasmic staining of von Willebrand 
factor. Light microscopy, X40 magnification.
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2.4.2 Immunofluorescence of endothelial cell surface receptors.
A brief description of the technique will be given here, as a more detailed 
account of the receptors examined has been provided in chapter 3. Confluent 
endothelial cells on Thermanox coverslips were dip-washed three times and 
placed into 24-well plates containing SOOpI M199. Added to this was a mouse 
monoclonal or rabbit polyclonal antibody recognizing the receptor of interest at a 
dilution of 1:200. Coverslips were incubated at 37°C in CO2 for 30 minutes, dip- 
washed, and placed into fresh 24-well plates containing FITC-labelled anti-mouse 
antibody (F0479, Dako) or anti-rabbit antibody (API32F, Chemicon) 1:200 in 
M199. After a further 30 minutes at 37°C in CO2, cells were rinsed, the 
coverslips mounted onto glass slides and examined using a fluorescence 
microscope (Zeiss).
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2.4.3 Bacterial preparation for endotheiial cell adherence assay.
S. aureus isolates were inoculated from frozen stocks into THB and 
incubated for 15 to 18 hours under constant rotation at 37°C in air. S. aureus 
containing plasmids were cultured in THB supplemented w ith antibiotics to 
maintain plasmid selection, as appropriate. Bacteria were collected from broth 
culture by centrifugation at 3,000 rpm for 10 minutes, washed four times with 
PBS, resuspended in Medium M199 with Earle's salt and 25mM HEPES, (M199) 
and filtered through a sterile 5pm filte r (Gelman Sciences) to remove any 
remaining bacterial aggregates. A subsequent Gram stain showed the cell 
suspension to comprise bacteria singly or in pairs. Final bacterial concentrations 
were adjusted to an ODeso of 0.90-0.94 corresponding to 1 x 10® cfu/m l.
2.4.4 Endothelial cell adherence assay.
Sterile 24-well flat-bottomed tissue culture plates were blocked w ith BSA 
(1%, v /v ) for 1 hour and rinsed twice with PBS. A bacterial inoculum of 10® cfu 
suspended in 500 pi M199 was added to each well. This inoculum was selected 
on the basis of dose response curves, the results for which are shown in Figure 
2.7. Confluent endothelial cells coating 13mm Thermanox coverslips were added 
after dip-washing three times in M199 to remove traces of culture media. The 
24-well plates were incubated at 37°C in CO2 for 1 hour. This incubation period 
was selected on the basis of time course studies, the results for which are shown 
in Figure 2.8. The coverslips were then dip-washed three times in M199 and 
once in PBS to remove non-associated bacteria. The endothelial cells were fixed 
with Cytofix, air dried, and stained with Crystal vio let (0.5% , v /v ) for five 
minutes. Following dip rinsing in water the coverslips were air dried and 
mounted on glass slides.
The number of endothelial cell-associated bacteria were quantitated using 
a visual method. The bacterial count included both adherent and internalized 
bacteria, but for simplicity bacteria are referred to as adherent in the remainder
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of the text when referring to this assay. Bacteria prepared for the adhesion 
assay as described above were shown not to divide over the course o f an hour in 
binding medium (see Fig. 2.9), making the number of visualized bacteria an 
accurate representation of those that had adhered. Each coverslip was scanned 
under low power to ensure confluence and in tegrity of the monolayer. Using a 
calibrated graticule under oil immersion and a XlOO magnification lens, the 
number o f bacteria associated with Im m ^ of confluent endothelial cells was 
enumerated by a standardised counting procedure. W ithout prior visual 
inspection at high power, 5 fields were selected for counting as follows: (1) the 
centre of the coverslip; (2) two points between the centre and le ft edge; and (3) 
two points between the centre and right edge. Light microscopy views of the 
endothelial cell monolayer following a standardised adherence assay are shown 
in Figure 2.10.
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Figure 2.7 Number of bacteria (S. aureus 8325-4) adherent to 1mm  ^ of 
endothelial monolayer over a range of bacterial inocula. Bacterial inocula of 
10^ 10^, 10®, or 10® cfu per well were added to confluent endothelial cells 
coating 13mm Thermanox coverslips in 24-well plates. Coverslips were washed, 
fixed and stained after incubation at 37°C in CO2 for 1 hour. The bacterial count 
per m m ^of endothelium was enumerated visually. Results represent the mean of 
triplicate experiments. .
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Figure 2.8 Number of bacteria (S. aureus 8325-4) adherent to 1mm  ^ of 
endotheiiai monoiayer over an incubation time course. A bacterial inoculum of 
10® cfu per well was added to confluent endothelial cells coating 13mm 
Thermanox coverslips in 24-weii piates. Coversiips were washed, fixed and 
stained after incubation at 37°C in CO2 for 30, 60 or 120 minutes. The bacteriai 
count per mm^ of endotheiium was enumerated visualiy. Resuits represent the 
mean of tripiicate experiments.
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Figure 2.9 Growth curve of S. aureus 8325-4 following suspension in binding 
media used in endothelial cell adherence assay. A washed bacterial suspension 
at a concentration of 10® cfu/m l in binding media was incubated at 37°C in CO2 
(to reproduce growth conditions used in the endothelial cell adherence assay). 
The subsequent growth curve was examined over a tim e course of 180 minutes 
using agar plate counts. Results represent the mean of trip licate experiments.
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Figure 2.10 Endothélial cell monolayer under light microscopy. Top view, 
endothelial cells sham-treated (no bacteria) during the assay, XIO magnification; 
bottom view, endothelial cells following standardised adherence assay, XlOO 
magnification.
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2.4.5 Endothelial cell adherence assay examined by scanning and
transmission electron microscopy.
Scanning and transmission electron microscopy (SEM and TEM,
respectively), of endothelial cell adherence assays were performed by Dr David 
Ferguson, Nuffield Department of Clinical Laboratory Sciences, University of 
Oxford. SEM was performed using endothelial cells on Thermanox coverslips 
following the adherence assay described above. This captures the assay with 
both adherent and internalized bacteria. Colour enhanced SEM views are shown 
in Figure 2.11. Bacteria appeared to be adherent to the monolayer, and were 
undergoing a process of uptake by the endothelial cell. Uptake appeared to be 
an active process, w ith endothelial cell projections (filaments and folds) seeming 
to envelop the bacteria. TEM was again performed following the standardised 
assay, with the exception that the monolayer was grown to confluence on
Transwells. TEM views are shown in Figure 2.12. Bacteria can be seen both
adherent to the endothelial cell surface, and in an intracellular location following 
uptake by the endothelial cell.
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Figure 2.11 Endothelial cell adherence assay examined by scanning electron 
microscopy. Colour enhanced views at a magnification of X8,800 (top view), 
and X17,500 (bottom view).
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Figure 2.12 Endothelial cell adherence assay exam ined by transm iss ion  
electron m icroscopy. Magnification X2500 (top view), and X IO ,000 (bottom 
view).
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2.4.6 Endothelial cell internalization assay for S. aureus.
Internalization of S. aureus by endothelial cells was evaluated by 
incubating the monolayer with lysostaphin at the end of the adherence assay. 
This has been shown to remove S. aureus adherent to the monolayer but does 
not affect the viab ility  of internalized bacteria (Vann & Proctor, 1987). The 
endothelial cell adhesion assay was performed using the method described 
above, at the end of which coverslips were rinsed three times in M199 and 
placed into 24-well plates containing lysostaphin at lOpg/m l in M199. These 
were incubated for 20 minutes at 37°C in CO2 then fixed and stained as before. 
Crystal vio let penetrated the endothelial cell and stain internalized bacteria.
Internalization of S. aureus was also examined in a second assay in which 
10® cfu were centrifuged onto the surface of the endothelium during a 5 minute 
spin at 1,000 rpm. The adherence assay was then allowed to continue over 1 
hour at 37°C in CO2, followed by lysostaphin treatm ent as described above. 
Coverslips were rinsed, fixed, and stained, and the numbers of bacteria per mm^ 
counted using the standardised counting procedure.
2.4.7 Endothelial ceil Internalization assay for L. lactis.
An alternative method was devised to measure invasion of endothelial 
cells by L  lactis expressing S. aureus adhesins, as the enzymes used to lyse 
external bacteria (mutanolysin and lysozyme) cause efficient bacterial cell lysis 
and death but do not result in effective bacterial removal from the endothelial 
cell surface, making visual counting unreliable. Sterile 24-well tissue culture 
plates were blocked with BSA (1%, v /v ) for 1 hour and rinsed twice w ith PBS. A 
washed bacterial Inoculum of 10® cfu/m l suspended in SOOpI M199 was added to 
each well. Confluent endothelial cells on Thermanox coverslips were added after 
dip-washing three times in M199, and the plates were incubated at 37°C in CO2 
for 1 hour. The coverslips were rinsed three times in M199 and placed into 24- 
well plates containing gentamicin 200pg/ml and Incubated at 37°C in CO2 for 1
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hour to kill extracellular bacteria. The coverslips were rinsed in PBS and the 
internalized bacteria released by incubating the coverslips in SOOpI PBS 
containing 1% Triton XlOO for 20 minutes at room temperature. Appropriate 
dilutions were plated onto M17 agar, and the number of colonies counted after 
overnight incubation at 30°C in air.
2.5 Methods used to evaluate cell wall-associated and secreted 
staphylococcal proteins.
2.5.1 Quantitative determination of total protease activity in S. aureus culture 
supernatant.
Isolates were Inoculated from frozen stocks into 10ml of TSB and 
incubated for 15 to 18 hours under constant rotation at 37°C in air. The culture 
was centrifuged at 3,000 rpm for 10 minutes, and the supernatant concentrated 
20 times using a Centricon-10 (Amicon). Quantitative determ ination of total 
protease activ ity in the 20-fold concentrated culture supernatants was performed 
using a protease assay kit according to the manufacturer's instructions 
(Calbiochem). In brief, fiuorescein thiocarbamoyl-casein derivative (FTC-casein) 
was incubated with the sample for 24 hours at 37°C. Trichloracetic acid (5%, 
w /v) was added to precipitate FTC-casein not cleaved into TCA-soluble peptides 
by protease activity. The sample was centrifuged and the absorbance of the 
supernatant measured at 492nm. A standard curve using V8 protease 
demonstrated that the intensity of colour was proportional to concentration.
2.5.2 Removal of surface proteins with proteinase K.
Bacteria were incubated in TSB for 15 to 18 hours under constant rotation 
at 37°C in air then centrifuged at 3,000 rpm for 10 minutes. The bacterial pellet 
from a 10ml culture was resuspended In proteinase K (500ng in 0.5m l o f 0.05M 
Tris pH 7.5) and incubated at 37°C for 45 minutes. Reactions were term inated 
by the addition of 30|liI of the proteinase K inhib itor phenylmethylsulfonyl fluoride
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(PMSF) at 4°C for 5 minutes, with centrifugation at 7,000 rpm for 10 minutes 
between and after treatments. The absence of residuai enzymatic activ ity was 
confirmed using geiatin on the surface of an unprocessed Kodak X-Omat film  as 
the substrate for proteolytic activity. A 50pi aliquot was applied onto a film  which 
was incubated in a moist chamber for 1 hour at 37°C and then washed in 
running water. PBS was used as a negative control, and 50pi of bacterial 
suspension treated with proteinase K alone was used as a positive control. A 
clear halo on the film  at the site of application was considered positive.
2.5.3 Preparation of cell wall-associated protein extracts.
Overnight cultures of S. aureus were sub-cuitured into 25mis of BHI to 
achieve an initial ODeoo of 0.1 and incubated with shaking at 37°C to an ODeoo of 
0.8. Ceils were harvested by centrifugation at 5,000 x g for 10 minutes, washed 
in PBS and adjusted to 10^° cfu/m l in raffinose (30% , w /v) prepared in Tris-HCi 
(0.05M) pH 7.5 and NaCI (0.145M) supplemented with a m ixture of proteinase 
inhibitors (Complete™, Boehringer Mannheim). Ceil wall proteins were released 
from protoplasts by incubating with lysostaphin lOOpg/mi (AMBI) at 37°C for 20 
minutes. The lysate was centrifuged at 12,000 x g for 10 m inutes, the 
supernatant containing extracted ceil wail proteins being removed and stored at 
-80°C.
2.5.4 SDS-polyacrylamide gel electrophoresis (PAGE) and Western ligand 
affinity blotting or immunoblotting.
Supernatant containing extracted cell wall proteins were boiled for 10 
minutes in an equal volume of sodium dodecyi sulfate (SDS)-sampie buffer 
(0.125 M Tris-HCi, pH 6.8; SDS 4%, w /v ; glycerol 20%, v /v ; p-mercaptoethanoi 
10%, v /v ; and bromophenoi blue 0.002%, w /v), and separated by SDS-PAGE 
using a 4.5%  to 10% acryiamide gradient using standard methods (Laemmii, 
1970). Proteins were transferred eiectrophoreticaiiy to PVDF Western blotting
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membrane (Boehringer Mannheim) by the semi-dry transblot system (BioRad) in 
Tris-HCi pH 8.3 (48mM), glycine (39mM) and methanol (20% ). Membranes were 
incubated for 15 hours at 4°C in lOmM Tris/HCi (pH 8.0), 500mM NaCi, 0.1% 
Tween 20 (TBST) containing BSA (2.5% , w /v).
Fibronectin-binding proteins were detected by ligand a ffin ity blotting or 
immunoblotting. In the former, the membrane was incubated w ith pure human 
fibronectin (Chemicon In t.) 30pg/mi in TBST. After rinsing in TBST the 
membrane was incubated w ith monoclonal antibody Mab-1936 raised against the 
N-terminus of fibronectin (1:5000, Chemicon) followed by peroxidase-conjugated 
anti-mouse antibody (1:10,000, Amersham In t.). Detection was enhanced by 
chemiiuminescence (Boehringer Mannheim) as instructed by the manufacturer. 
Imm unoblotting was performed using polyclonal rabbit antibody to fibronectin- 
binding protein (1:2000, provided by Professor's M. Hook and M. McGavin), and 
aikaline-phosphatase conjugated protein A (1:2000) as the detection reagent.
Western immunoblotting was used to detect serine (V8) protease 
production by S. aureus using rabbit polyclonal anti-V8 protease antibody 
(1:2000, a g ift from Dr S. Arvidson), followed by peroxidase-conjugated goat 
anti-rabbit immunoglobulin (1:2000, Dako).
2.6 Molecular biology techniques.
2.6.1 Phage transduction.
Phage plate stock: The bacterial strain containing the marker to be 
transduced was incubated with shaking overnight in THB at 37°C in air. A 20pi 
aliquot was diluted in 2mi of phage broth containing lOmM calcium chloride and 
incubated at 37°C in air with shaking for 4 hours. Phage 85 stock was diluted 
from 10'^ to 10’  ^ in phage broth containing lOmM calcium chloride, and 300pi of 
bacterial ceils were added to 200pl of phage at each concentration. A fter 30 
minutes at room temperature, lOmi of molten phage agar at 55°C containing 
lOmM calcium chloride was added and the mixture immediately poured over two
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phage base plates. The plates were placed base down In a plastic bag to prevent 
drying and incubated at 37°C in air overnight, then examined visually to identify 
the plate with the highest dilution to give confluent lysis. The top layer was 
scraped off from this plate and centrifuged at 15,000 rpm for 10 minutes. The 
supernatant was filtered through a 0.45pm filter, checked for s te rility  by plating 
lOpi onto a blood agar plate which was incubated overnight at 37°C in air, and 
stored at 4°C.
Phage transduction: Recipient bacteria were grown overnight in 20mi of 
TSB in a 250mi flask with shaking at 37°C in air, centrifuged at 10,000 rpm for 
10 minutes at 4°C and resuspended in Im i of TSB. 500pl of bacterial cells were 
added to Im i of LB containing lOmM calcium chloride and heated to 56°C in a 
water bath for 2 minutes, after which 1ml of phage containing the marker to be 
transduced was added. The control was 500pi bacterial cells and 1.5mi LB with 
calcium chloride minus phage. These were incubated at 37°C in a water bath for 
25 minutes then transferred to ice where Im i of ice cold 0.02M sodium citrate 
was added. This was spun at 10,000 rpm for 10 minutes at 4°C and the ceils 
resuspended in 1ml of 0.02M sodium citrate and left on ice for 2 hours. Aliquots 
of lOOpi were then spread onto TSA plates containing 0.05% sodium citrate and 
the appropriate antibiotic to select for the marker, and incubated for 48 hours at 
37°C in air. Single colonies were plated to blood agar, and the presence of the 
transduced marker verified by PCR and phenotypic assay.
2.6.2 Competent cells.
E. coil: Two m illilitres of an overnight culture of DH5a or X L l-b iue  in LB 
media was added to 400 mi of fresh LB in a 2 litre glass flask and incubated at 
37°C in air with shaking for 2-2.5 hours until the ceils reached 0.4-0.5 at OD500. 
Cells were chilled on ice for 1 hour and spun at 4,000 x g for 10 m inutes at 4°C. 
The pellet was resuspended in 30mi ice cold lOOmMgCiz, spun again as above, 
resuspended in 100ml ice cold lOOmM CaCiz and placed on ice fo r an hour. Ceils
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were spun and resuspended in 20mi fresh CaCiz to which 3mi of giyceroi (80%, 
v /v ) was gradually added. Cells were aliquoted, snap frozen in liquid nitrogen 
and stored at -80°C until required.
S. aureus: Three m illilitres of an overnight culture grown in TSB was 
added to 500mi of LB and incubated with shaking at 37°C in air to an OD450 of 
0.2. Ceils were chilled on ice for 10 minutes and harvested by centrifugation at
3,000 X g for 10 minutes at 4°C. The pellet was washed twice w ith 50mi of ice 
cold 0.5M sucrose and finally resuspended in Im i of the same solution. After 
maintaining the ceils on ice for 20 minutes the ceils were harvested and 
resuspended in Im i ice cold 0.5M sucrose, aliquoted, snap frozen in liquid 
nitrogen and stored at -80°C until required.
L  lactis: An overnight culture was diluted 1:100 in M17 supplemented 
with 2.5% glycine and incubated at 30°C static for approximately 6 hours to 
reach 0 .5-0 .6 at ODeoo- The ceils were then treated as described for S. aureus 
above.
2.6.3 Transformation and electroporation.
E. coli: cells were transformed following CaCiz treatm ent {Sambrook e t 
al., 1989). In brief, 200pi of competent ceils were added to 20pi of plasmid DNA 
and placed on ice for 30 minutes, then heat shocked at 42°C fo r 2 minutes. A fter 
a further 2 minutes on ice, Im i of LB was added and the m ixture incubated in a 
water bath at 37°C for 1 hour. Neat and concentrated suspension (lOOpi of each) 
was then plated onto Luria agar containing the appropriate antibiotic.
S. aureus: recombinant plasmids constructed in E. coli cannot be 
transformed into, or inherited stably by, wild type or even restriction-deficient 
mutants of S. aureus such as 879R4 or 80CR3 (Stobberingh & Winkler, 1977). 
Strain RN4220 is used as the first host for receiving chimaeric plasmids. This is 
defective in a restriction modification system but must carry an additional 
mutation tha t allows chimaeric plasmids transferred from E. coll to be inherited
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stably. Once established in RN4220 the plasmids are easily transferred to other 
strains by electroporation or transduction.
The methodology used to transform S. aureus by electroporation was as 
follows. Electroporation was carried out using 200pi of competent ceil 
suspension. Ceils were mixed with 0.1 to l.Opg of plasmid DNA and placed in a 
Gene Puiser cuvette with a 0.2cm electrode gap. The settings for transformation 
were voltage, 2.5kV; capacitor, 25pF; and resistance, lOOohms. After 
electroporation the ceils were immediately placed in 300pi of TSB and incubated 
with shaking at 37°C in air, then plated onto TSA containing the appropriate 
antibiotic.
L. lactis: electroporation was carried out as above, except tha t 
electroporated ceils were suspended in Im i of M17, chilled on ice for 10 minutes 
then incubated at 30°C for 2 hours. These were plated onto M17 agar containing 
the appropriate antibiotic.
2.6.4 Extraction of genomic DNA.
Genomic DNA was extracted from S. aureus and coaguiase-negative 
staphylococci using a genomic DNA purification k it using the manufacturer's 
instructions (Advanced Genetic Technologies Corp.), modified by the addition of 
lysostaphin lOU/m i (Ambi) to each sample at the lysis step.
2.6.5 Manipulation of DNA.
DNA manipulations were performed by standard procedures (Sambrook e t 
a/., 1989). Restriction enzymes were purchased from New England BioLabs or 
from Boehringer Mannheim and were used as recommended by the suppliers. 
DNA amplified by PCR and used in cloning experiments was purified by Wizard® 
PCR Preps DNA purification system (Promega Corp.). Plasmid DNA for cloning 
was purified by WizardPius® minipreps (Promega Corp.), w ith the addition of
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either mutanoiysin (500U/m i) and iysozyme (200pg/m i), or lysostaphin (lO U /m i) 
in the ceii resuspension buffer to iyse L  lactis and S. aureus, respectively.
2.6.6 Polymerase chain reaction.
PCR amplifications were performed in a DNA thermal cycler (Perkin-Eimer 
Cetus) or a PTC-200 Peltier thermal cycler (MJ Research) using Taq or Pfu 
polymerase (Boehringer Mannheim). Final concentrations of PCR reaction 
components were IX  PCR buffer, 0.2mM of each dNTP, variable magnesium 
(detailed in later chapters), lOOpmoi of forward and reverse primers, template 
DNA and 2.5U units of polymerase in a lOOpi volume. Cycling parameters are 
provided in the relevant chapters.
2.6.7 Southern hybridization.
Probes were made using PCR based DIG-iabeiiing. DNA fragments were 
generated by PCR amplification using sequences in the GenBank database, 
details of which are given in subsequent chapters. Aliquots of the PCR reaction 
mixtures were analyzed by 1% agarose gel electrophoresis, purified by means of 
a DNA extraction k it (Boehringer Mannheim) and DIG-dUTP labelled by PCR 
using the method recommended by the suppliers (Boehringer Mannheim). DNA 
hybridization was otherwise performed by the method of Southern (Southern, 
1975). In brief, genomic DNA was digested with one or more restriction enzymes 
and run on a 1.5% agarose gel. The DNA was depurinated, denatured, 
neutralized and then transferred onto a nylon membrane by capillary transfer. 
DNA was fixed by baking at 80°C for 10 minutes. Membranes were prehybridized 
for 4 hours at 68°C, then hybidized overnight using 1.5pi/m i of probe. 
Membranes were then washed and developed using anti-DIG antibody and 
chemoiuminescent detection. Where dot blots were used, 2pi of genomic DNA 
was spotted onto nylon membrane, fixed by baking and hybridized as above.
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2.6.8 Constructing a defective bacterial mutant using allelic replacement.
Allelic replacement by recombination allows a mutation tha t has been 
deliberately constructed in a cloned gene to be introduced into the chromosome 
by homologous recombination. This approach was used to construct a S. aureus 
m utant defective in serine (V8) protease. Details are provided in chapter 5, but 
the principles on which this was based are shown in Figure 2.13.
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Figure 2.13. Plasmid integration and excision. The plasmid integrates into the 
chromosomai iocus by a single cross-over event, and subsequently excises by a 
recombination event on the opposite side of the chromosomai iocus. The wiid 
type gene is thus replaced by the m utant copy.
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2.6.9 Protein constructs and their expression by S. aureus and L. lactis.
Construction of piasmids encoding one or more regions of S. aureus 
fibronectin-binding protein A and protein expression by S. aureus and L  lactis 
was used extensiveiy in chapter 3 where it is described in detaii.
2.7 Statistical analysis.
Resuits for the numbers of bacteria adherent to purified fibronectin where 
visuai counting was used, or adherent to or internaiized by endothelium, were 
expressed as the mean count per Im m ^ surface area. Ail points were performed 
in tripiicate or quadruplicate and each experiment was performed three times. 
Statisticai anaiysis was carried out using the Statview 4.5 statisticai software 
package (Abacus). Comparison of the mean count between bacteriai strains was 
performed using a t-test. For the non-visual m icrotitre piate adherence assay, all 
points were performed in quadrupiicate and each experiment was performed 
three times. Comparison was then made between the mean opticai density. 
Other statistical tests used are described in subsequent chapters.
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Chapter 3. Bacterial fibronectin-binding proteins and endothelial cell 
surface fibronectin mediate adherence and invasion of human 
endothelial cells by S. aureus.
3.1 Chapter content.
The bacterial determinants that promote adherence and invasion of 
endothelium by S. aureus in vitro  had not been elucidated prior to the start of 
this work. The aim of this study was to evaluate the role of a number of bacterial 
surface structures in this process. The basic approach taken was to compare the 
adherence of a range of defective bacterial mutants with tha t of the isogenic 
parent. The bacteriai determinants chosen were those known to interact with 
human soluble and/or m atrix proteins at the beginning of the thesis. The 
experimental system used to determine adherence and subsequent bacteriai 
uptake was a standardised endothelial ceil assay, as described in chapter 2.
3.2 Bacterial strains.
The laboratory strains of S. aureus used, and their sources, are listed in 
Table 1. The clinical S. aureus strains JR75, JR76, JR77, JR78, and JR80 were 
isolated in the Oxford microbiology department in 1995 from blood cultures of 
patients with native valve endocarditis. Phillips and a m utant strain o f Phillips 
defective in coiiagen-binding protein (PHIOO) were gifts from Drs. Magnus Hook 
and Jo Patti, Texas. The fnbAwTc^ fnbB::Em'^ mutations (the double m utation for 
genes encoding fibronectin-binding proteins A and B) were co-transduced from 
DU5883 to strains PI and JR80 by phage 85 mediated transduction (Asheshov, 
1966), to construct strains DU5947 and DU5953, respectively. Transductants 
resistant to tetracycline 2pg/mi and erythromycin lOpg/m l were selected. The 
lack of adherence to purified human fibronectin lO ^g/m i was confirmed by 
m icrotitre adherence assay.
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Table 3.1 Strains of S. aureus used in this study.
Strain Relevant
genotype
Properties Reference or 
source
S. a u r e u s  
8325-4 NCTC 8325 cured of prophages (Novick, 1967)
DU5883 f n b A : : T d ^  f n b B :  \E m ^ Mutant strain of 8325-4 defective in 
fibronectin-binding proteins A and B
(Greene e t a ! . ,  
1995)
DU5883
(pFNBA4)
fn b A '.  :T c ^  f n b B \ : E m ^  
{ p E N B A 4 : f n b A ^  Cm"^ )
Mutant strain of 8325-4 defective in 
fibronectin-binding proteins, complemented 
with multicopy plasmid expressing fn b A '^
(Greene e t a L ,  
1995)
DU5883
(pFNBB4)
f n b A :  :T c '^  f n b B :  \E m ^  
(pFNBB4^%68+ Cm"^ )
Mutant strain of 8325-4 defective in 
fibronectin-binding proteins, complemented 
with multicopy plasmid expressing f n b B ^
(Greene e t  a l . ,  
1995)
DU5880 c//7\::Tn9i7(Em'^) Mutant strain of 8325-4 defective in 
fibrinogen-binding protein ClfA
(McDevitt e t  a l . ,  
1994)
DU5857 Acoa: :Em"^ Mutant strain of 8325-4 defective in 
coagulase
(Phonimdaeng e t  
a l . ,  1990)
DU5875 AspaxTc"^ Mutant strain of 8325-4 defective in 
protein A
(Patei e t a ! . ,  1987)
Phillips Clinical osteomyelitis isolate expressing 
coiiagen-binding protein
(Patti e t a ! . ,  
1994b)
PHIOO cna: :Gm* Mutant strain of Phillips defective in 
collagen-binding protein
(Patti e t a ! . ,  
1994b)
Newman High level of fibrinogen-binding protein CifA (Duthie & Lorenz, 
1952)
DU5917 cps::Tn977 (Em'^) Mutant strain of Newman defective in 
capsular polysaccharide
(Sau e t a ! . ,  1997)
PI Isolated from a rabbit inoculated with 
ATCC 25923
(Sherertz e t  a ! . ,  
1993)
DU5947 f n b A : : T c ^  f n b B r . E m ^ Mutant strain of PI defective in fibronectin- 
binding proteins A and B
This study
DU5908 c l f A : : T n 9 1 7 { E m ^ ) Mutant strain of PI defective in fibrinogen- 
binding protein CifA
TJ Foster
JR80 Isolate from a patient with endocarditis This study
DU5953 f n b A ’. :T c ^  f n b B ’.:E n ) '^ Mutant strain of JR80 defective in 
fibronectin-binding proteins A and B
This study
Em, erythromycin; Cm, chioramphenicoi; Tc, tetracycline; Gm, gentamicin.
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3.3 Results.
Experimental results for endothelial ceii assays are shown throughout as 
the mean of trip licate experiments ± standard error of the mean.
3.3.1 Isogenic mutants deficient in fibronectin-binding protein demonstrate 
reduced adherence to endotheiiai ceils.
Adhesion to endothelium was compared for the isogenic mutants and 
parental strains shown in Table 1. Evaluation of 8325-4 and related mutants 
demonstrated a significant reduction in the number of adherent bacteria for the 
8325-4 m utant deficient in FnBPA and FnBPB (P = 0.0008, Fig. 3.1). This 
contrasted w ith 8325-4 mutants defective in coagulase, protein A or fibrinogen- 
binding protein ClfA, for which adhesion was unaffected (P > 0.05, Fig. 3.1).
There was no difference between strain Newman and its isogenic m utant 
defective in capsular polysaccharide (P > 0.05, Fig. 3.2), or strain Phillips and its 
isogenic m utant defective in coiiagen-binding protein (P > 0.05, Fig. 3.2). 
Reduction in adherence of the 8325-4 FnBP-deficient m utant was reproducible 
using FnBP-deficient mutants of strains PI and JR80 whose adherence was 9.2% 
and 14.7% respectively, compared with tha t for the parent strains (P < 0.0001 
in both cases. Fig 3.3).
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Figure 3.1 Adherence of S. aureus mutants to human endothelial cells in vitro.
Isogenic mutants of 8325-4 were defective in coaguiase (coa), the fibrinogen- 
binding protein CifA, fibronectin-binding proteins FnBPA and FnBPB, or protein A.
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Figure 3.2 Adherence of S. aureus mutants to human endothelial cells in vitro.
Isogenic mutants of Newman and Phillips were defective in capsular 
polysaccharide (cps) and coiiagen-binding protein (cna), respectiveiy.
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Figure 3.3 Adherence of FnBP-defective S. aureus  mutants to human 
endothelial cells in  vitro. Isogenic mutants with three different genetic 
backgrounds defective in fibronectin-binding proteins FnBPA and FnBPB.
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3.3.2 Complementation of 8325-4 FnBP-deficient mutant with a multicopy 
plasmid carrying an fnb gene restores bacterial adherence to endothelial cells.
Further evidence for the involvement of S. aureus FnBP in bacteriai 
adherence to endotheiiai ceiis was provided by adhesion assays using the 8325-4 
FnBP-deficient m utant complemented with a multicopy piasmid carrying either 
fnbA (pFNBA4) or fnbB (pFNBB4). Adherence was fu iiy  restored, both 
compiemented stains demonstrating significantiy greater ieveis of adhesion than 
that of the FnBP-deficient m utant (P < 0.0001 and P = 0.0003, respectiveiy), 
and wiid type (P = 0.0012 and 0.0024, respectiveiy), (Fig. 3.4).
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Figure 3.4 Effect of complementation of FnBP-defective S. aureus  mutants 
with fnbA  or fnbB  on adherence to endothelial cells in  vitro. S. aureus 8325-4 
FnBPA+B' is the doubie FnBP mutant complemented w ith pFNBA4 encoding fnbA, 
and 8325-4 FnBPA'B^ is the double FnBP m utant complemented w ith pFNBB4 
encoding fnbB.
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3.3.3 The recombinant form of the ligand-binding region of Streptococcus 
dysgalactiae FnBPB inhibits adherence of S. aureus to endothelial cells.
The involvement of region D of S. aureus FnBP (a region w ith iigand 
binding activity) in the interaction between this organism and human endotheiiai 
ceiis was evaiuated by competitive adherence inhibition assays using the 
recombinant form of the binding region of FnBPB from Streptococcus 
dysgalactiae (rFNBD-B, a g ift from Dr. Magnus Hook, Texas, referred to beiow as 
rFNBD protein). This protein has been shown to inhib it the binding of I- 
iabeiied intact fibronectin or the N-terminai fibronectin domain to S. aureus (Job 
et al., 1994). Endotheiiai ceii adhesion assays were performed using the method 
described in chapter 2, with the exception that rFNBD protein was added to the 
weiis at a final concentration of l^ ig /m i, lOpg/m i or SO^g/ml immediateiy prior to 
bacteriai inocuiation. To controi for the possibiiity that recombinant protein non- 
specificaiiy interfered with bacteriai adherence, paraiiei assays were performed 
in the presence of a recombinant truncated CifA protein (Cif41, residues 221- 
559) (O'Conneli et al., 1998) at a finai concentration of 25pg/m i. A second 
controi was bacteria in the absence of recombinant protein. The tota i volume 
was maintained at 500pi for aii weiis.
The effect of lOpg/m i rFNBD protein on adherence of S. aureus 8325-4, 
PI and five recent ciinical isolates is shown in Fig. 3.5. The presence of rFNBD 
protein resuited in a significant reduction in adherence for ali isoiates, (P < 
0.0001), whiie the recombinant truncated CifA protein (Cif41, residues 221-559) 
had no effect on adherence (range 89.6% -95.5%  of the controi, P > 0.05) (data 
not shown). These results imply that the D region o f S. aureus FnBP participates 
in the interaction between S. aureus and the endotheiiai monoiayer. The 
inhibitory effects were comparable for recombinant protein concentrations of 
Ipg /m i, 10|ig/m i and 50|xg/mi (Fig. 3.6). However, adhesion o f 8325-4 and JR80 
to the monolayer was not completely abolished at any of the concentrations of 
rFNBD protein used (Fig. 3.6). This concurs w ith the observation tha t FnBP
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defective mutants can adhere to the monolayer, albeit at a reduced ievel 
compared to wiid type.
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Figure 3.5 Effect of the recombinant form of the ligand-binding region of 
FnBPB from Streptococcus dysgalactiae  on adherence of S. aureus  to 
endotheiiai cells in  vitro. Adherence assays were performed in the absence or 
presence of lOpg/m i of the recombinant form of the iigand-binding region of 
FnBPB encoded by fnbB of Streptococcus dysgalactiae.
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Figure 3.6 Effect of variable concentration of the recombinant form of the 
ligand-binding region of FnBPB from Streptococcus dysgalactiae on 
adherence of S. aureus to endothelial cells in vitro.
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3.3.4 Anti-fibronectin antibodies inhibit bacterial adherence to endothelial 
cells.
The above findings suggest tha t fibronectin is the host ceii surface 
receptor for adherence of S. aureus to endotheiiai ceiis in vitro. This was further 
evaiuated by examining the effect of a panei of anti-human fibronectin 
antibodies on adherence of 8325-4 defective in protein A (DU5875). This m utant 
was used to controi for the confounding interaction between protein A and the Fc 
region of IgG. The foiiowing antibodies were used at a concentration o f lO pg/m i: 
rabbit polyclonal antibody to purified human fibronectin (F3648, Sigma); sheep 
poiycionai antibody to purified human fibronectin (Serotec UK, Oxford); 
monocional antibody recognising an epitope located w ithin the 5th type I I I  
repeat of human piasma fibronectin, (mouse Ig G l, clone IST-4, F0916, Sigma); 
and monoclonal antibody recognising the N-terminus of fibronectin (mouse IgG3 
cione 10B7, Biogenesis Ltd, Pooie, UK). The foiiowing controi antibodies were 
used at a concentration of lOjug/mi: normal sheep IgG (I 5131, Sigma); normai 
rabbit IgG (I 5006, Sigma); mouse Ig G l, Kappa (M0PC-31c, M9035, Sigma); 
and mouse IgG3, Kappa (FLOPC-21, M3645, Sigma). Aii antibodies were added 
to the weiis immediateiy prior to bacteriai inocuiation.
A significant reduction in adhesion was seen in the presence o f rabbit or 
sheep poiycionai anti-human fibronectin antibodies (P = 0.0004 in both cases), 
or a monocionai antibody to the N-terminus of human fibronectin (P = 0.0008, 
Fig. 3.7). A monocional antibody recognising the 5th type I I I  repeat o f human 
fibronectin had no significant effect.
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Figure 3.7 The effect of anti-human fibronectin antibodies on the adherence of 
a protein A deficient mutant of 8325-4 to human endothelial cells in vitro.
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3.3.5 Adherence of S. aureus to purified fibronectin is associated with 
adherence to endothelial cells.
Adherence to endothelial cells was compared with adherence to solid- 
phase purified human fibronectin for 8325-4 and related fibronectin-binding 
protein mutants, P I, JR80 and Newman. Bacteriai adherence to purified human 
fibronectin was evaiuated using a visuai counting method as described in chapter 
2. Adhesion to endotheiiai ceiis was associated with adhesion to purified 
fibronectin (Fig. 3.8). As predicted, the 8325-4 FnBP-deficient m utant showed no 
binding to purified fibronectin. The same m utant complemented w ith a multicopy 
piasmid expressing either fnbA (pFNBA4) or fnbB (pFNBB4) showed enhanced 
binding to fibronectin compared with the isogenic parent. This enhancement has 
been reported previously (Greene e t a!., 1995), and may be due to the surface 
expression of higher number of FnBP's. S. aureus PI adhered strongly to 
endotheiiai ceiis and fibronectin, while Newman adhered poorly to both 
substrates. The weak adherence of Newman to solid-phase fibronectin in this 
study has been observed by others (Vaudaux e t al., 1995), and occurs despite 
the presence of two apparently functional fnb genes that express FnBP protein 
detectable by iigand-affinity blotting (Greene e t a!., 1995). The association 
between the ability to adhere to soiid-phase purified human fibronectin and 
endotheiiai cells provides further indirect evidence for fibronectin as the 
endotheiiai ceil receptor for S. aureus.
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Figure 3.8 Association between adherence of S. aureus to purified fibronectin 
and endotheiiai ceiis in vitro.
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3.3.6 Effect of plasma proteins on adherence of S. aureus to endothelial cells.
The effect o f plasma proteins was evaiuated by pre-coating endotheiiai 
monolayers w ith purified human fibronectin or fibrinogen, or by adding these 
host proteins into the assay. Adherence assays were performed using one of two 
modifications:
(1) Confluent endotheiiai cells coating Thermanox coversiips were pre-coated for 
30 minutes at 37°C in air w ith either purified human fibronectin at 300pg/ml 
(Sigma), or purified human fibrinogen at Im g /m i (Sigma). The coversiips were 
then dip-rinsed in M199 four times prior to use in the adherence assay.
(2) Adherence assays were performed in the presence of either purified human 
fibronectin at 300^g/m l or purified fibrinogen at Im g /m l, w ith or w ithout rFNBD 
protein.
Contamination of commercially available human fibrinogen by fibronectin 
is common, and is a potential confounder in these assays. The human fibrinogen 
used in this study was therefore evaiuated and purified prior to use, as follows. 
The presence of contaminating fibronectin was confirmed by Western 
immunoblotting foiiowing fractionation by SDS-PAGE of a 15pi aliquot o f 2m g/m i 
fibrinogen solution dissolved in M199, as previously described (McDevitt e t al., 
1992). Fibronectin was removed by passing the fibrinogen solution through a 
geiatin-Sepharose column (Pharmacia Biotech) as instructed by the 
manufacturer. The absence of contaminating fibronectin in the eiuate was 
confirmed by Western immunoblot. Western im munoblotting did not 
demonstrate the presence of contaminating immunoglobulin.
Pre-coating the monoiayer with fibronectin followed by rinsing prior to use 
in the adherence assay had no effect on bacteriai adherence (Fig. 3.9). This 
contrasted w ith the effect of adding fibronectin at the start of the adherence 
assay, which led to agglutination of bacteria and adherence of large aggregates 
to the monolayer.
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Figure 3.9 Adherence of S. aureus to endothelial cells in vitro pre-coated with 
fibronectln. Endothelial monolayers were pre-incubated w ith purified human 
fibronectin at SOOpg/mi for 30 minutes followed by rinsing prior to use in the 
bacterial adherence assay.
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Precoating the endothelial monolayer with fibrinogen also failed to 
influence adherence o f 8325-4 or PI (Fig. 3.10). The adherence assay was 
repeated for mutants of 8325-4 and PI defective in ClfA. There was no 
significant difference in adherence to fibrinogen pre-coated endothelium between 
these two pairs (Fig. 3.10).
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Figure 3.10 Adherence of S. aureus to endothelial cells in vitro pre-coated with 
fibrinogen. Endothelial monolayers were pre-incubated w ith purified human 
fibrinogen at 1 mg/m l for 30 minutes followed by rinsing prior to use in the 
bacterial adherence assay. 8325-4 ClfA 'and PI C lfA 'are mutants defective in the 
fibrinogen-binding protein ClfA.
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The relative importance of FnBP and ClfA in the adherence of S. aureus to 
endothelial cells in vitro in the presence of fibrinogen was then assessed by 
assays in which fibrinogen (Im g /m l) was added, with or w ithout rFNBD protein 
(lO pg/m l). This was performed for 8325-4, PI and the 5 clinical isolates (JR75- 
78 and JR80), which all behaved similarly. Fibrinogen alone resulted in the 
formation of a latticework of bacterial aggregates adherent to the monolayer (Fig 
3.11). The entire inoculum appeared to become consumed into the aggregates, 
with virtually no bacteria adherent to the monolayer in singles, pairs or small 
clusters. In the presence of rFNBD protein and fibrinogen together, large 
bacterial aggregates formed but these were not adherent to the monolayer and 
were readily rinsed off at the end of the assay. Thus, S. aureus fibronectin- 
binding proteins appear to predominate in importance over the fibrinogen- 
binding protein ClfA during bacterial adherence to endothelial cells in the 
presence of fibrinogen.
Figure 3.11 Effect of fibrinogen on adherence of S. aureus 8325-4 to 
endothelial cells in vitro. View under light microscopy using xlO  magnification. 
Human fibrinogen Im g /m l was added to the bacterial adherence assay.
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3.3.7 S. aureus mutants deficient in fibronectin-binding protein do not invade 
endothelial cells in vitro.
The number of bacteria internalized by endothelial cells was compared 
between wild type and FnBP-deficlent mutants using the standardised adherence 
assay followed by Incubation with lysostaphin to removed extracellular adherent 
bacteria. The number of bacteria internalized by endothelial cells was 9%, 25% 
and 21% of the total (adherent + intracellular) for w ild-type 8325-4, PI and 
JR80, respectively. This contrasted w ith the three isogenic FnBP-deficient 
mutants, for which no intracellular bacteria were visualised either in the standard 
Im m ^ surface area of endothelium examined, or during detailed scanning of the 
monolayer In multiple fields.
I t  is possible that the apparent lack of Internalization of the FnBP- 
defective mutants resulted from the low number of bacteria adherent to the 
monolayer rather than Interruption of a specific uptake pathway. This was 
examined by centrifuging 10® CFU onto the monolayer at the s ta rt of the 
adherence assay. The numbers of internalized bacteria per mm^ of endothelium 
were 397, 826 and 790 respectively, for 8325-4, PI and JR80 after 60 minutes 
incubation at 37°C in CO2. This compared w ith <1 bacterium per mm^ for FnBP- 
defective mutants of 8325-4, PI and JR80. The lack of intracellular bacteria for 
all three mutants indicates that fibronectin-blnding proteins are critical for 
Internalization of S. aureus by endothelial cells in vitro.
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3.4 Discussion.
This study has demonstrated that the S. aureus fibronectin-binding 
proteins play an Important role In adhesion to live human endothelial cells. All 
the Isogenic mutants tested that were defective in expression of fibronectin- 
binding proteins showed a marked reduction in adhesion to endothelial cells. This 
was true for two laboratory strains and a recent clinical isolate. Restoration, 
through plasmid complementation, of the fibronectin-binding ability of a FnBP- 
defective m utant also restored adherence to endothelium. Adhesion was 
inhibited by anti-fibronectin polyclonal and monoclonal antibodies, and by a 
recombinant protein based on the fibronectin-binding region of Streptococcus 
dysgalactiae FnBPB. In addition to providing evidence that staphylococcal FnBPs 
interact w ith endothelial fibronectin, these data also Indicate tha t this is through 
the known interaction of the D region of FnBP with the N-term inal five type I 
domains of fibronectin (Sottile et a!., 1991). Invasion of endothelial cells was 
also dependent on the presence of FnBPs, an observation which is explored 
further during work presented in Chapter 4.
These findings are im portant because they cast light on a key interaction 
in the pathogenesis of metastatic S. aureus infection, the adherence o f bacteria 
to endothelial cells. Since this organism is able to Infect apparently normal bone 
and jo in t tissues, a direct interaction with endothelial cells Is likely as a firs t step 
in the invasion of these deeper tissues. Fibronectin is well placed to act as a 
receptor In this regard. I t  is a normal component of the extracellular m atrix on 
the luminal surface of an endothelial monolayer and the findings presented here 
are consistent with a previous report of the ultrastructural localization of 
fibronectin between bovine endothelial cells and adherent S. aureus (Vann e t a!., 
1989). Given tha t the defect In endothelial cell adhesion seen w ith the FnBP 
deficient m utant was restored by the presence of a multicopy plasmid encoding 
one of fnbA or fnbB, either FnBPA or FnBPB alone can mediate adherence of 
8325-4. Understanding the relative importance of each protein in the interaction
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of staphylococci w ith endothelial cells will require further study. The relative 
importance of the two FnBPs in the pathogenic potential of S. aureus Is the 
subject of further study In Chapter 5.
Adhesion of S. aureus to live endothelial cells Is rapidly followed by 
bacterial internalization, a process that requires the presence of bacterial 
fibronectin-binding proteins. Fibronectin, through its known interactions with 
integrin receptors present on endothelium (Albelda et a/., 1989), is an ideal 
candidate molecule to orchestrate these events. Many other invasive pathogens 
use integrins as cellular receptors (for review see Berendt & McCormick, 1997), 
and Streptococcus pyogenes has already been shown to invade a number of 
epithelial cell lines through the interaction between fibronectin and epithelial cell- 
surface integrins (Ozeri e t a!., 1998). The observations of this study thus prompt 
the speculation that S. aureus invades endothelial cells through sim ilar 
mechanisms. This question has been addressed during work described in 
Chapter 4.
Under physiological conditions, the interaction of S. aureus w ith 
endothelial cells takes place at greatly lower bacterial density. In whole blood 
and under conditions of flow. The relevant activation status of the endothelial 
cells in vivo Is unknown and the ir phenotype will vary according to site. 
Im portant differences have been reported between microvascular and large 
vessel endothelium in the expression and function of host receptors fo r the 
adhesion of malaria-infected erythrocytes (McCormick et al., 1997). 
Furthermore, for adhesion of both leukocytes and malaria-infected erythrocytes, 
endothelial receptors show differential adhesion under shear flow conditions, 
with "rolling" and "static" receptors. I t  therefore remains possible tha t under 
conditions of flow and cytokine activation, additional adhesion pathways operate 
independently of, or alongside, the fibronectin pathway. Elucidating this under 
the full range of conditions that m ight prevail in vivo requires fu rther detailed 
studies.
Plasma proteins are also an im portant component of these interactions. I t  
is surprising to find no convincing role In adhesion for fibrinogen, which has been 
previously reported to act as a bridging molecule (Cheung e t al., 1991a). There 
are a number of differences between the previous study and this work tha t may 
explain this, including the bacterial strains used and the method of quantifying 
bacterial adherence. An additional difference Is that Cheung and co-workers used 
an assay where the endothelial cells were fixed with glutaraldehyde. This may 
have modified the affin ity or accessibility of the binding sites on the fibronectin 
molecules, rendering them unable to interact w ith the fibronectin-binding 
proteins on the bacteria. This was supported by the findings of a pilot 
experiment performed during this thesis. Purified fibronectin immobilised to 
plastic was treated with glutaraldehyde in the same manner as tha t described by 
Cheung (Cheung et a!., 1991a). This led to a 95% and 92% reduction, 
respectively, in adherence of S. aureus 8325-4 and the clinical isolate JR80 
compared w ith the non-treated control (data not shown). I t  is still possible that 
under different conditions of growth or activation, the fibronectin pathway plays 
a lesser role or that if it is inoperative, secondary adhesion mechanisms become 
important. Indeed, in the system used in this work, low levels o f residual 
bacterial adherence (approximately 10-20%) were seen when the fibronectin- 
binding pathway was non-functional due to mutation, or the presence o f rFNBD 
protein or anti-fibronectin antibodies. The receptor for this secondary pathway is 
unknown and warrants further study.
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3.5 Chapter summary.
This study has demonstrated that the S. aureus fibronectin-binding 
proteins play an im portant role In adherence to and invasion of human 
endothelial cells in vitro. Isogenic mutants deficient in fibronectin-binding protein 
had reduced adherence to endothelial cells, while complementation of an 8325-4 
FnBP-deficient m utant w ith a multicopy plasmid carrying an fnb gene restored 
bacterial adherence to endothelial cells. Anti-fibronectin antibodies and the 
recombinant form of the ligand-binding region of Streptococcus dysgalactiae 
FnBPB inhibited adherence of S. aureus to endothelial cells. FnBPs were also 
shown to be o f central Importance to Invasion of endothelial cells. These results 
represent a starting point for the in-depth investigation of S. aureus FnBP- 
endothelial cell interactions.
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Chapter 4. Fibronectin-binding protein A of S. aureus  has muitiple, 
substituting, binding regions that mediate adherence to fibronectin and 
invasion of endothelial cells.
4.1 Chapter content.
S. aureus fibronectin-binding proteins are central to the invasion of 
endothelium, fibronectin form ing a bridge between bacterial FnBPs and host cell 
receptors. The aim of this study was to dissect further the mechanisms of S. 
aureus invasion of endothelial cells. This was achieved by:
1 Expressing a series of truncated FnBPA proteins that lacked one or more 
of the A, B, C or D regions on the surface of S. aureus and the non- 
invasive Gram-positive organism L  lactis.
2 Testing these strains for the ir adherence to fibronectin and endothelial
cells, and invasion of endothelial cells in vitro.
3 Investigating the role of Integrin aspi in uptake of S. aureus by
endothelial cells.
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4.2 Materials and Methods.
4.2.1 Bacterial strains and plasmids.
The strains and plasmids used in this study are listed in Table 4.1.
4.2.2 Construction of plasmids encoding truncated forms of S. aureus FnBPA.
Regions o f DNA encoding one or more regions of FnBPA were deleted 
from fnbA carried on plasmid pFNBA4 (Greene e t a/., 1995; provided by 
Professor T. Foster) by inverse PGR, using the strategy shown in Figure 4.1 and 
oligonucleotide primers listed in Table 4.2. A site for the restriction enzyme BglU 
was incorporated at the 5' end of each primer to facilitate ligation o f the PGR 
product. Herculase™ Enhanced DNA Polymerase (Stratagene) was used In 
accordance w ith the manufacturer's instructions to amplify the DNA encoding the 
fnbA gene and plasmid backbone, using an annealing temperature of 65°G. 
Amplified DNA was purified using a SpinX® tube (Gostar®), digested w ith the 
restriction enzyme BglU, and self-ligated with T4 DNA ligase. The plasmids 
constructed are listed in Table 4.1.
4.2.3 Verification of deletions in fnbA.
Regions of fnbA were amplified from the plasmids (pR M l-8 ) described 
above using Pfu DNA Polymerase (Promega) and appropriate forward and 
reverse primers to generate a PGR product spanning the deletion. This was 
sequenced using BigDye^^ Term inator Gycle Sequencing Ready Reaction k it 
(Applied Biosystems), and the reactions analysed by the DNA Sequencing Facility 
in the Biochemistry Department, University of Oxford.
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Table 4.2 Oligonucleotide primers.
Primers Sequence
FnBPl 5'-GAAGATCTATCGTGCCACCAACGCCAC-3'
FnBP2 5'-GAAGATCIACCTTCATAACCTAATTC-3'
FnBP3 5'-GAAGATCTTGCAGCTTCTTTGTCTTGTC-3'
FnBP4 5'-GAAGATCTGAAGAGGAATATGATTCATC-3'
FnBP5 5'-GAAGATCTAACAGTAGTTACTAAATTC-3'
FnBP6 5'-GAAGATCTTCTGAGGAATCAAATCCAATTG-3'
FnBP7 5'-GAAGATCTATTTTCATGTGTAGATTCTTC-3'
FnBP8 5'-GAAGATCTACAACAGTTGAAGATACGAAAG-3'
pKSFor 5'-GGCGGATCCGTGAAAAACAATCTTAGGTACGGC-3'
pKSrev S'-GGCGGATCCTTATGCTTTGTGATTC I I I I IATTTC-3'
Endonuclease restriction sites are underlined
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FnBP3 FnBPS FnBP7 FnBP2
4  4 4
FnBP4 FnBPB FnBPB FnBPl
pFnBA4
B
FnBP;
FnBP4
pFnBA4
ir
i r
Figure 4.1 Construction of plasmids encoding fnbA mutants. (A) Diagrammatic 
representation of the plasmid pFnBA4 illustrating the 5'-3' orientation of the binding sites 
of each primer (FnBPl-8) used to delete regions of the fnbA gene. (B) An example of the 
inverse PCR method used to construct deletion mutants. To delete the A region, the 
primers FnBP3 and 4 were used to amplify the plasmid DNA as indicated by the arrows. 
Restriction sites for the enzyme Bglll were incorporated at the 5' end each primer. The 
resulting product of this PCR amplification was digested with the enzyme Bglll and self­
ligated. The restriction site for the enzyme Bgill replaces the A region.
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4.2.4 Confirmation of surface expression of truncated FnBPA by S. aureus.
Qualitative assessment of truncated forms of FnBPA on the surface of S. 
aureus was confirmed using Western immunoblotting. Cell wall-associated 
proteins were extracted, separated by 7.5% SDS-PAGE gel and transferred onto 
a nitrocellulose membrane. The membrane was blocked by incubation for 1 hour 
at room temperature in 1% BSA (v /v) in PBS, then incubated fo r a fu rther hour 
at room temperature w ith anti-AB region antibodies (provided by Professor M. 
Hook) and anti-D region antibodies (provided by Professor M. McGavin) 
(Ip g /m i). The membrane was rinsed and incubated in PBS containing BSA (1%, 
v /v ) and aikaiine-phosphatase conjugated protein A (Sigma) 2 pg/ml. 
Conjugated protein A was used to prevent non-specific binding of antibodies to 
protein A in the celi wall extracts.
4.2.5 Cloning of fnbA into a L. lactis piasmid.
The coding region of FnBPA was cioned downstream of a L  lactis 
constitutiveiy expressing promoter LPS2 on the piasmid vector pKSSO (Hartford 
e t al., 2001), to give strain SP9 expressing full-length FnBPA. The genes were 
amplified using the piasmids pFNBA4 or pRMl-pRM8 where appropriate as 
templates. A single pair of oligonucleotide primers were used (pKSfor and 
pKSrev in Table 4.2), which incorporated a site for the restriction enzyme Bam HI 
at the S' end. The DNA was ampiified using Pfu DNA Polymerase (Promega) in 
accordance with the manufacturer's instructions. The resulting PCR product was 
digested with the restriction enzyme Bam HI and iigated into the Bc/I restriction 
site on the plasmid pKS80. The plasmids constructed are listed in Table 4.1. The 
ligation product was electroporated into L  lactis as described above.
4.2.6 Confirmation of surface expression of FnBPA by L. iactis.
Whole cell immunoblotting was used to confirm surface expression of fuil 
length and truncated forms of FnBPA by L  lactis. Bacteria were cultured
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overnight in M17 broth with 0.5% giucose, 5p,i of which was spotted onto a 
nitroceilulose membrane and allowed to dry at room temperature. The 
membrane was blocked by incubation for 1 hour at room temperature in BSA 
(1%, v /v ) in PBS, then incubated for a 1 hour at room temperature w ith the 
antibodies used to detect FnBPA on the surface of S. aureus, detailed above. The 
membrane was rinsed in PBS and incubated in BSA containing alkaline 
phosphatase-iabelled goat anti-rabbit antibody (0.6 |ig /m i) (Chemicon) for 1 
hour. Antibody was visuaiised using the AP Conjugate Substrate Kit (Biorad) in 
accordance w ith the manufacturer's instructions.
4.2.7 Adherence of S. aureus and L. lactis to fibronectin.
Adherence of S. aureus and L  lactis to purified human fibronectin 
lOpg/m i was assessed using a standardised m icrotitre piate assay, as described 
in chapter 2 .
4.2.8 Adherence of S. aureus to fibronectin in the presence of recombinant 
forms of FnBPA.
Fibronectin adherence assays were performed using the m icrotitre plate 
method w ith the exception that recombinant forms of either fuli iength FnBPA or 
subunits representing the CD (residues 584-845) (Joh et ai., 1994), A (residues 
37-544) or B (residues 303-568) regions of S. aureus FnBPA were added to the 
wells immediately prior to bacteriai inoculation at a finai concentration of 
O.lpmol (provided by Professor M. Hook). Controi welis contained either 
recombinant truncated CifA protein (ClfA41, residues 221-559, provided by 
Professor T. Foster) (O'Connell e t ai., 1998) at a final concentration of O .lpmol, 
or no recombinant protein. The totai volume was maintained at lOOpi in each 
well.
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4.2.9 Immunofluorescence of endothelial cell receptors.
Confluent endothelial cells on Thermanox covers lips were dip-washed 
three times and placed into 24-well plates containing SOOpI M199. Added to this 
was a mouse monoclonal antibody recognizing either integrin asPi (clone JBS5, 
Chemicon MAB1969), residues 383-447 of heat shock protein 60 (clone LK l, 
Sigma H4149); or a rabbit polyclonal antibody recognizing fibronectin (F3648, 
Sigma) at a dilution of 1:200. Controi antibodies used were normal rabbit IgG 
(15006 Sigma) or mouse IgG (M9035 Sigma). Coverslips were incubated at 37°C 
in CO2 for 30 minutes, dip-washed, and placed into fresh 24-weil plates 
containing FITC-iabeiled anti-mouse antibody (F0479, Da ko) or anti-rabbit 
antibody (API32F, Chemicon) 1:200 in M199. After a further 30 minutes at 37°C 
in CO2/ cells were rinsed, mounted onto glass slides and examined in a 
fluorescence microscope (Zeiss).
4.2.10 Effect of anti-integrin and anti-HspSO antibodies on S. aureus invasion 
of endotheiial ceils.
This was evaluated using S. aureus 8325-4 defective in protein A 
(DU5875) to avoid the confounding interaction between protein A and the Fc 
region of IgG. Antibodies at a final concentration of lOpg/m l were pre-incubated 
with endothelial monolayers for 30 minutes and remained during invasion 
assays. The antibodies used were the anti-Hsp60 (L K l) and the function-blocking 
anti-in tegrin asPi described above in immunofluorescence, and a controi 
antibody to integrin P3 (clone B3A, MAB2023Z, Chemicon) (ail were Ig G l 
antibodies). Assays were performed in parallel in which coverslips were pre­
treated w ith M199 alone.
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4.2.11 Effect of recombinant FnBPA regions on S. aureus invasion of 
endotheiial ceiis.
Invasion assays were performed w ith the wild type S. aureus strain 8325- 
4 in the presence o f O.lpM of each of the following recombinant proteins: A 
region (residues 37-544), B region (residues 303-568), and the CD regions 
(residues 584-845) of S. aureus FnBPA (Joh et a!., 1994). Control wells 
contained either no recombinant protein or recombinant truncated ClfA protein 
(ClfA41, residues 221-559) (O'Connell e ta !., 1998).
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4.3 Results.
4.3.1 Heterologous expression of FnBPA allows bacterial invasion of 
endothelial ceiis.
To investigate whether S. aureus factors other than FnBPA are required 
for invasion of endotheiial cells, fuil length FnBPA was expressed on the surface 
of L  lactis, a Gram-positive bacterium that does not adhere to fibronectin or 
endothelium. Functional expression of FnBPA by this strain was demonstrated 
using the m icrotitre plate fibronectin adherence assay (Fig. 4.2). The expression 
of fuil length FnBPA by L  iactis conferred the ability to invade endothelial cells (P 
<0.001) (Fig. 4.3). This indicates that a S. aureus co-receptor is not required for 
FnBPA-mediated invasion of endothelial cells.
4.3.2 FnBPA has multiple, substituting fibronectin-binding regions that 
mediate adherence to fibronectin and attachment and invasion of endotheiial 
cells.
To investigate which regions of FnBPA are involved in invasion of 
endothelial ceils, truncated FnBPA proteins lacking one or more o f the A, B, Du 
or D regions were expressed on the surface of S. aureus and L. iactis. The Du 
region was deleted rather than the entire C region as it was previously 
considered to be the ligand binding site of the C region. Figure 4.4 shows a 
diagrammatic representation of each m utant form of FnBPA constructed.
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Figure 4.2 Functional expression of FnBPA on the surface of L. lactis confers 
the ability to adhere to fibronectin. Wild type L. lactis (MG1363); L. lactis 
carrying the expression plasmid pKS80; L. lactis expressing full length FnBPA. 
Results are shown as the means ± SEM.
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Figure 4.3 Functional expression of FnBPA on the surface of L  lactis confers 
the ability to invade endotheiial cells. Wild type L  lactis (MG1363); L  lactis 
carrying the expression plasmid pKSSO; L  lactis expressing full length FnBPA. 
The results represent the counts for two independent experiments, and the thick 
bar represents the median value.
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(a) Bi;2 Du; c
1— I— r
01:2:3:4 w M DU5883(pFnBA4), SP9.
(b) B i:2 Du: c
-i—I—I—
01:2:3:4 w M SP1,SP10
(c)
(d )
s A Ou: C 31:2:3:4 w m :
s A B1:2 C * 01:2:3:4
» ■ :
W m :
SP2, SP11
SP3, SP12
( e ) Bi:2 ou: c w M SP4, SP13
(f) Ou : c 01:2:3:4 w M SP5, SP14
(g) 01:2:3:4 w M SP6, SP15
(h ) B i:2 w M SP7, SP16
(i) w M SP8, SP17
Figure 4.4 Fibronectin-binding protein A constructs. Diagrammatic 
designations, the first is for the construct expressed on the surface o f S. aureus, 
the second on the surface of L  lactis. (S: signal sequence; A: region with 
fibrinogen-binding activity; B: region containing two repeats; C: region 
containing the Du repeat which has fibronectin-binding activ ity; D: fibronectin- 
binding region with representation of constructs lacking regions of FnBPA. (a) full 
length; (b) A"; (c) B'; (d) Du'; (e) D'; (f) AB'; (g) BC; (h) CD'; (I) BCD'. Each 
construct has two four repeats (D1-D4); W: wall-spanning region; M: 
membrane-spanning region). The star indicates that the Du repeat has been 
deleted from the C region.
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Surface expression of truncated proteins by S. aureus was verified by 
Western immunoblotting of cell wall proteins using anti-FnBPA antibodies (Fig. 
4.5a). This confirmed that all truncated proteins had been expressed on the 
bacterial cell surface. Full length fibronectin-binding proteins have an apparent 
molecular mass of approximately 180 kDa on SDS-PAGE gel; due to the ir acidic 
nature this is higher than predicted from the amino acid sequence. Relative 
decreases in apparent molecular mass were observed for the truncated proteins 
(Fig. 4.5a). I t  was also observed tha t loss of the A region had a destabilizing 
effect on the in tegrity of FnBPA which can be visualized as degradation in the A" 
and the AB' strains (Fig. 4.5a). Surface expression of all truncates expressed by 
L  lactis was confirmed by whole cell Immunoblotting (Fig. 4.5b).
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Figure 4.5 Verification of surface-expression of FnBPA constructs by S. aureus and L. 
lactis. (a) Visualisation of fibronectin-binding protein A constructs by Western 
immunoblotting of cell wall-associated protein extracts from S. aueus. Lane 1, 
molecular weight standards, Lane 2: full length FnBPA (strain DU5883 
(pFnBPA4)); Lane 3-10: FnBPA lacking the following regions: A ; B"; Du'; D'; AB' 
; BC; CD'; BCD'.
(b) Wholecell immunoblot verifying surface expression of the FnBPA constructs 
on the surface of L. lactis. 1: wild type L  iactis containing expression plasmid; 2: 
full length FnBPA; 3-9: FnBPA lacking the following regions: A'; B'; Du'; D'; AB'; 
CD'; BCD'.
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Adherence to immobilized fibronectin was evaluated for all S. aureus and 
L  lactis mutants (Fig. 4.6). Deletion of regions individually and In pairs had no 
effect on the ability to adhere to fibronectin. Loss of adherence was only seen for 
S. aureus or L. iactis strains expressing a truncated protein consisting of the A 
region alone (P <0.001 in both cases). Adherence to fibronectin of S. aureus or 
L  iactis strains expressing truncated proteins consisting of the A and B regions 
indicates the presence of fibronectin-binding activity w ithin the B region. The 
expression of a given FnBPA truncate appeared to confer sim ilar fibronectin- 
binding ability to S. aureus and L  iactis.
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Figure 4.6 Adherence to fibronectin of bacterial strains expressing FnBPA constructs.
(a) S. aureus, and (b) L  lactis expressing full length and truncated forms of FnBPA. 
Results are shown as the means ± SEM.
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To determine the role of each region o f FnBPA in the interaction with 
endothelial cells, assays were performed with the S. aureus FnBPA mutants 
described above. The initial adherence event and the subsequent uptake process 
were examined by parallel assays of attachment and invasion combined, and 
invasion alone (Fig. 4.7 and 4.8). Invasion was demonstrated fo r strains 
expressing FnBPA truncates that lacked one or two of the B, C and D regions. 
Invasion assays were performed for all L  lactis FnBPA mutants (Fig. 4.9). These 
behaved in a sim ilar manner to the S. aureus FnBPA mutants, emphasizing the 
lack of secondary S. aureus factors required for invasion of endothelial cells. 
Invasion of S. aureus and L  lactis was not lost until all fibronectin-blnding 
activity was abolished (i.e. when the B, C and D regions were simultaneously 
deleted) (P <0.001), illustrating tha t adherence to fibronectin is the crucial factor 
In endothelial cell Invasion. Comparison of the results for S. aureus invasion w ith 
those for S. aureus adhesion plus Invasion demonstrated tha t bacterial counts 
for mutants In the two assays were directly proportional. I t  was observed tha t 
strains defective in fibronectin binding (strains DU5883 and SP8) adhered to 
HUVEC at a low level (Fig. 4.7), suggesting that S. aureus may have a second 
adhesin for endothelium.
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Figure 4.7 Adherence to endothelial ceils by S. aureus strains expressing 
FnBPA constructs. The number of associated bacteria (adherent and
intracellular) per mm^ of endothelium for strains expressing the following FnBPA
constructs: full length FnBPA; FnBP"; A'; B’ ; Du'; D'; AB'; BC ; CD'; BCD'. The
open dots represent 20 counts per strain and the thick bars represent the
median value.
109
3000 -
OO 00
ooo
00000
ooooo1000 -
0000
ooo
00
ooo
00
ooo
ooooooo
00
ooo
oooo
00
00
ooooo
oo ooo
ooo
ooo
000
000
00
oo
oo
oooo
oooo
00100  -
a
10 -
SI 000
00oo
ooooooooo
.o'
s. aureus FnBPA phenotypes.
Figure 4.8 invasion of endothelial cells by S. aureus strains expressing FnBPA 
constructs. The number of internalized bacteria per mm^ of endothelium for 
strains expressing the following FnBPA constructs: full length FnBPA; FnBP'; A'; 
B'; Du'; D'; AB'; BC; CD'; BCD'. The open dots represent 20 counts per strain 
and the thick bars represent the median value.
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Figure 4.9 Invasion of endothelial cells by L. lactis strains expressing FnBPA 
constructs. The number o f internalized bacteria per coversiip of endothelium for 
L  lactis strains expressing the following FnBPA constructs: wild type; full length 
FnBPA; A '; B'; Du'; D'; AB'; CD'; BCD'. The open dots represent colony counts 
for each strain and the thick bars represent the median value.
I l l
4.3.3 Recombinant B, C and D regions of FnBPA can competitively Inhibit S. 
aureus adherence to fibronectin.
I t  has been demonstrated previously tha t the D regions of S. aureus 
FnBPA and Streptococcus dysgalactiae FnBPB can competitively Inhibit S. aureus 
adherence to fibronectin (chapter 3; SInha e t a!., 1999). To verify  tha t the B 
region has fibronectin-blnding activity, the effect of recombinant protein 
incorporating this region was examined on bacterial adherence to fibronectin. 
Microtitre plate adherence assays were performed in the presence o f the 
recombinant forms of full length FnBPA, A, B or CD regions. Recombinant B 
region protein was found to be unstable, but could be stabilized by the inclusion 
of 314 amino acids of the C term inal A region (personal communication, 
Professsor M. Hook). For clarity, this protein is subsequently referred to as 
recombinant B region protein. Recombinant full length FnBPA, the B protein and 
the CD protein reduced adherence of S. aureus to fibronectin (P < 0.001), while 
the control protein (recombinant truncated fibrinogen-binding protein, CifA41, 
residues 221-559) had no effect (P >0.05) (Fig. 4.10). Recombinant A region 
protein had no blocking effect (P >0.05). A gradient of recombinant protein 
concentrations was used to further verify the competitive nature of blocking by 
the B region relative to the A region. Figure 4.11 illustrates the increase in 
blocking of S. aureus adherence to fibronectin as the concentration o f B protein 
increases.
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Figure 4.10 Inhibition of S. aureus  adherence to fibronectin by recombinant 
FnBPA proteins. Adherence of wild type S. aureus 8325-4 to fibronectin In the 
presence of equlmolar amounts of recombinant proteins of FnBPA or the 
fibrlnogen-blnding protein ClfA. None: no exogenous protein added; ClfA: 
recombinant fibrlnogen-blnding protein (residues 221-559); Full: recombinant 
full length FnBPA; A: recombinant A region; B: recombinant B region; CD: 
recombinant CD regions. The results are shown as the means + SEM.
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Figure 4.11 inhibition of S. aureus  adherence to fibronectin by recombinant 
FnBPA proteins. Adherence of wild type S. aureus 8325-4 to fibronectin in the 
presence of increasing amounts of recombinant A and B proteins of FnBPA. 
Results are shown as the means ± SEM.
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4.3.4 Adherence of S. aureus to fibronectin via the B region can be blocked by 
recombinant CD region protein.
Fibronectin adherence assays were performed using the S. aureus strain 
expressing the A and B regions of FnBPA only (thus adherence is via the B 
region), in the presence of recombinant B or CD protein. As anticipated, the B 
recombinant protein blocked adherence to fibronectin (P >0.001). The presence 
of CD protein also led to an equally efficient inhibition of adherence (P >0.001) 
(Fig. 4.12). This suggests that the B region interacts w ith fibronectin at the same 
site as the C and D regions, or that the interaction w ith an alternative 
fibronectin-blnding site is blocked through steric hindrance.
4.3.5 Recombinant B, C and D regions of FnBPA can competitively inhibit S. 
aureus invasion of endothelial cells.
S. aureus invasion assays were performed in the presence o f recombinant 
forms of FnBPA. Invasion was blocked in the presence of the recombinant B 
region and CD regions of FnBPA (P <0.001), while the control protein ClfA (as 
described above) and the A region of FnBPA had no blocking effect (P >0.05) 
(Fig. 4.13).
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Figure 4.12 Adherence of S. aureus to fibronectin via the B region is blocked 
by recombinant CD region protein. Adherence to fibronectin of the S. aureus 
strain which expresses only the A and B regions of FnBPA in the presence of 
equlmolar amounts of recombinant B or CD region proteins. None: no exogenous 
protein added; ClfA: recombinant fibrinogen-binding protein; Full: recombinant 
full length FnBPA; B: recombinant B regions; CD: recombinant CD regions. 
Results are shown as the means ± SEM.
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Figure 4.13 Invasion of endothelium by S. aureus in the presence of 
recombinant FnBPA proteins. Invasion of endothelium by w ild-type S. aureus 
8325-4 in the presence of equimolar amounts of recombinant FnBPA proteins. 
None: no recombinant protein added; ClfA: recombinant fibrinogen-binding 
protein; A: recombinant A region; B: recombinant B region; CD: recombinant CD 
regions. Results are shown as the means ± SEM.
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4.3.6 S. aureus invasion of endothelial cells is mediated by the integrin asPi.
Immunofiuorescent microscopy was used to confirm the presence of 
fibronectin and integrin asPi on the surface of the endothelial monolayer (Fig. 
4.14). To test the role of integrin asPi in invasion of endothelial cells, S. aureus 
invasion assays were performed after pre-incubation of endothelium with 
function-blocking anti-aspi antibodies (Fig. 4.15). An antibody to the as integrin 
subunit was used as the control. Invasion by S. aureus was reduced in the 
presence of the anti-aspi antibody (P <0.001), while the control antibody had no 
effect (P >0.05).
I t  has been reported tha t S. aureus fibronectin-binding protein interacts 
with Hsp60 on the membrane of bovine mammary epithelial cells, and that the 
anti-Hsp60 antibody, LK l, reduced bacterial internalization (Dziewanowska et 
al., 2000). The relevance of these findings to S. aureus invasion of endothelial 
cells was examined. Immunofluorescence failed to demonstrate recognition by 
LK l of surface-expressed epitopes of Hsp60 on human endothelial cells. In 
addition, pre-treatm ent of the monolayer w ith LK l had no effect on invasion of 
endothelium by S. aureus (P >0.05) (Fig. 4.15).
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Figure 4.14 Immunofiuorescent microscopy of endothelial cells. Endothelial 
monolayers labelled with antibodies recognising either: (a) fibronectin, (b) 
integrin «spi, or (c), Hsp60 (LK l, recognizing residues 383-447). Magnification 
X40.
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Figure 4.15 Integrin osPi mediates S. aureus invasion of endothelial cells.
Invasions assays were performed after pre-incubation of endothelium with 
lOpg/m l of the following antibodies: none: no antibody; anti-^? antibody 
(control); anti-asPi antibody; and anti-Hsp60 antibody (L K l). The open dots 
represent the 20 counts per antibody and the thick bar shows the median value.
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4.4 Discussion.
The expression of fibronectin-binding proteins is common to many diverse 
species of pathogenic bacteria inciuding Borrelia burgdorferi (Probert e t a!., 
2001), Listeria monocytogenes (Giiot et ai., 1999), and Mycobacteria 
tuberculosis (Arm itige et ai., 2000). However, a roie in host ceii invasion has 
only been ascribed for the fibronectin-binding protein of staphylococcal (Peacock 
et a/., 1999) and streptococcal (Molinari et ai., 1997) species. S. aureus 
expresses many adhesins that bind host proteins, but to date the fibronectin- 
binding protein is the only endothelial cell invasin to be identified (Peacock e t ai.,
1999). Others have confirmed the role of FnBPs as invasins for endothelial cells 
(Sinha e t ai., 1999), and for other cell types including bovine mammary gland 
cells (Lammers e t ai., 1999), epithelial cells (Dziewanowska e t ai., 2000; Sinha 
e t ai., 1999), fibroblasts (Fowler e t ai., 2000) and osteoblasts (Ahmed e t ai., 
2001). In a number of non-endothelial cell types, invasion has been shown to be 
dependent on the integrin asPi (Dziewanowska et ai., 2000; Fowler e t ai., 2000; 
Sinha et ai., 1999). Unresolved questions before this study was conducted 
included the role of accessory bacterial or host molecules in the adhesion and 
uptake process, the structure-function relationship of the S. aureus fibronectin- 
binding proteins and the role of Pi integrins in endothelial cell invasion.
This work has shown that expression o f FnBPA is not only necessary, but 
is also sufficient to mediate invasion of endothelial cells by S. aureus. This is 
consistent w ith the findings of others using transformed human embryonic 
kidney cells (Sinha et ai., 2000). Heterologous expression o f functional FnBPA in 
the non-adhesive Gram-positive organism L. lactis conferred the ab ility  to invade 
endothelial cells, extending previous observations tha t deletion of FnBPs from  S. 
aureus was associated with a poorly adhesive, non-invasive phenotype (Peacock 
et ai., 1999). Having established that FnBPA is solely responsible for invasion of 
endothelial cells, the contribution made by each region of th is protein was then 
examined. S. aureus expressing FnBPA constructs deficient in one or more o f the
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four regions termed A, B, Du and D were in itia lly tested fo r adherence to 
immobilised fibronectin. The D repeat region of FnBPA was previously considered 
to be the main fibronectin-binding region. I t  seemed reasonable, therefore, to 
predict that deletion o f the D region would result in a reduction in adherence to 
fibronectin, and tha t simultaneous deletion of the C and D regions would lead to 
loss of function as a fibronectin-binding protein. However, adherence to 
fibronectin of S. aureus expressing FnBPA constructs deficient in either one or 
both of these binding regions was maintained. The existence o f a third 
fibronectin-binding region w ithin the B region was demonstrated by the failure of 
S. aureus expressing FnBPA deficient in the B, C and D regions to adhere to 
fibronectin. This concurs w ith findings that a recombinant FnBPA protein 
consisting of the A and B regions interacts with fibronectin (Miyamoto e t al., 
2001).
Having defined the fibronectin-binding ability of S. aureus expressing 
FnBPA constructs deficient in one or more region, the interaction of these strains 
with endothelial cells was examined. Invasion of endothelial cells by S. aureus 
strains expressing FnBPA constructs defective in one region (Du or the A, B or C 
region) or two regions (AB, BC or CD) was demonstrated. The only strains tha t 
were unable to invade endothelial cells were those devoid of FnBPs or expressing 
FnBPA deficient in the B, C and D regions. The presence of recombinant B region 
protein in the invasion assay inhibited adhesion, verifying that this region also 
interacts w ith fibronectin on the surface of endothelium. This is consistent w ith a 
previous report that a recombinant AB region protein reduced invasion of a 
mouse fibroblast line by S. aureus (Fowler e t a!., 2000). The observation here 
that the soluble CD regions exhibit cross-inhibition suggests tha t although FnBPA 
has multiple binding regions, they either all interact w ith a sim ilar region of 
fibronectin or tha t steric hindrance is occurring.
Lack of endothelial cell invasion by FnBP mutants of S. aureus could be 
due to either lack of initial adherence, or failure of uptake once bound to the
122
endothelial surface. In response to this, parallel assays were performed to 
assess either invasion alone, or adherent extracellular plus internalized bacteria 
combined. Although strains of S. aureus defective in FnBPs or expressing the A 
domain alone were not internalized, adherence of these strains was not 
completely abolished. Thus, it is possible to conclude that FnBPs are essential for 
invasion, but tha t S. aureus has a second adhesin for endothelial cells. This is 
consistent w ith findings of a previous study in which 21% of an inoculum of S. 
aureus 8325-4 defective in FnBPs adhered to MAC-T cells compared w ith 35% 
for the isogenic parent (Dziewanowska e t al., 1999). The A region did not appear 
to interact w ith endothelium, the results for both invasion and adhesion/invasion 
reflecting those for the FnBP defective mutant.
Study of the host cell determinants involved in uptake of S. aureus by 
endothelium reported here was preceded by reports from others tha t invasion of 
293 cells, Hep-2 cells and mouse fibroblasts required the integrin asPi. However, 
the function blocking anti-aspi antibody failed to block uptake by MAC-T cells in a 
study that implicated Hsp60 as the mediator of invasion (Dziewanowska et a!.,
2000). This work therefore focused on the effect of function-blocking antibodies 
to integrin aspi, and the anti-Hsp60 antibody LK l which blocked invasion o f MAC- 
T cells. A significant reduction was demonstrated in invasion in the presence of 
anti-in tegrin asPi antibody, but there was no reduction in invasion in the 
presence of anti-Hsp60 LK l antibody. In eukaryotic cells Hsp60 is mainly 
localized in the mitochondria where it functions as a molecular chaperone 
involved in protein folding, but smaller amounts are present at o ther sites 
including the plasma membrane (Soltys & Gupta, 1996; Soltys & Gupta, 1997). 
Expression of HspSO does not occur in rat endothelial cells in vitro  unless 
stressed, for example following pre-incubation with cytokines (Xu e t a!., 1994). 
In addition, antibody LK l, recognizing residues 383-447 of HspSO, does not 
recognize surface expressed epitopes of HspSO on rat endothelial cells (Xu e t a!., 
1994). A role for HspSO in adherence of S. aureus to stressed endothelial cells
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has not been excluded, but based on current evidence it is unlikely to be a major 
host factor in the invasion of resting cells. Although fu rther work is required 
using antibodies tha t recognize HspSO epitopes expressed by stimulated human 
endothelium, there is a difficult but nonetheless fundamental issue tha t needs to 
be addressed to put this and other host receptor work into context. That is, what 
is the initial level of endothelial cell receptor expression in vivo when these cells 
become associated w ith S. aureus during invasive human disease?
This study has investigated the mechanism of invasion of resting human 
endothelial cells by S. aureus. The model is one in which adherence to 
endothelium occurs through the interaction between bacterial fibronectin-binding 
proteins and fibronectin, followed by uptake mediated by integrin asPi. The 
presence of fibronectin on the endothelial cell surface was demonstrated by 
immunofluorescence and soluble fibronectin was not added to the adherence 
assays, so it can be concluded that S. aureus interacts w ith host cell-associated 
fibronectin in this system.
I t  has also been demonstrated that FnBPA has multiple, substituting 
fibronectin-binding regions including the B region. Why should a protein have 
this degree of apparent redundancy? One explanation is tha t the presence of 
multiple binding regions allows other regions to substitute activ ity should one 
become neutralized by host antibodies. A lternatively, multiple binding sites may 
allow bacteria to adhere despite negative effects found in vivo such as circulatory 
flow.
Future investigations should include a detailed analysis of the role of 
plasma proteins, the effect of flow and endothelial stimuation, and the interplay 
between these factors. Some of this work is underway or has been reported by 
other investigators. The effect of flow has been examined by two groups; Reddy 
et ai. found that shear stress prevented FnBP-mediated adherence of S. aureus 
8325-4 to resting endothelial cells (Reddy & Ross, 2001). Shenkman e t ai. did 
not find a difference in adherence of wild type between static and flow
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conditions, although adherence of mutants defective in sar or sarjag r  was 
reduced by around 50% (Shenkman e t al., 2001). Pre-treatment of endothelial 
cells w ith human a-throm bin increased bacterial adherence under conditions of 
flow (Shenkman et a!., 2000). The presence of fibrinogen in the bacterial 
suspension also increased adherence, although detection of binding was 
performed using radiolabelled bacteria, and the possibility of adherence of 
agglutinated bacteria was not excluded (Shenkman et a!., 2000).
4.5 Chapter summary.
This study has dissected the FnBPA-dependent mechanism o f invasion of 
human umbilical vein endothelial cells by S. aureus. FnBPA was shown to have 
multiple, substituting fibronectin-binding regions, each capable of conferring 
both adherence to fibronectin and endothelial cells, and endothelial cell invasion. 
Invasion of endothelial cells did not require additional S. aureus factors, and as 
w ith other cell types was mediated by integrin asPi.
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Chapter 5. Clinical isolates of S. aureus  exhibit diversity in fnb  genes 
and adhesion to human fibronectin.
5.1 Chapter content.
S. aureus FnBPs have been implicated in the pathogenesis of prosthetic 
material-related infection (Greene e t al., 1995; Vaudaux e t al., 1984; Vaudaux 
et al., 1993), and chapters 3 and 4 of this thesis have described the ir 
involvement in the interaction with human endothelial cells In vitro. Despite the 
likely importance of these adhesins in disease pathogenesis, FnBPs expressed by 
clinical isolates have not been characterized extensively. This chapter examines 
the phenotypic and genotypic characteristics of the FnBPs of a large population 
of recent clinical isolates of S. aureus associated w ith nasal carriage or disease. 
This was achieved by:
1 Examining adherence of 163 clinical isolates of S. aureus associated with 
carriage and disease to immobilised fibronectin, and comparing 
adherence w ith clinical association.
2 Studying further a subgroup of isolates with poor adherence to fibronectin 
using:
i. Western ligand affin ity blotting.
ii. Adherence assays following growth in the presence o f a protease 
inhibitor, thereby examining whether poor adhesion could be 
explained by proteolysis of adhesins during growth.
3 Determining the number of genes encoding fibronectin-binding proteins 
using Southern hybridization and dot blot, and examining this in relation 
to fibronectin adherence, and to source of the clinical isolate.
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5.2 Materials and methods.
5.2.1 Bacterial isolates.
Staphylococcus epidermldls NCTC 11047 was obtained from the National 
Collection of Type Cultures, Central Public Health Laboratory, U.K. The 163 
clinical isolates of S. aureus evaluated were cultured from specimens submitted 
to the microbiology laboratories of the John Radcliffe Hospital, Oxford, UK 
(N=103), and the Auckland, Green Lane and Middlemore Hospitals, Auckland, NZ 
(N=60), between 1993 and 1996. All were methicillin-susceptible by the 
comparative disc diffusion method.
5.2.2 Classification of isolates according to clinical history.
Isolates were divided into four groups according to the clinical history of 
the patient from whom they were isolated: nasal carriage in the absence of S. 
aureus disease (n=44); native-valve endocarditis (n=34); prim ary septic 
arthritis  and/or osteomyelitis (n=56); and orthopaedic implant-associated 
infection (n=29). The firs t three categories represented isolates from individuals 
w ith community-acquired carriage or infection. Endocarditis isolates were from 
patients who satisfied published criteria for definite endocarditis (Durack e t al., 
1994). Isolates from patients with implant-associated infection were cultured 
from operative samples, the presence of infection being confirmed by the clinical 
appearance o f infection, histology of intra-operative tissue biopsies and the 
isolation of S. aureus from multiple independent samples.
5.2.3 Bacterial adherence assay.
Adherence of bacterial isolates to purified human fibronectin lO pg/n il was 
assessed using a m icrotitre plate assay. Each isolate was tested in quadruplicate 
in an individual assay and each experiment was performed three times. All assay 
plates included S. aureus 8325-4 as a positive control, and PBS w ithout bacteria
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as a negative control. The OD405 used in the analysis was the mean value for a 
given strain, minus the background OD405 taken from the reading for the 
negative control on the same plate.
5.2.4 Determining the number of fnb genes in S. aureus isolates using 
Southern hybridization and DNA dot blot.
DNA fragments used as fnb probes were generated by PCR amplification. 
Using sequences in the GenBank database, oligonucleotide primers were 
designed to amplify unique gene fragments encoding region A o f S. aureus 
8325-4 FnBPA and FnBPB. The primer sequences 5'-CAACAACCAGCAAATATAG-3' 
(forward) and 5'-CTGTGTGGTAATCAATGTC-3' (reverse) were used to amplify a 
probe corresponding to bases 431-1792 of fnbA (as assigned by the GenBank 
sequence); and 5'-TAGAAACTTCGCGAGTTG-3' (forward) and 5'- 
TCAAGTTCATAGGAGTAC-3' (reverse) to amplify a probe corresponding to bases 
830-1997 of fnbB. Template DNA was plasmid pFNBA3 or pFNBB3 which carry S. 
aureus 8325-4 fnbA and fnbB, respectively as described by Greene e t al. 1995. 
The magnesium concentration used was 1.5 mM, and amplification consisted of 
30 cycles of 94°C for 1 min, 50°C for 1 and 72°C for 1 min 30sec. Aliquots were 
analyzed by 1% agarose gel electrophoresis, purified using a DNA extraction k it 
and DIG-dUTP labelled by PCR using the method recommended by the suppliers 
(Boehringer Mannheim). DNA hybridization was otherwise performed by the 
method of Southern (Southern, 1992).
5.2.5 Statistical analysis.
This was performed using the Statview 4.5 statistical software package 
(Abacus, Berkeley, LA), and the Stata statistical software package (Stata Corp., 
College Station, Texas). Categorical variables were compared using Fisher's
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exact test. Normally distributed variables were compared between groups using 
the unpaired t-test, and skewed data using the Kruskal-Wallis test.
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5.3 Results.
5.3.1 Clinical isolates of S. aureus adhere variably to fibronectin and include 
poor binders.
Adherence of 163 clinical isolates was variable, as shown in Figure 5.1. 
Isolates clustered into two groups, the adherence of 155 isolates (95.1% ) 
ranging from 56% -124.7%  of the mean adherence fo r S. aureus 8325-4, while 
the adherence of the remaining 8 isolates (4.9% ) was less than 20% (range 
4.2%  to 19.6%).
The isolates were divided into the clinical categories as defined above to 
determine whether adherence to fibronectin (as a percentage of S. aureus 8325- 
4 adherence), was comparable between the four groups. Adherence o f the 
bacterial group associated with orthopaedic Implant-associated infection was 
significantly greater than that for the remaining groups (Table 5.1). This finding 
was reproduced on re-analysis of the data set after exclusion o f the 8 isolates 
that adhered poorly.
The prevalence of isolates w ith poor adherence to fibronectin was: nasal 
colonising, 0/44 (0% ); endocarditis, 2/34 (6% ); septic arthritis/osteom yelitis, 
5/56 (9% ); and orthopaedic implant-associated, 1/29 (3% ). There was no 
significant difference in the proportion of low binders between the groups 
(p=0.196, Fisher's exact test).
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Figure 5.1 Adherence of 163 clinical isolates of S. aureus to fibronectin.
Fibronectin adherence is expressed as a percentage of the mean of S. aureus 
8325-4.
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5.3.2 Two of 8 poor fibronectin-binding isolates have detectable FnBPs on 
ligand affinity blotting.
The presence of functional FnBPs was evaluated by Western ligand affin ity 
blotting for the 8 poor binders and a clinicai isolate tha t had equivalent 
adherence to S. aureus 8325-4 (isolate number 80 from a patient with 
endocarditis), together w ith S. aureus 8325-4 as the positive control (Fig. 5.2). 
A band with an apparent molecular mass of approximately 180kDa was present 
in S. aureus 8325-4, 80, and two out o f 8 poor binders (isolates numbered 53 
and 233, lanes 3 and 10 in Fig. 5.2, respectiveiy). The adherence o f 53 and 233 
to fibronectin was 19.6% and 9.7% respectiveiy, compared w ith S. aureus 8325-
4.
kDa 1 2
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Figure 5.2 Visualisation of fibronectln-blnding proteins by Western ligand 
affinity blotting of cell wall-associated protein extracts. Lane 1, 5. aureus 
8325-4; iane 2, isolate number 80 whose adherence to fibronectin was 
comparable to 8325-4; lanes 3 to 10, isolates w ith poor adherence to fibronectin 
by m icrotitre assay. These are numbered consecutively as follows: isolate 53, 
74, 122, 168, 207, 225, 226 and 233.
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5.3.3 Poor adherence to fibronectin does not result from cleavage of FnBPs by 
bacterial proteases.
Modification of the adhesive phenotype and celi surface protein profile of 
the FnBPs of S. aureus by endogenous V8 protease has been described, whereby 
FnBPs undergo proteolysis during growth in broth culture (McGavin e ta l. ,  1997). 
The possibility that poor adherence to fibronectin was related to cleavage of 
FnBP by bacterial proteases secreted during culture was evaluated for the 8 poor 
binders. Isolates were incubated for 18 hours in TSB at 37°C in a ir under 
constant rotation, either in the presence or absence of the universal protease 
inhibitor az-macroglobuiin 0.125U/mi (Boehringer Mannheim). The positive and 
negative controls (for the presence or absence of an effect of a2-macroglobulin 
on adherence to fibronectin) were S. aureus 8325-4 and Staphylococcus 
schleiferi NCTC 12218, respectiveiy. The fibronectin adherence assay was 
performed using the m icrotitre plate assay. The OD405 for the 8 clinical isolates 
and the negative control were not significantly different between the treated and 
untreated samples (p > 0.05 for all isolates, paired t-tes t), while tha t for S. 
aureus 8325-4 increased by 114% following culture in the presence o f az- 
macroglobulin (Fig. 5.3).
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Figure 5.3 Effect of bacterial proteases on adherence of S. aureus to 
fibronectin.
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5.3.4 Clinical isolates vary in their complement of fnb genes.
The specificity of the two probes for region A o f fnbA or fnbB was 
confirmed by Southern hybridization of genomic DNA from S. aureus 8325-4, as 
foiiows. DNA was cieaved with several different enzymes or combinations of 
enzymes and probed with the fnbA- or fnbfî-specific probes. In each case the A 
probe hybridized to a fragment of different size compared to the B probe (Fig.
5.4).
Southern dot biot was used to evaluate the number o f fnb  genes in the 
163 clinical isolates. S. aureus 8325-4 and S. epidermidis NCTC 11047 were 
used as positive and negative controls, respectively. Independent dot blots were 
performed on two occasions. Overall, 126 of 163 isolates had two detectable 
genes (77% ), and 37 of 163 had one detectable gene (23% ), (Table 5.2).
Table 5.2 Number of fnb genes detected by Southern dot blot in 163 clinical 
isolates of S. aureus.
Clinical association fnb genes detected by Southern dot blot, number (%)
fnM'*' fnbB^ fnbA^ fnbB ' fnbA' fnbB^ fnbA' fnbB '
Nasal carriage 28 (63.6) 16 (36.4) 0 0
Endocarditis 29 (85.3) 5 (14.7) 0 0
Septic arthritis/osteomyelitis 47 (83.9) 9 (16.1) 0 0
Orthopaedic implant-associated 22 (75.9) 6 (20.7) 1 (3.4) 0
Total (no., % of ail isolates) 126 (77.3) 36 (22.1) 1 (0.6) 0
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Figure 5.4 Southern hybridization analysis of the fnb loci of S. aureus 8325-4.
Top diagram shows map of the fnb iocus o f 8325-4 to demonstrate the fnbA and 
fnbB probes and position o f the restriction sites used. Chromosomal DNA was 
cleaved with Spel, lane 1; Hpal, lane 2; EcoRl/Spel, lane 3; and Sphl/S pe l, lane 
4, and probed w ith : (i) a 1.36kb probe specific for the fnbA gene of 8325-4 (le ft 
gel), or (ii) a 1.17kb probe specific for the fnbB gene of 8325-4 (righ t). Lane M, 
molecular size marker.
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5.3.5 There is a relationship between the number of fnb genes and invasive 
disease.
The number o f isolates w ith two fnb genes were as foiiows: nasal carriage 
28/44, (63.6% ); endocarditis 29/34, (85.3% ); septic arthritis/osteom yelitis 
47/56 (83.9% ); and orthopaedic impiant-associated 22/29 (75.5% ), (p = 0.07, 
4 x 2  Fisher's exact). The number o f isoiates w ith two genes in the community- 
acquired invasive disease groups (endocarditis + septic arth ritis  and/or 
osteomyelitis), was significantiy higher than that for carriage isoiates (defined as 
nasai carriage + and orthopaedic impiant-associated isolates), (84.4%  versus 
68.4% , respectively; p = 0.023, Fisher's exact test).
The inclusion of impiant-associated isolates in the carriage group was 
based on the assumption that deep wound infections are caused by entry of 
colonising flora at the tim e of surgery. A second comparison o f nasal carriage 
isolates w ith the three remaining groups combined gave an equivalent result, 
(64% and 82%, respectively; p = 0.019, Fisher's exact test).
5.3.6 The number of fnb genes does not correlate with overall fibronectin 
binding.
The adherence of 163 ciinicai isoiates was compared w ith the number of 
fnb genes on Southern dot blot. There was no significant difference in adherence 
between isolates with one or two genes (Tabie 5.3). However, the number of 
isoiates demonstrating poor adhesion, (iess than 20% of tha t for S. aureus 
8325-4) was significantiy greater in isoiates with one, compared to two, fnb 
genes (7/37 and 1/126, respectively, p = 0.0003, Fisher's exact test).
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Table 5.3 Number of fnb genes versus adherence to fibronectin for 163 clinicai 
isolates of S. aureus.
% adherence compared w ith 8325-4
1 fnb gene 2 fnb  genes
Median 95.0 99.8
Range 6.9-124.7 4.2-128.2
Interquartile  range (25% -75% ) 79.9-108.3 89.7-106.0
There was no significant difference in adherence between isolates w ith one or 
two fnb genes (p = 0.40, Kruskai-Waiiis test).
Re-anaiysis of the data after exclusion of the 8 strains tha t exhibited poor 
adherence to fibronectin gave a p value of 0.35.
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5.4 Discussion.
This study has undertaken an evaiuation of the FnBPs of 163 ciinicai 
isolates of S. aureus. These were collected from two geographically distant 
countries to reduce the chance of studying organisms derived from a restricted 
number of clones. Organisms were selected on the basis of clinical history, but 
were otherwise chosen by taking consecutive methiciliin-susceptibie isoiates 
identified in the laboratory in a given ciinicai group. Orthopaedic impiant- 
associated infection was used as a modei of deep wound infection because the 
use of muitiple criteria, (the ciinicai picture, positive histoiogy in the absence of 
inflammatory jo in t disease and positive culture of multiple deep specimens), 
increases the reiiability of a diagnosis of infection (Atkins e t al., 1998). This 
compares favourably with other infections (eg. superficiai surgicai wound 
infection, leg ulcer-associated ceiiulitis), where the diagnosis is often made on 
ciinicai grounds in association w ith a single surface swab tha t is cuiture positive 
for S. aureus (Waidvogel, 2000).
A m icrotitre assay was used to evaiuate bacteriai adherence to purified 
human fibronectin in vitro. The demonstration of an approxim ately linear 
reiationship between OD405 and the number of adherent bacteria (as shown in 
Chapter 2) faciiitated the use of this assay to compare adherence between 
isolates. Comparison between the four groups as defined by ciinicai history 
demonstrated that adherence of those associated w ith orthopaedic im piant- 
reiated infection was greater than tha t for the other three groups. Bone- 
impianted metailic devices become coated with fibronectin in animai modeis 
(Fischer et ai, 1996), and it is possibie tha t efficient adherence to this host 
protein is an im portant factor in the pathogenic process. The reservoir o f S. 
aureus for wound-reiated infection is predominantly tha t of the patient's 
endogenous flora (Wenzel & Perl, 1995), and adherence m ight, therefore, be 
expected to m irror that of nasai carriage isolates. This is cieariy not the case, 
and raises the question as to whether a process o f in vivo selection has taken
140
place in which efficient adherence to fibronectin is associated w ith an enhanced 
pathogenic potential. Isolates that adhered poorly were, however, present in ail 
three groups associated w ith clinicai disease including community-acquired 
infection. Hence it appears tha t functional FnBPs are not essential for the 
survival of organisms during invasive disease. Studies of deficient mutants in 
animal models support the view tha t disease is sustainable in the absence of 
FnBPs (Flock e t a!., 1996; Kuypers & Proctor, 1989).
Taken overall, adherence of 155/163 isolates ranged from 56% to 
124.7% of tha t of S. aureus 8325-4. This degree o f variation has previously 
been reported for adherence of clinical isolates to collagen (Thomas e t al., 1999) 
and fibronectin (Switaiski e t a!., 1983), and is not unexpected given the likely 
genetic heterogeneity w ithin the bacterial population. The reason for the poor 
adherence of 8/163 isolates was evaluated. I t  seems unlikely tha t this resulted 
from proteolysis of FnBPs since there was no difference in adherence after 
culture in the presence of an universal protease inhibitor. Two of 8 strains had 
bands consistent w ith fibronectin-binding proteins on Western ligand affin ity biot 
which were of the same intensity as that for good binders. I t  is possible that 
poor binding in these two isolates was due to conformational effects when 
expressed on the bacterial cell surface. For example, there could be masking of 
FnBP ligand binding regions through incorrect protein folding or interference 
from other surface components, or the D region of FnBP may be buried in the 
peptidogiycan as a result of a truncated wall-spanning region. The Western biot 
did not demonstrate functional expression of FnBPs for 6 poor binders. The mean 
adherence for these was 10% of 8325-4, and it is possibie tha t this level of 
binding was mediated via non-specific mechanisms in the absence of FnBPs. The 
molecular explanation for the negative phenotype could be no/poor transcription 
of fnb genes, no/poor translation of FnBP proteins, expression of m utant FnBP 
that cannot bind fibronectin detectabiy by ligand a ffin ity blotting, or defective 
sorting/anchoring of the FnBP.
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Three quarters of the 163 isolates had two genes by dot blot and the 
remainder had one detectable gene. No isolate lacked both genes. This is 
consistent w ith a more recent study which divided 62 isoiates into 5 polymorphic 
groups based on number of fnb genes plus the number o f D repeats in each D
• 2—00 I Cv.
region (Rice I af»d-4 -2001"69=5 7 ^ ) . The m ajority (>70% ) fell into a group with 
two genes, each of which had three D repeats. Studies w ith site-specific fnbA 
and fnbB insertion mutants of S. aureus 8325-4 have shown tha t either FnBPA or 
FnBPB can mediate adherence to fibronectin-coated coversiips, and tha t there is 
no significant difference in adherence between the w ild-type and single fnb 
mutants (Greene e t a!., 1995). This concurs w ith the results of this dissertation 
in which adherence to fibronectin did not differ between isoiates w ith one or two 
fnb genes.
S. aureus isoiates associated with invasive disease were significantly 
more likely to have two fnb genes. The explanation for this observation is 
unclear, but may be due to the presence of other virulence determ inants that 
are associated with a genotype containing two FnBP genes. Isoiates w ith one 
gene were over-represented in the low adherence group and although only one 
gene is required for efficient adhesion to fibronectin, two genes may confer 
protection against loss of functional FnBP expression following a significant 
mutation in a single fnb gene.
Stationary phase bacteria were used for the adherence assays. This 
represents a potential criticism of the methodology since in vitro  studies have 
demonstrated that FnBPs are synthesised during the early exponential phase of 
growth (Saravia-Otten e t ai., 1997), and may become modified during stationary 
phase by staphylococcal proteases (McGavin e t ai., 1997). I t  is d ifficu lt to predict 
which phase is relevant to human disease, since the predominant phase of 
bacteriai growth and the pattern of FnBP expression and protease secretion in 
vivo is not known. However, it has recently been shown tha t RNAIII, the 
mediator of the agr response, is expressed early by S. aureus following
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aggregation w ith piasma proteins (J. Lindsay, personal communication), 
suggesting tha t study of function in stationary phase is im portant. In addition, 
the effect of V8 protease secreted during stationary phase on FnBPs varies 
between isoiates. McGavin e t a!, clearly demonstrated tha t V8 protease was 
responsible for FnBP degradation in a single selected ciinicai isolate (McGavin e t 
a/., 1997). He also reported that variation in fibronectin bindng among 44 MRS A 
isolates was inversely related to protease activ ity (Rice e ta L ,  2001a). However, 
V8 protease was not responsible for degradation of this adhesin in V8 protease- 
defective isogenic mutants constructed in two different genetic backgrounds (see 
Chapter 6).
5.5 Chapter sum mary.
This study has demonstrated diversity in adherence to fibronectin and in 
the number o f genes encoding FnBPs in a large population of ciinicai isoiates. 
There was no difference in adherence between isolates w ith one or two fnb, but 
isolates associated with invasive disease were more likely to have two genes. In 
addition, adherence of the bacterial group associated with orthopaedic implant 
infection was significantly greater than that for other isolate groups. These 
findings suggest tha t the interplay between pathogenesis and a single virulence 
determ inant is unlikely to be a uniform process across a spectrum of infections 
and hosts. This confirms the need to extend the study of staphylococcal 
pathogenesis from the laboratory to real, albeit non-uniform populations of 
clinically relevant isolates.
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Chapter 6. Adherence of S. aureus 8325-4 and S. aureus V8 to 
fibronectin is not modified by serine (V8) protease.
6.1 Chapter content.
Proteases secreted by S. aureus may influence cell wall associated 
adhesins of the bacterium through a process of degradation. This chapter 
examines the effect of serine (V8) protease on the fibronectin binding phenotype 
of S. aureus. This was achieved by:
1 Construction of S. aureus mutants defective in the gene encoding serine 
(V8) protease. These were verified at genotypic and phenotypic levels 
using Southern hybridization, Western immunobiotting and tota l protease 
assay.
2 Comparison between m utant and w iid-type of:
i. FnBP expression using Western blotting.
ii. Adherence to fibronectin using a m icrotitre plate assay,
ill. The interaction with human endothelial cells in vitro.
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6.2 Materials and methods.
6.2.1 Construction of an sspAxTc"  ^mutant.
Two internal fragments of the gene encoding serine (V8) protease, 
hereafter caiied sspA (staphyiococcai serine protease A), were amplified by PCR 
from S. aureus 8325-4 chromosomal DNA. A 754 b.p. fragm ent (corresponding 
to bases 4-758) was amplified using the following primers: 
CCCATCGATTTGTTCTTCGAAACTTAAGC and
CCCAAGCTTAGGGAATGL I I I lAAAGC. which introduced a C/a I restriction site at 
the 5' end o f the fragment and a H in d lll restriction site at the 3' end of the 
fragment. A 796 b.p. fragment (corresponding to bases 759-1555) was also 
amplified using the following primer set: CCCAAGu i i i CT G C A ATTA ACCAAG AC
and CGCGGATCCTCGGcI i IG G cl I lATTG. which introduced a H in d lll restriction 
site at the 5' end of the fragment and a B a m lll restriction site at the 3' end of 
the fragment. The magnesium concentration used was 1.5 mM, and amplification 
consisted of 30 cycles of 94°C for 1 min, 50°C for 1 min, and 72°C for 1 min. 
Aliquots of the reaction m ixtures were analyzed by 1% agarose gel 
electrophoresis. The fragments were purified, ligated at the H in d lll site and 
cloned into pBluescript at the 8amHI and Cial sites. The resulting plasmid was 
linearized by digestion w ith H in d lll and ligated with a 2.1kb H in d lll fragment 
from pCW59 that confers tetracycline resistance. A shuttle plasmid was 
constructed by combining the resulting plasmid with the S. aureus temperature 
sensitive plasmid pTS2 (fs, chloramphenicol resistant). The shuttle plasmid was 
electroporated into S. aureus 8325-4 following transformation into the restriction 
negative host, RN4220. Temperature shift experiments resulted in the isolation 
of an aileiic replacement m utant in sspA of 8325-4 (strain DU5956). The 8325-4 
sspA::Tc'^ m utant was transduced by phage 85 (Asheshov, 1966) into S. aureus 
strain V8 forming DU5957.
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6.3 Results.
6.3.1 Verification of the mutant genotype.
The chromosomal sspAr.Tc^ mutation was verified by Southern 
hybridization. Chromosomal DNA from the w ild-type and sspA: :Tc"  ^ m utant was 
isolated, digested w ith H in d lll and probed using a DIG-labeiied probe generated 
by PCR and specific to the fuii length gene using primers and conditions 
described above, w ith the exception of the elongation time which was 1 min 30s. 
The product was purified from 1% agarose gel using a DNA extraction k it and 
DIG-dUTP labelled by PCR. A single band of approximately 2.1kb hybridized from 
the w ild-type parent (Fig. 6.1). Two fragments of approximately 1.2kb and 
950bp hybridized from the 8325-4 sspA::Tc^ mutant, showing tha t the fu il- 
iength gene had been separated by the introduced H in d lll site (Fig. 6.1). The 
8325-4 sspAwTc^ m utant was transduced into S. aureus strain V8, and the 
mutation verified by Southern hybridization.
6.3.2 Verification of the mutant phenotype.
The presence of SspA in the supernatant was analysed by Western 
immunobiotting. Isolates were inoculated from frozen stocks into 10ml of TSB 
and incubated for 15 to 18 hours under constant rotation at 37°C in air. The 
cuiture was centrifuged for 10 minutes at 3,000 rpm and the supernatant 
concentrated 20 times using a Centricon-10 (Amicon). This was analysed by 
Western immunobiotting using rabbit polyclonal anti-V8 protease antibody 
(1:2000, a g ift from Dr S. Arvidson), followed by peroxidase-conjugated goat 
anti-rabbit immunoglobulin (1:2000, Da ko). Figure 6.2 demonstrates the loss of 
an immunoreactive band with an apparent molecular mass of approximately 
30kDa from the supernatant of the sspAwTc^ 8325-4 m utant compared w ith the 
parent strain. This is consistent with the loss of SspA production.
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Figure 6.1 inactivation o f S. aureus  sspA. Southern hybridization biot of 
/Y/ncyill-digested chromosomal DNA from parent strain 8325-4 (WT) and its 
sspAwTc^ mutant, probed with a PCR-ampiified fuii length sspA gene. Marker 
sizes in kiiobases are shown on the ieft.
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Figure 6.2 Visuaiization of SspA by Western immunobiotting of S. aureus  
culture supernatant. Lane 1, 8325-4; lane 2, 8325-4 DU5723 defective in 
protein A; iane 3, 8325-4 sspA ::Tc\ Molecular mass markers (on the left) are in 
kiiodaitons. The ioss of an immunoreactive band with an apparent moiecular 
mass of approximateiy 30kDa is shown for 8325-4 sspA::Tc^ consistent with the 
ioss of SspA production. The ~55kDa band was absent from the culture 
supernatant o f a protein-A defective 8325-4 m utant (DU5723).
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Quantitative determination of total protease activ ity in 20-fold 
concentrated culture supernatants was performed using a protease assay kit. 
Assays were performed in triplicate for 8325-4 and V8 together w ith the ir 
respective SspA-deficient mutants. Protease activ ity of the 8325-4 sspA: iTc"  ^and 
V8 sspA::Tc^ mutants was reduced by 51% and 67%, respectiveiy, compared 
with the parent strain (Fig. 6.3). This indicates that these isoiates produce other 
proteases in addition to SspA.
6.3.3 Effect of sspA mutation on adherence of S. aureus to fibronectin in vitro.
Adherence of S. aureus to purified human fibronectin lO pg/m i was 
assessed using a standardised m icrotitre piate assay. Each isoiate was tested in 
quadruplicate in an individual assay and each experiment was performed three 
times. Adherence of S. aureus 8325-4 and V8 to fibronectin was compared with 
that of the SspA-deficient mutants. The production of SspA during overnight 
cuiture did not affect bacterial adherence to fibronectin (p = 0.97 and 0.94 for 
8325-4 and V8 respectiveiy, paired t-test. Fig. 6.4). Foilowing culture in the 
presence o f the universal protease inhib itor a2-macroglobuiin 0.125U/m l 
(Boehringer Mannheim), 8325-4 and V8, together with the ir respective SspA- 
deficient mutants, ali demonstrated a significant increase in adherence to 
fibronectin (p < 0.05 in ali cases). This suggests tha t adherence o f 8325-4 and 
V8 to fibronectin is modified by a protease other than SspA.
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Figure 6.3 Totai protease activity of S. aureus strains 8325-4 and V8 compared 
with their respective SspA-deficient mutants. The assay was based on cleavage 
of fluorescein thiocarbamoyi-casein derivative by proteases as detected by a 
change in absorbance. Protease activity was evaluated using 20-foid 
concentrated supernatants from overnight broth culture. Results are shown for 
the mean ± SEM.
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6.3.4 Effect of sspA mutation on fibronectin-binding proteins.
Cell wall-associated proteins were isolated from standardised inocuia of S. 
aureus 8325-4 and the 8325-4 sspA'.iTc^ mutant. Equal amounts of cell wall- 
associated protein extract were separated by SDS-polyacrylamide gei 
electrophoresis and evaluated by Western ligand affin ity blotting. A protein with 
an apparent moiecular mass of approximately 180kDa (consistent with 
fibronectin-binding protein) was present in ali extracts. The intensity o f the band 
was comparable between 8325-4 w lld-type and the 8325-4 sspA m utant (Fig.
6.5). A comparison was made between 8325-4 cultured in the presence or 
absence of az-macroglobulin 0.125U/m l. Growth in the presence of a%- 
macroglobuiin resulted in a marked increased in band intensity (Fig. 6.5). This 
indicates tha t while degradation of the FnBP of S. aureus 8325-4 occurs during 
cuiture, the process is mediated by a protease other than SspA.
6.3.5 Effect of sspA mutation on S. aureus adherence to, and uptake by 
endothelial cells in vitro.
Adherence of S. aureus to, and uptake by endothelial cells in vitro  is 
mediated by the interaction between bacterial fibronectin-binding protein and 
endothelial cell-surface fibronectin (Peacock e t ai., 1999). The effect of SspA on 
this interaction was assessed using the standardised endothelial cell adherence ass^  
as previously described. The number of bacteria either associated w ith (adherent 
+ intracellular), or internalised by Im m ^ of confluent endothelial cells was not 
significantly different between 8325-4 and the 8325-4 sspAr.Tc^ m utant (p >
0.05 for both assays, paired t-test).
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Figure 6.5 Visualization of fibronectin-binding proteins by Western ligand 
affinity blotting of cell wall-associated protein extracts. Equal amounts of cell 
wall- associated protein extract were loaded into each lane. S. aureus 8325-4 
following cuiture in the absence (iane 1), or presence of cx2-rnacroglobulin at 
0.125U/ml (iane 2); iane 3, 8325-4 sspAr.Tc^ mutant following culture In the 
absence of a2-macroglobulin. Molecular mass markers (on the left) are in 
kiiodaitons.
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6.4 Discussion.
Serine (V8) protease was firs t purified from the culture supernatant of S. 
aureus strain V8 in 1972, and found to specificaily cleave peptide bonds on the 
carboxyi term inal side of aspartate or giutamate (Drapeau e t al., 1972). Two 
mutants with increased protease production isolated after chemical mutagenesis 
were described the following year, the phenotypes of which were markedly 
different from that of wild type in terms of carbohydrate utilisation, and altered 
patterns of extracellular alkaline phosphatase and deoxyribonulcease (Ryden et 
a/., 1973). In retrospect, these p l^ tro p ic  changes were probably related to a 
mutation in one of the staphyiococcai global regulators, since synthesis of serine 
protease is now known to involve positive regulation by agr and negative 
regulation by sarA (Chan and Foster 1998). This is reflected by the findings that 
serine protease is expressed in the post-exponential phase (consistent w ith up- 
reguiation by agr), and that production is increased in a sarA defective m utant 
(Chan & Foster, 1998). Availability of S. aureus sequence data (an event 
occurring after completion of the work for this chapter), has since added further
to our understanding of serine protease expression. Sequence analysis of the S.
ccJC-
aureus strain COL genome reveals that the ssp gene encoding serine protekj. 
(sspA) is followed closely by an open reading frame (ORF) encoding a cysteine 
protease designated sspB (Rice e t a!., 2001b). The sspA and sspB proteases are 
transcribed as an operon, which also Includes a third ORF sspC of unknown 
function. A nonpolar alieiic replacement mutation of sspA resulted in ioss of 
autoiysin activ ity and proteolytic maturation of the SspB cysteine protease, 
indicating that SspA controls SspB (Rice e t a!., 2001b). Furthermore, SspA is 
itself expressed as an inactive precursor that is activated by a metaiioprotease 
(Drapeau e ta l. ,  1972).
Signature tagged mutagenesis has shown tha t serine protease 
contributes to In vivo growth and survival of S. aureus (Coulter e t a!., 1998), 
although inactivation of sspA did not result in attenuation in a tissue abscess
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model of Infection (Rice e t a!., 2001b). So what role, if any, does SspA play in 
modelling ceil surface-expressed adhesins? Since the work for this thesis was 
completed, two papers have been published which add to the findings described 
here. The first, by Rice e t al. in January 2001, recognised the potential 
importance of nonpolar mutations in relation to ssp genes and constructed an 
sspA m utant w ithout affecting sspB or sspC (Rice e t al., 2001b). Binding to 
labelled fibronectin did not differ between the m utant and wild type in either 
mid-exponential or stationary phase. These findings are in agreement with those 
of this thesis, although it should be noted tha t the strain constructed during this 
work was probably defective in ali three genes contained on the ssp operon. The 
second publication in August 2001 reported the effects of mutating the ssp 
operon by alieiic replacement in 8325-4, finding that there was a three-fold 
increase in ceii-bound FnBPs as detected by Western immunobiotting (Karlsson 
e t al., 2001). Comparison of fibronectin adherence between m utant and wild 
type strains was not reported by these investigators, making it d ifficult
to directly compare w ith this thesis. I t  is possibie that ceil wall fractions from ssp 
mutants contain more FnBP than w iid-type, but tha t this can only be detected by 
the more sensitive immunobiotting technique (as compared w ith ligand affin ity 
blotting used during this chapter, a choice based on the lack o f anti-FnBP 
antibodies at tha t tim e). However, it remains to be seen whether this difference 
translates to an effect on function.
6.5 Chapter summary.
This study has demonstrated tha t FnBP expressed by S. aureus 8325-4 
and the adherence of 8325-4 and V8 to fibronectin is not modified by SspA. S. 
aureus FnBP expression and bacterial adherence to fibronectin was increased for 
w ild-type 8325-4 and V8 and the ir SspA-deficient mutants following growth in 
the presence of the universal protease Inhibitor az-macroglobuiin. Thus,
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degradation of FnBPs during growth of S. aureus V8 and 8325-4 appear to be 
mediated by a protease other than SspA.
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Chapter 7. Staphylococcus sch le lferl subsp. sch le lferl expresses a 
fibronectin-binding protein.
7.1 Chapter content.
S. schleiferi is a nosocomial pathogen that causes infection prim arily in 
association with prosthetic material. Bacterial adhesins recognizing fibronectin 
and fibrinogen play a central role in the pathogenesis of colonization of medical 
devices by S. aureus (Vaudaux e ta !.,  1989, 1993, 1995). S. schleiferi has been 
reported to bind fibrinogen as assessed by commercial agglutination kits 
(Hébert, 1990; Personne e t ai., 1997; Vandenesch et ai., 1994), but adherence 
to fibronectin and the identification of cell wail-associated adhesins have not 
been described for this organism. This study set out to investigate the possibility 
that S. schieiferi expresses a fibronectin-binding protein. This was achieved by:
1 Determining adherence of laboratory and clinical S. schieiferi isolates to 
fibronectin, and examining the effect on adherence of recombinant FnBP 
protein and removal of surface proteins w ith proteinase K.
2 Examining S. schieiferi fibronectin-binding protein by Western ligand 
affin ity blot.
3 Amplifying (by PCR) and sequencing a fragment o f the gene encoding the 
fibronectin-binding protein of S. schieiferi.
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7.2 Bacterial strains.
S. schleiferi NCTC 12218 and S. epidermidis NCTC 11047 were obtained 
from the National Collection of Type Cultures, U.K. Twenty five clinical isolates of 
S. schieiferi were obtained from the Centre Nationale de Reference des Toxemies 
à Staphylocoques, Lyon, France. These were isolated from : blood culture 
( n = l l ) ;  pacemaker lead, device or wound (8); intravenous cannula (1); brain 
abscess (1 ); cerebrospinal fluid (1); and wound infections (3).
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7.3 Results.
Experimental results for m icrotitre plate adherence assays are shown 
throughout as the mean of triplicate experiments (each isolate being tested in 
quadruplicate in an individual assay) ±  standard error of the mean.
7.3.1 S. schleiferi adheres to purified fibronectin in vitro.
Adherence of bacterial isolates to purified human fibronectin lO pg/nil was 
assessed using a m icrotitre plate assay. Adherence of S. schleiferi NCTC 12218 
to purified fibronectin was compared w ith S. aureus 8325-4 (positive control), 
and w ith S. epidermidis NCTC 11047 which adheres poorly. The ability of S. 
schieiferi to adhere to purified fibronectin in vitro  was demonstrated (Fig. 7.1). 
The level of binding was comparable to the positive control, w ith no significant 
difference in OD405 for S. schieiferi compared w ith tha t for S. aureus 8325-4 (p = 
0.45, unpaired t-tes t). The adherence of S. schieiferi and S. aureus was 
significantly greater than that for S. epidermidis (p < 0.0001 for both strains, 
unpaired t-tes t). Equivalence of bacterial inocula (1 x 10® cfu per well) for the 
three strains was confirmed.
To evaluate whether recent isolates of S. schieiferi associated with 
disease were also able to adhere to fibronectin, adherence assays were 
performed for 25 clinical isolates. All isolates adhered to fibronectin, but there 
was marked variation in OD405 values w ithin the group, w ith a 7.4 fold difference 
in absorbance between the lowest and highest binders (Fig. 7.1). This variation 
was highly reproducible, as reflected by the values for the standard error of the 
mean (Fig. 7.1). Colony count experiments excluded variation in bacterial 
inocula as the cause.
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Figure 7.1 Adherence of S. schleiferi to purified human fibronectin in vitro.
Adherence was compared between S. aureus 8325-4, S. epidermidis NCTC 
11047, S. schleiferi NCTC 12218 and 25 clinical isolates of S. schieiferi from  the 
following microbiological specimens: blood culture (numbered 1-11); pacemaker 
lead, box or wound (nos. 12-19); intravenous cannula (no. 20); brain abscess 
(no. 21); cerebrospinal fluid (no. 22); and wound infection (nos. 23-25).
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7.3.2 Adherence to fibronectin is inhibited by the recombinant form of the 
ligand binding region of Streptococcus dysgalactiae FnBPB.
The m icrotitre plate assay was repeated for S. aureus 8325-4 and S. 
schleiferi NCTC 12218 in the presence of the recombinant form of the ligand 
binding region of Streptococcus dysgalactiae FnBPB (Joh et ai., 1994) (rFNBD-B, 
a g ift from Dr. Magnus Hook, Texas, referred to below as rFNBD protein). This 
was added to the wells immediately prior to bacterial inoculation at a finai 
concentration of 10|ig/m l. Control wells were incubated w ith bacteria in the 
absence of rFNBD protein. The total volume was maintained at lOOpI for ali 
wells.
S. aureus adherence was significantly reduced in the presence of rFNBD 
protein (15% of control, p = 0.0002, paired t-test) (Fig. 7.2), consistent with 
published data (Joh e t ai., 1994). S. schieiferi adherence was also significantly 
reduced in the presence of rFNBD protein (10% of control, p < 0.0001, paired t- 
test). This provides further evidence for the expression of a cell surface- 
associated fibronectin-binding protein by S. schieiferi tha t has homology to 
rFNBD protein, or whose function is sterically hindered by its presence.
7.3.3 Adherence of S. schleiferi NCTC 12218 to purified fibronectin is 
significantly reduced by treatment with proteinase K.
Surface proteins were removed from the bacterial pellet o f 10ml 
overnight cultures of S. schieiferi NCTC 12218 and S. aureus 8325-4 using 
proteinase K. Adherence to purified human fibronectin was compared between 
organisms pre-treated with proteinase K and untreated controls (Fig. 7.2). 
Proteinase K treatm ent resulted In a highly significant reduction in adherence for 
both S. schieiferi NCTC 12218 (p < 0.0001), and S. aureus 8325-4 (p = 0.0002, 
paired t-tes t). The results for S. aureus are consistent w ith the proteolytic 
degradation of fibronectin-binding protein. The observation tha t binding of S.
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schleiferi to fibronectin was almost abolished following exposure to proteinase K 
suggests that adherence of this organism to fibronectin is also mediated by a cell 
surface-expressed protein.
0.40
0.35 H 
0.30 
^ 0.25 i
ë  0.20 -
§
0.10  -
0.05 - 
0.00
■  control
EH 10mcg/ml rFNBD protein 
treated with proteinase K
8325-4 12218
Figure 7.2 Effect of proteinase K and the recombinant form of the ligand 
binding region of Streptococcus dysgalactiae FnBPB on adherence to purified 
human fibronectin in vitro. Adherence of S. schleiferi NCTC 12218 and S. aureus 
8325-4 was evaluated: (i) following treatm ent with proteinase K; and (ii) in the 
presence of lOpg/m l of the recombinant form of the ligand binding region of 
FnBPB (rFNBD protein) encoded by fnbB of Streptococcus dysgalactiae.
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7.3.4 S. schleiferi express a fibronectin-binding protein on Western ligand 
affinity blot.
Cell wall-associated protein extracts were prepared from S. aureus 8325- 
4 and S. schleiferi, separated by SDS-polyacrylamide gel electrophoresis (PAGE) 
and evaluated by Western ligand affin ity blotting. S. aureus 8325-4 was used as 
a positive control and was shown to express a protein w ith an apparent 
molecular mass of approximately 180kDa (Fig. 7.3), consistent w ith previous 
reports ((Bisognano e t al., 1997; Greene et al., 1995; Vaudaux e t al., 1998). 
The extracts from S schlelferl NCTC 12218 and two randomly selected clinical S. 
schlelferl isolates (numbered 3 and 18 In Fig. 7.1) also contained a reactive 
protein band (Fig. 7.3). That for NCTC 12218 had a molecular mass of 
approximately 200kDa. The bands for the two clinical S. schlelferl isolates were 
of greater density on visual inspection compared both with S. schlelferl NCTC 
12218 and S. aureus 8325-4. Western ligand affin ity blot was repeated using a 1 
in 4 dilution of the initial cell wall extract from the clinical isolates to facilitate 
assessment of the molecular mass o f these positive bands. This demonstrated 
the reactive bands to be 180kDa for both clinical isolates (data not shown). The 
greater band density for the two clinical isolates using the original extract 
occurred despite standardization of the bacterial inoculum used during ceii wall- 
associated protein extraction, and was reproducible on repeat testing w ith an 
independently prepared protein extract (data not shown). However, greater band 
density did not predict an enhanced adherence to fibronectin In vitro, the 
adherence of strain 18 being greater than, and that for strain 3 being iess than 
NCTC 12218 (Fig. 7.1).
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Figure 7.3 Visualization of fibronectin-binding proteins by Western ligand 
affinity blot of cell wall-associated protein extracts. Equal amounts of cell wall- 
associated protein extract were loaded into each lane. Lane 1, S. aureus 8325-4; 
lane 2, S. schleiferi NCTC 12218; lanes 3 and 4, clinical S. schleiferi isolates, 
(numbered 18 and 3 in figure 7.1, respectively). Molecular mass markers (on the 
left) are in kilodaltons.
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7.3.5 PCR amplification and sequencing of a fragment of S. schleiferi fnb.
PCR analysis was performed to determine the presence of homology 
between primers to the D1-D3 binding region of S. aureus 8325-4 fnbA and 
genomic DNA from S. schleiferi NCTC 12218. The rationale for th is choice of 
primer site was tha t the D-repeat region is highly conserved between the fnbA 
and fnbB of S. aureus 8325-4, probably as a result of functional requirements of 
the binding domains, and represents the area of greatest homology between 
FnBPs of d istantly related species (Joh et al., 1994). Oligonucleotide primers 
were synthesized by Genosys, as follows: 5'-GGCCAAAATAGCGGTAACC-3' 
(forward) and 5'-GCTTAcl i i IGGAAGTGTATC-3' (reverse) corresponding to 
bases 2349-2367 and 2674-2694 of fnbA, respectively (as assigned by the 
GenBank sequence). The magesium concentration used was 1.5 mM, and 
ampiification consisted of 30 cycles of 94°C for 1 min, 54°C for 1 min and 72°C 
for 3 min. Agarose gel electrophoresis of an aliquot o f the PCR reaction m ixtures 
is shown in Figure 7.4.
A predictabie band of approximateiy 350bp was seen fo r S. aureus 8325- 
4, together w ith a second band of approximately 3.7kb. The prim er recognition 
sites used for fnbA had only 1 and 2 base pair differences for forward and 
reverse primers, respectively between fnbA and fnbB. Figure 7.4 shows a map of 
the possible positions at which the fnbA primers could anneal in the fnb locus. I t  
is likely that the 3.7kb band represents amplification of the region from D1 of 
fnbA to D3 of fnbB. The resuits for S. schleiferi shown in lane 4 o f Figure 7.4 
demonstrate a single band of approximately 350bp.
The 350bp S. schlelferl fragment was purified and sequenced w ith Big- 
Dye term inator chemistry (ABI Prism) and visualized on an ABI 377 sequencer. 
This demonstrated 100% homology between the fragment from S. schlelferl and 
region D of S. aureus 8325-4 fnbA (data not shown). This surprising resuit was 
verified by repeat sequencing of a PCR product amplified from newiy extracted
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DNA from S. schleiferi NCTC 12218, all reactions for which were carried out 
under conditions that ensured the absence of S. aureus genomic DNA.
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Figure 7.4 PCR analysis of fibronectin-binding protein gene fragments. Top
diagram shows map of the possible positions at which the fnbA primers could 
anneal in the S. aureus 8325-4 fnb locus ( f denotes forward, and r denotes 
reverse PCR primer, respectively). Gel image: genomic DNA from S. aureus 
8325-4 (lane 3) and S. schleiferi NCTC 12218 (lane 4) amplified w ith primers 
complementary to the 345bp D1-D3 binding region of S. aureus 8325-4 fnbA. 
Lane 1, 500-bp molecular size marker; lane 2, 100-bp molecular size marker.
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7.4 Discussion.
Following the description of S. schleiferi subsp. schlelferl in 1988 (Freney 
et ah, 1988), this coagulase-negative staphylococcus has been implicated as the 
causative pathogen in a range of hospital-acquired infections. These include 
bacteraemia (Jean-Pierre e t a/., 1989; Latorre et al., 1993), brain abscess 
(Grattard e t al., 1993), pacemaker and other intravenous device-related 
infections including prosthetic valve endocarditis (Celard e t a i ,  1997; Da Costa 
e t al., 1998; Grattard e t al., 1993; Leung e t al., 1999), and infections of the 
urinary tract (Ozturkeri e t al., 1994), orthopaedic implants (Jean-Pierre e t al., 
1989) and surgical wounds (Calvo e ta l. ,  2000; Grattard e t al., 1993; Hernandez 
et al., 2001; Kluytmans et al., 1998). The mechanisms by which S. schlelferl 
causes such diseases are unknown, but there is a degree of sim ilarity between 
the spectrum of infections caused by this microorganism and those associated 
with S. aureus. I t  is plausible, therefore, that the two species share one or more 
virulence determinants.
The process by which S. aureus colonises prosthetic material has been 
studied in detail, and has been attributed to the interaction between host 
fibrinogen and fibronectin that rapidly coats foreign material, and bacterial ceil 
wall-associated adhesins. Isolation of S. schlelferl from cultures of prosthetic 
material suggests the presence of one or more bacterial adhesins w ith host 
protein specificity sim ilar to tha t of S. aureus. To date, evaluation of the 
adherence of S. schlelferl to host proteins has been limited to the description of 
bacterial clumping in the presence of fibrinogen using commercial agglutination 
kits (Hebert, 1990; Personne et al., 1997; Vandenesch e t al., 1994). The role of 
FnBPs in the colonization of prosthetic material by S. aureus led to the 
hypothesis that S. schlelferl expresses a fibronectin-binding protein.
This study has described the adherence of S. schlelferl subsp. schlelferl 
NCTC 12218 to purified human fibronectin In vitro. The level of adherence was 
comparable to that of S. aureus 8325-4. To confirm that th is interaction occurred
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in recent clinical strains, adherence was evaluated for S. schleiferi isolates 
associated w ith a range of significant infections. All 25 isolates tested adhered to 
fibronectin, but the degree to which this occurred showed variab ility  between the 
strains. This variability could not be accounted for and the reason remains 
unclear. Sim ilar observations have been made for the adherence o f a collection 
of clinical strains of S. aureus to purified collagen In vitro  (Thomas e t al., 1999). 
I t  is possible tha t there is variation between isolates in the number o f cell 
surface-expressed binding sites, or the efficiency w ith which FnBPs bind 
fibronectin, which could in turn be related to the relative genetic heterogeneity 
that is reported to exist for S. schlelferl (Grattard et al., 1993). The small 
number of isolates in each disease group lim its comment on the level of 
adherence versus clinical diagnosis.
The reduction in adherence of S. schlelferl to fibronectin in the presence 
of the recombinant form of the binding region of Streptococcus dysgalactiae 
FnBPB and following treatm ent with proteinase K, together w ith the bands seen 
on Western ligand affin ity blotting using fibronectin as the substrate, provide 
phenotypic evidence for a bacterial cell surface-expressed fibronectin-binding 
protein. The visualization of a band from lyostaphin cell wail preparations 
suggests that this is cell wall-anchored. The reason for the variation in apparent 
molecular mass of the fibronectin-binding proteins from S. schlelferl NCTC 12218 
and the two clinical isolates is not apparent. One possibility is tha t the protein 
has one or more regions that are characterized by a variable number o f tandem 
repeats. This has been well documented for S. aureus, examples being the B- 
repeat region of the collagen-binding protein (Giilaspy e t al., 1998), and the D- 
repeat region of the fibronectin-binding protein in clinical isolates (Rice e t al., 
2001a). Protein A variants have also been described tha t result in variation in 
apparent molecular mass (Cheung e t al., 1987). An alternative explanation is 
that the protein from the clinical strains underwent degradation before 
processing, w ith loss of a small N-terminal fragment.
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PCR was utilized during this study to amplify a fragm ent of genomic DNA 
from S. schleiferi NCTC 12218 using primers to the 345bp region of fnbA 
encoding the D1-D3 binding region of S. aureus 8325-4 FnBPA. The product from 
S. schlelferl and the smaller of the two fragments from S. aureus were of a 
comparable size. Sequencing o f the S. schlelferl fragment provided further 
evidence for the presence of a fibronectin-binding protein, w ith a surprising 
degree of homoiogy (100% ) w ith S. aureus fnbA. Suspicious o f contamination, 
PCR and sequencing was repeated under fastidious conditions w ith newiy 
extracted DNA and a control with reagents but no DNA. The same result was 
obtained. I t  is possible tha t S. schlelferl has acquired the fnb gene through 
horizontal transfer from S. aureus (or vice versa).
7.5. Chapter summary.
This study provides phenotypic and genotypic evidence fo r the expression 
of a cell wall-associated fibronectin-binding protein by the nosocomial pathogen 
S. schlelferl. Understanding the role of this adhesin in disease pathogenesis 
requires further study In vitro  and in animal models. Studies are aiso needed to
clone and sequence the complete S. schlelferl fnb gene, details of which may 
shed light on the origins of this adhesin.
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Chapter 8. fnbA  is one of seven genes associated with S. aureus  
virulence.
8.1 Chapter content.
One of the aims of this study was to compare the presence o f the gene 
encoding S. aureus fibronectin-binding protein A in isolates from healthy blood 
donors and from patients with invasive disease. However, most cases o f severe 
S. aureus disease cannot be explained by the action of a singie virulence 
determ inant, and it is iikely tha t a number of factors act in combination during 
the infective process. In view of this, a total of 33 factors were considered in 
parailel. The basis of the work was to:
1 Examine isolates of S. aureus associated w ith community carriage and 
w ith both community and hospitai-acquired disease in the Oxfordshire 
area, and study the reiationship between disease in man and 33 putative 
virulence determinants, both individuaily and in combination.
2 Analysis was performed as foliows:
i univariate analysis, comparing the presence of bacterial factors in 
carriage and disease isoiates.
ii re-analysis after adjusting for the effect of clonaiity.
iii analysis of the individual and cumulative effect o f virulence- 
associated determinants.
iv defining whether given combinations of genes were either more or 
iess likely to cause disease.
V exploring the role of horizontal transfer in acquisition o f virulence-
associated genes.
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8.2 Materials and Methods.
8.2.1 Bacterial isolates.
The bacteria examined were 155 isolates recovered from patients with 
invasive S. aureus disease (94 hospital-acquired and 61 community-acquired), 
and 179 isoiates recovered from healthy individuals. These were collected within 
Oxfordshire, UK between 1997 and 1998 by Dr's Moore, Day and Berendt using a 
prospective case control design (Peacock e t a!., 2002). Cases o f invasive 
infection were identified prospectively through the microbiology laboratory 
serving the main hospitals in the Oxford area. Clinical details were recorded and 
the bacterial Isolate was stored. Community-acquired disease was defined as 
admission to hospital with an illness consistent with invasive S. aureus disease, 
w ith isolation of S. aureus from a normaily steriie site w ith in 24 hours of 
admission. Hospital-acquired disease was defined as an iilness consistent with 
invasive S. aureus disease and isoiation of the organism from a normally sterile 
site 48 hours or more after admission for another condition. Control bacteria 
were obtained from nasal swabs of blood donors drawn from the same 
population catchment area as the Oxford Radcliffe Hospitals.
8.2.2 Evaluation of bacterial determinants.
A total o f 33 bacterial determinants were evaiuated. Twenty nine 
determinants were examined for the presence of the gene using the polymerase 
chain reaction (PCR), and four determinants were evaiuated by phenotypic tests. 
The bacteriai determinants examined incorporated the m ajor putative virulence 
factors reported in the published iiterature at the start of the study (Tabie 8.1).
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Table 8.1 Bacterial determinants examined.
Bacterial Putative function Ref. Method of detection
determinant
Adhesins
FnBPA Adhesin for 
fibronectin
(Greene e ta l.,  1995) PCR for fnbA
ClfA and ClfB Adhesins for 
fibrinogen
(McDevItt e t al., 1994; 
Ni Eidhin e t al., 1998)
PCR for dfA  & dfB
Cna Adhesin for 
collagen
(Patti e ta l.,  1992) PCR for cna
Protein A Binds Fc domain of (Forsgren e ta l. ,  1983; PCR for spa
Ig and vWF Hartleib e ta l.,  2000)
SdrC, SdrD, SdrE Unknown; putative 
adhesins
(Josefsson e ta l., 1998) PCR for sdrC, sdrD, & 
sdrE
Bbp Adhesin for bone 
sialoprotein
(Tung e ta /., 2000) PCR for bbp
EbpS Adhesin for elastin (Downer e ta l.,  2001; 
Park e ta l.,  1996)
PCR for ebpS
Map/Eap MHC ciass I I  analog 
protein
(Boden & Flock, 1992; 
Jonsson e ta l. ,  1995; 
McGavin e ta l. ,  1993a; 
Palma e ta l.,  1999)
PCR for map/eap
Toxins
TSST-1 Exotoxin with 
superantigen activity
Reviewed in (Bohach e t 
al., 1990)
PCR for ts t
Enterotoxins A, B, Exotoxins with Reviewed in (Bohach e t PCR for sea, seb, etc.
C, D, E, G, H, I, & 
j
superantigen activity al., 1990)
Exfoiiative toxins Exotoxins with Reviewed in (Bohach et PCR for eta & etb
A & B superantigen activity al., 1990)
Alpha toxin Cytolytic pore- Reviewed in (Bhakdi & lysis of rabbit
form ing toxin Tranum-Jensen, 1991) erythrocytes
Beta toxin Sphingomyelinase Reviewed in 
(Arbuthnott, 1982)
hot-cold lysis o f sheep 
erythrocytes
Delta toxin Cytolytic toxin Reviewed in 
(Arbuthnott, 1982)
Syngergy o f lysis with 
p toxin producer
Panton-Valentine Bicomponent (Prévost et al., 1995; PCR for pv l
ieukocidin ieukocidin Supersac e ta l. ,  1993)
Gamma toxin Bicomponent
ieukocidin
(Prévost e ta l. ,  1995; 
Supersac e ta l.,  1993)
PCR for hig
Other factors
ica locus Polysaccharide 
intercellular adhesion
(Cramton e ta l. ,  1999) PCR for IcaA
coagulase Binds prothrombin, 
activating conversion 
of fibrinogen to fibrin
(Hemker e ta l., 1975; 
Kawabata e ta l. ,  1985)
Coagulase test
Efb Binds to fibrinogen (Boden & Flock, 1994) PCR for efb
VS protease Serine protease (Drapeau e ta l. ,  1972) PCR for V8
agr subgroup Global regulator (Jarraud et al., 2000; 
Ji e ta l.,  1997)
PCR for agr subgroup 
I, I I ,  I I I  and IV
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8.2.2.1 PCR analysis.
Genomic DNA from S. aureus was extracted using the Wizard Genomic 
DNA purification kit, with the modification that lysostaphin 30|ig/m l (Ambi) was 
added at the cell lysis step, sea-i and ts t were amplified by m ultiplex PCR using 
the primers and conditions described elsewhere (McLauchlin e t al., 2000); sej, 
eta & etb were amplified using primers and conditions provided by G. O'Neill 
(personal communication). Primers and conditions used to am plify efb, p v l and 
hIg were as described in references (Boden Wastfelt & Flock, 1995) {efb), and 
(Lina e t aL, 1999) (pW and hig). Primer design for the remaining determinants 
was based on gene sequences avaiiable from GenBank (Appendix 1). This was 
straightforward with the exception of map/eap, agr subgroup, and sdrE and bbp. 
There were three GenBank sequences avaiiable for map, (AJ243790, clinical 
isolate 7; AJ245439, Wood 46; AJ223806, Newman), and one for a gene termed 
map/eap (AJ290973, Newman). These were aligned and common forward and 
reverse primers designed. To distinguish between agr groups I, I I,  I I I  and IV, 
use was made of sequence differences in or around agrD, the region encoding 
the autoinducing peptide. The forward primers for agr subgroups I and IV 
started nine bases upstream of the region encoding the peptide; primers fo r agr 
subgroup I I  and I I I  started at the ninth or firs t base, respectively, o f the region 
encoding the peptide. The reverse primers fo r ail agr subgroups were w ithin 
agrC.
Primer design for amplification of sdrE and bbp was complicated by the 
fact that these independentiy described genes are known to share significant 
homology (Tung et al., 2000). Were these alleles of the same locus? The 
sequences fo r sdrE (GenBank accession number A3005647) and bbp (Y18653) 
were blasted against the available genome sequence for two isolates undergoing 
sequencing at the Sanger Centre, Cambridge, UK using the website 
f h ttD ://www.sanaer.ac.uk/Proiects/S aureus/blast server.shtmH. These isolates 
were provided to the Sanger centre by Dr Nicholas Day and Dr Sharon Peacock
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and will be called isolate 252 (m ethicillin-resistant isolate) and 476 (methicillin- 
sensitive) in the remainder of this work. Blast analysis demonstrated that sdrE 
and bbp co-localised to identical positions in the respective isolates. Isolate 252 
shared 94% homology at the amino acid level w ith bbp and 79% with sdrE. In 
contrast, isoiate 476 shared 80% homology with bbp and 93% with sdrE. The 
sequences for sdrE and bbp were aligned using Gene Jockey I I  (Biosoft, 
Cambridge, UK), and primers were designed to distinguish between what was 
assumed to be two aiieles of a single gene by using a common forward primer 
but unique reverse primer. These primers were piloted using 50 randomiy 
seiected isolates. A clear distinction was seen between the prim er pairs, with 
amplification of a single band product of the appropriate size for either SdrE 
(766bp), bbp (1054bp) or neither, and were used to evaluate the remaining 
isolates.
PCR amplifications were performed in a PTC-200 DNA engine (MJ 
Research, Waltham, Mass.) w ith Taq polymerase (Bioline). The finai 
concentration of PCR reaction m ixtures were Ix  reaction buffer, variabie 
magnesium concentration depending on optim ization results (see Appendix 1), 
lOOpmoi of forward and reverse primers, Ijxl of 1/5 diiution template DNA, 
200fxm 4dNTP mix, and 2.5 units of Taq polymerase. The PCR primers and 
cycling conditions not referred to eisewhere are shown in Appendix 1. Aliquots of 
the reaction mixtures were anaiyzed by 1% agarose gel electrophoresis. A 
positive control and negative control (reaction m ixture minus DNA) was inciuded 
in each PCR run (see Appendix 1).
B.2.2.2 Phenotypic tests.
Production of coagulase was evaluated using standard methodology 
(Collee e t a!., 1996). Production of hemolysins was determined by streaking 
isolates onto a range of blood agar plates and incubated in air at 37°C for 18 
hours. Isoiates were considered positive for a-toxin if hemolytic on 5% rabbit
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blood agar, positive for p-toxin if haemolytic on 5% sheep biood agar foilowing 
incubation at 37°C for 18 hours then 4°C fo r 30 minutes (hold-coid lysis), and 
positive for 6-toxin if synergy was observed between the test isolate and a p- 
toxin producer on 3% washed sheep erythrocytes. Positive controls were 
NCTC5655 (a-toxin positive), NCTC 7428 (p-toxin positive), and NCTC 9715 (6- 
toxin positive).
8.2.3 Analysis.
The isolates used in this study were chosen for two reasons. First, the 
case-control study design helps to avoid the potential confounding effect of 
comparing isolates from different geographicai locations or tim e periods. Second, 
having defined the population structure of these isolates it was possible to adjust 
for the effects of clonaiity on associations between bacterial determ inants and 
invasive disease. For example, a given determ inant could become over­
represented in the invasive group if it is linked to a 'tru e ' virulence gene with in a 
given iineage. However, analysis linked to interpretation of MLST results 
becomes model dependent. In view of this, in the primary analysis isolates were 
evaluated according to origin (nasal carriage isolate or invasive), and further 
sub-divided depending on whether the disease was hospital- or com munity- 
acquired. The second round of analysis used isolates grouped by lineage as 
defined by MLST results and analysis repeated for associations w ith in each 
iineage. A lineage (or clonai complex) was defined for the purposes o f this 
anaiysis as a group of organisms tha t had identical sequence at 5 or more of the 
7 MLST loci examined. Further detail of the genetic structure o f S. aureus can be 
found on the MLST website (www.m lst.net), and in Appendix 2.
Contingency tabies were used to compare proportions between groups. 
To adjust for the 'h itchhiker effect', analyses were stratified by MLST-defined 
iineage using either the Mantel-Haenszel method or conditional logistic 
regression. Strains tha t were unrelated to any other at 5 o f 7 loci were arb itrariiy
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grouped as a 'lineage' for the purpose of this stratification. No corrections were 
made for multipie comparisons. For the purpose of interpretation and discussion 
statistical significance was set at p=0.01, and for this reason conservative 99% 
confidence intervals are used throughout.
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8.3 Results.
8.3.1 Univariate analysis.
Eight o f the 33 determinants (24% ) were significantly more common in 
invasive isoiates (Table 8.2). The 8 determinants were as foi lows: 3 genes 
encoding ceil wall-associated adhesins {fnbA encoding fibronectin binding protein 
A, cna encoding coilagen binding protein, and sdrE which encodes a protein of 
unknown function); 4 genes encoding toxins (sea and se j encoding 
staphyiococcal enterotoxins A and J, eta encoding exfoiiative toxin A, and hig 
encoding gamma tox in ); and IcaA (a marker for the Ica operon), which is 
involved in biofiim production.
8.3.2 Adjusting for the effect of clonaiity.
That such a large proportion of the genes examined were associated with 
disease (aibeit all positively) raises the question of whether the result can be 
explained by iinkage disequiiibrium between these genes and one or more 'tru e ' 
virulence determ inants elsewhere in the genome (the hitchhiker effect). In an 
attem pt to adjust for th i^  the analysis was repeated, this tim e stratifying for 
clonaiity. The clonal structure of this collection of isolates has been defined by 
MLST (ww w.m lst.net); using this information and the Mantei-Haenszel method 
the prevaience o f each gene was compared in the disease and carriage groups 
within but not between clonal complexes (Table 8.2, Fig. 8.1). Foliowing this 
stratification all 8 genes remained positiveiy associated w ith disease, seg was 
associated w ith disease on stratified anaiysis aione. Analysis was also repeated 
om itting what was by far the single largest clone, EMRSA-16 tha t contained 22 
disease strains from a singie group of hospitals but no carriage strains; w ithout 
this clone sea was not associated with disease. In view of this, sea was not 
included as a virulence-associated gene in the remaining anaiysis. The other 
results were not affected, leaving 7 putative viruience determ inants positiveiy 
associated w ith disease across muitiple S. aureus lineages.
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Table 8.2 Presence of putative virulence determinants in carriage and disease 
isolates -  univariate analysis and analysis stratified by clonal complex.
Unstratified analysis Stratified analysis
Carriage Invasive Odds ratio P Odds ratio * p *
n=178 n=155 (990/0 C l) ( 990/0 C l)
Adhesins
fnbA 154 (87%) 152 (98%) 7.9 (1.7to 77) 0.0001 12.0 (1.6 to 89) 0.0001
clfA 174 (98%) 155 (100%) - 0.13 - 0.13
ClfB 178 (100%) 155 (100%) - 1 - -
cna 57 (32%) 81 (52%) 2.3 (1.3 to 4.3) 0.0002 2.0 (1.1 to 3.7) 0.003
spa 160 (90%) 145 (94%) 1.6 (0.54 to 5.4) 0.24 1.7 (0.55 to 5.5) 0.20
sdrC 178 (100%) 156 (100%) - 1 - -
sdrD 73 (41%) 74 (48%) 1.3 (0.71 to 2.3) 0.27 1.9 (0.8 to 4.4) 0.05
sdrE 72 (40%) 87 (56%) 1.9 (1.0 to 3.4) 0.006 3.1 (1.4 to 6.7) 0.0001
bbp 76 (43%) 59 (38%) 0.82 (0.45 to 1.5) 0.43 0.74 (0.37 to 1.5) 0.27
ebpS 110 (62%) 105 (68%) 1.3 (0.70 to 2.4) 0.30 1.5 (0.65 to 3.4) 0.20
map/eap 165 (93%) 149 (96%) 2.0 (0.50 to 9.4) 0.24 1.7 (0.42 to 6.5) 0.34
Toxins
tst 44 (25%) 46 (30%) 1.3 (0.68 to 2.6) 0.27 1.2 (046 to 2.9) 0.68
sea 30 (17%) 48 (32%) 2.3 (1.1 to 4.7) 0.003 2.6 (1.0 to 6.6) 0.007
seb 13 (7%) 14 (9%) 1.3 (0.41 to 3.9) 0.72 0.79 (0.22 to 2.8) 0.33
sec 20 (11%) 15 (10%) 0.84 (0.30 to 2.2) 0.72 0.85 (0.32 to 2.3) 0.66
sed 9 (5%) 8 (5%) 1.0 (0.24 to 4.2) 1 1.2 (0.34 to 4.4) 0.68
see 0 0 - 1 - -
seg 113 (64%) 85 (55%) 0.69 (0.38 to 1.3) 0.12 0.42 (0.2 to 0.9) 0.003
seh 18 (10%) 24 (15%) 1.6 (0.65 to 4.1) 0.19 1.4 (0.63 to 3.3) 0.25
sel 106 (60%) 81 (52%) 0.73 (0.40 to 1.3) 0.18 0.50 (0.24 to 1.0) 0.01
sej 12 (7%) 38 (25%) 4.5 (1.8 to 13) <0.001 4.4 (1.7 to 11) <0.0001
eta 11 (6%) 34 (22%) 4.2 (1.6 to 13) <0.001 6.3 (2.0 to 20) <0.0001
etb 6 (3%) 0 (0%) - 0.03 - 0.06
pvl 3 (2%) 6 (4%) 2.3 (0.31 to 27) 0.31 2.7 (0.38 to 19) 0.18
hig 157 (89%) 150 (97%) 3.6 (0.97 to 19) 0.01 4.5 (1.0 to 19) 0.004
Alpha toxin 178 (100%) 153 (99%) - 0.21 - 0.15
Beta toxin 160 (89%) 122 (79%) 0.45 (0.18 to 1.0) 0.02 0.43 (0.17 to 1.1) 0.01
Delta toxin 144 (80%) 106 (69%) 0.54 (0.27 to 1.1) 0.02 0.55 (0.27 to 1.1) 0.03
Others
Ica 136 (77%) 143 (92%) 3.5 (1.4 to 9.8) <0.000
1
3.5 (1.4 to 9.1) 0.0002
V8 168 (94%) 149 (96%) 1.5 (0.34 to 7.5) 0.61 1.8 (0.42 to 7.9) 0.28
efb 105 (60%) 105 (68%) 1.5 (0.79 to 2.7) 0.11 1.7 (0.86 to 3.4) 0.03
Coagulase 175 (99%) 155 (100%) - 1 - 0.30
agr
subgroup I 65 (37%) 53 (34%) 0.91 (0.57 to 1.5) 0.73 0.43 (0.15 to 1.2) 0.10
subgroup II 43 (24%) 34 (22%) 0.89 (0.51 to 1.5) 0.70 3.3 (1.0 to 11) 0.04
subgroup III 65 (37%) 65 (42%) 1.3 (0.80 to 2.0) 0.31 0.78 (0.22 to 2.8) 0.70
subgroup IV 5 (3%) 2 (1%) 0.46 (0.04 to 2.8) 0.46 0.79 (0.13 to 14) 0.79
Odds ratio and p value after Mantel-Haenszel stratification for MLST-defined 
iineage. This was carried out to account for any influence o f underlying clonaiity 
on the results.
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8.3.3 Disease origin: community or hospitai.
The relative importance of the 33 bacterial factors In hospital versus 
community-acquired isolates was assessed by a comparison of carriage isoiates 
and community-acquired disease alone. The presence of genes encoding six of 
the seven virulence-associated factors from the primary anaiysis {fnbA, cna, 
sdrE, sej, eta and ica) remained associated with disease once hospital-acquired 
strains were removed. Although hig  was numerically more common in the 
community-acquired disease group than the hospital-acquired group (98%  vs 
95% ), the comparison with the carriage isolates (88% ) was no longer 
statistically significant.
8.3.4 Multivariate anaiysis.
8.3.4.1 Linkage disequiiibrium between viruience-associated genes.
The possibility tha t identification of one or more of these 7 virulence- 
associated genes was actually the result of linkage disequilibrium with in this 
group was examined. Logistic regression modelling of the relationship of the 7 
factors to both disease and to each other suggested that four of the factors {sej, 
fnbA, cna, and sdrE) were both independent of each other and independently 
associated w ith disease. Two of the remaining three factors, ica and hig, were in 
iinkage disequilibrium with fnbA, though each contributed significantly to 
virulence after taking this association into account, eta was in linkage 
disequiiibrium with sej, but also contributed independently to virulence. I t  was 
thus concluded that all 7 factors were associated w ith virulence.
8.3.4.2 Role of individual genes in disease.
Although on univariate analysis the odds ratio for disease fo r fnbA was 
twice as high as any of the other viruience-associated genes, in the full 
m ultivariate model the odds ratios for disease for each gene fell between 2.2 
{eta) and 3.3 {fnbA). This suggests tha t each of the 7 genes contributed
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approximately equally to virulence, and that no single bacterial factor 
predominated as the major predictor o f viruience.
S.3.4.3 Cumulative effect of genes.
There was a iinear trend between the number o f these 7 viruience 
determinants carried by particuiar isoiates, and the proportion of isoiates causing 
disease (p<0.0001, Fig. 8.2A). This suggested that the effects o f the factors on 
viruience were cumuiative. The association between number o f determ inants and 
the odds o f disease was iog-linear, consistent with the iogistic regression modei 
in which there is a cumulative effect of each subsequent factor on viruience. 
None of the remaining 26 putative viruience determinants were associated with 
disease on univariate anaiysis, either separateiy or combined as a count of the 
number o f determinants in each organism.
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Figure 8.2 Association between number of virulence-associated determinants and:
(A) proportion of isolates from cases of disease (rather than carriage). For example, 20% 
of isolates with one virulence-associated gene were from cases of disease and 80% 
were carriage strains.
(B) proportion of isolates with a given gene combination from cases of disease.
Each combination is identified by a letter; for the actual gene complifnent refer to table 
8.3. The 12 commonest combinations representing 80% of isolates are shown. The area 
of each circle is proportional to the number of isolates with that number of determ inants.
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8.3.5 Gene combinations and virulence.
Given tha t the effects o f the seven genes on the odds o f being a disease- 
causing strain are additive, anaiysis was performed to address whether particular 
gene combinations were either (i) more commonly found together in an 
organism than by chance, or (ii) more virulent.
In the study population there were 46 (o f a possible 128) different 
combinations of the seven genes, w ith more than 80% of the isoiates accounted 
for by 12 of these gene combinations (Table 8.3).
Table 8.3 Table of the 12 most common gene combinations.
Combination fnbA cnasdrE sej eta hig ica N * Num ber of Overall %  Cum ulative
isolates of to ta l %  of to ta l
A 1 0 1 0 0 1 4 64 19.6 19.6
B 1 1 0 0 0 1 4 64 19.6 39.1
C 1 0 0 0 0 1 3 39 11.9 51.1
D 1 1 1 0 0 1 5 35 10.7 61.8
E 1 0 1 0 0 0 3 10 3.1 64.8
F 1 0 1 1 1 1 6 9 2.8 67.6
G 1 1 0 1 1 1 6 8 2.4 70.0
H 1 0 0 0 0 0 2 8 2.4 72.5
I 1 1 1 1 1 1 7 7 2.1 74.6
J 0 0 0 0 0 0 1 7 2.1 76.8
K 1 0 1 1 0 1 5 6 1.8 78.6
L 1 0 1 0 1 1 5 6 1.8 80.4
*  Number of virulence-associated determinants w ithin the gene combination (out 
of 7).
Actual and predicted frequencies of each gene combination were 
compared, assuming independent segregation of the genes. One common 
combination (denoted 'B' in Table 8.4) was over-represented in both carriage 
and disease (19.4%  observed versus 11.7% predicted in carriage, and 18.6% 
versus 10% in disease); two virulent combinations (F & G, each w ith 6 virulence- 
associated genes) were over-represented in the disease group (5.2%  versus
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1.3%, and 5.2% versus 1.1%, respectively), and one less v iru lent combination 
(J, w ith 1 virulence-associated gene) was over-represented in the carriage group 
(4.1%  versus 0.9% ). No gene combinations were significantly under-represented 
compared with the ir predicted frequency. Are these discrepancies due to the 
effect of clonaiity, or do particuiar combinations of genes have either less or 
greater virulence than expected? None of the 12 most common combinations 
were either more or less likely to cause disease than others w ith the same 
number of virulence-associated genes, suggesting the effect was due to the 
clonal population structure (Fig. 8.2B).
Table 8.4 Observed and predicted distribution of gene combinations.
Gene
c o m b in a tio n
N *
O bserved
O/o
D isease
P red ic ted  %
C arriage  
O bserved %  P red ic ted  %
A 4 20.0 13.8 19.2 14.2
B 4 19.4 > 11.7 18.6 > 10.0
C 3 9.0 10.8 14.5 21.3
D 5 14.2 14.9 7.6 6.7
E 3 2.6 1.2 3.5 4.2
F 6 5.2 > 1.3 0.6 0.1
G 6 5.2 > 1.1 0.0 0.0
H 2 0.6 0.9 4.1 6.4
I 7 4.5 1.4 0.0 0.0
J 1 0.0 0.0 4.1 >  0.9
K 5 2.6 4.6 1.2 1.1
L 5 1.9 3.9 1.7 0.9
*  Number o f virulence-associated determinants w ithin the gene combination (out 
of 7). Where the observed frequency of a combination differs significantly from 
that expected, this is indicated by a '> ' or '< ' sign. Significance was determined 
by whether or not the exact binomial 99% confidence intervals around the 
observed percentage included the predicted percentage.
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8.3.6 Effect of clonaiity on genes and gene combinations.
8.3.6.1 Distribution of individual genes between lineages.
Contingency tabie anaiysis was used to examine whether individual genes 
were apparently randomly distributed between the m ajor MLST-derived clonai 
complexes, or whether the ir distribution was significantly influenced by the 
underlying clonaiity of the population. clfB, sdrC and see were excluded from this 
analysis as they were present in ali isoiates. The genes feii into two distinct 
groups. The distribution o f the enterotoxins, tst, the exfoliatins {eta and etb), 
beta and deita toxins, the variable sdr genes {sdrD, sdrE and bbp), cna, ebpS 
and efb w ith in the population were ail highly significantly related to clonal 
complex (p<0.001 in ail cases). In contrast the distributions of fnbA, clfA, 
coaguiase, spa, map, pvl, hIg, alpha toxin, ica and V8 appeared to be unrelated 
to the underlying clonal structure (p>0.1 in all cases). Most of this second group 
are genes which are either very common or very rare, and it is possible tha t the 
absence of a significant association with cionai complex is due to lack of power, 
leading to a type I I  error. However the difference in the p value range between 
the two groups is striking, and even after removing from the second group those 
genes which are either present or absent in more than 95% of isolates fnbA, 
spa, ica, map and hig remain apparently unrelated to underlying clonaiity (and 3 
of these are 'virulence-associated' genes).
Although there is strong statistical evidence for an association with 
clonaiity for the firs t group of genes listed above, there is also evidence to 
suggest tha t horizontal transfer o f genes plays an im portant role in determining 
the distribution of these genes. Ail the genes with a prevalence o f more than 
30% were found in isolates from all 11 major lineages. The exceptions to this 
diversity are agr subgroup I to IV, which were very tigh tly  (but not completely) 
linked to the underlying clonai structure (Tabie 8.5).
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Table 8.5 Background clonaiity and agr subgroups
Clonal
complex
agr I ag r I I agr I I I agr IV Total
CC30 2 2 90 (96%) 0 94
CC39 0 0 24 (100% ) 0 24
CC15 0 31 (100% ) 0 0 31
CC45 28 (93% ) 0 1 1 30
CC22 25 (100% ) 0 0 0 25
CC25 23 (100% ) 0 0 0 23
CC5 3 18 (86% ) 0 0 21
CCI 3 0 13 (81% ) 0 16
CC8 16 (100% ) 0 0 0 16
CC12 0 11 (100% ) 0 0 11
CC51 1 3 1 5 (50% ) 10
*  Percentages represent % of organisms within tha t cionai complex. The 
population genetic structure o f S. aureus can be found on the MLST website 
(www.m ist.net) and in Appendix 2.
The most clonal of all the genes characterised as either present or absent 
was tst, w ith 92% of positive isolates occurring in clonal complexes termed CC30 
or CC39. These two clonal complexes are closely related (the only two which 
are), and probably derive from the same progenitor strain. One interpretation is 
tha t CC30 and CC39 represent a relatively recent but highly successful clonal 
expansion (perhaps fuelled by tst) which has had less tim e to diversify through 
horizontal transfer than other lineages. That other genes {sea and bbp) were 
also heavily polarised with respect to this complex lends support to th is view. 
The distributions of the 7 virulence-related genes plus sea and ts t  are shown in 
Figure 8.3, along with the distribution of the agr subgroups; this selection 
includes genes which are chromosomaily encoded {ica, fnbA, sdrE), and 
associated with plasmids {sej), bacteriophage {sea) and the SaPI 1 pathogenicity 
island {tst).
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S.3.6.2 Distribution of gene combinations.
Underlying clonaiity had an im portant effect on the distribution of certain 
combinations o f genes (linkage disequilibrium). The over-representation in both 
disease and carriage populations of virulence-associated gene combination B 
(containing ica, fnbA, hig  and cna, but lacking sdrE, se j and eta) (Table 8.4), is 
entirely because it was present in 51% of isolates from clonal complexes CC30 
and CC39; its frequency in other cionai complexes was only 6%, not significantly 
different from its 'predicted' frequency. However, this clonaiity was not the 
explanation for the association of these genes w ith virulence; combination B was 
not itself associated with disease, and three of the four genes {ica, fnbA, and 
big) were significantly associated with disease w ithin CC30/39, even after 
excluding those isolates w ith combination B. Despite the underlying clonaiity 
there was stiii considerable variation within clonai complexes and even w ithin 
MLST sequence types. The 22 isolates of the nosocomial disease-causing 
EMRSA-16 clone, (a single MLST sequence type ST36), were represented by 10 
different gene combinations, despite ail being isolated w ithin the same city over 
a two year period (see Tabie 8.6). ST36 was not unique in showing this 
diversity; the five most common combinations were ail present in over half of 
the MLST-defined clonai complexes (data not shown), suggesting tha t horizontal 
transfer of genes between lineages is a relatively frequent occurrence.
Table 8.6 Combinations of virulence-associated genes within the nosocomial 
infection-associated cione EMRSA-16 (sequence type 36).
Combination
Frequency Percent FnbA cna SdrE sej eta hig ica
B 7 32 1 1 0 0 0 1 1
G 4 18 1 1 0 1 1 1 1
C 3 14 1 0 0 0 0 1 1
M 2 9 1 0 0 0 0 0 0
N 1 5 1 1 0 0 0 1 0
0 1 5 1 1 1 1 1 1 0
P 1 5 1 1 0 0 1 1 1
Q 1 5 1 0 0 1 0 1 1
R 1 5 1 1 0 1 0 1 1
I 1 5 1 1 1 1 1 1 1
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8.4 Discussion.
8.4.1 Viruience-associated genes and clonaiity.
These data represent a comprehensive analysis of virulence determ inants 
in a iarge, natural population o f S. aureus isoiates of ciearly defined clinical 
provenance. The finding that several bacterial factors were associated with 
invasive disease may directly reflect the ir involvement in the pathogenesis of 
severe disease. I t  is unlikely that one or more of the determ inants have become 
over-represented due to the hitchhiker effect, as the positive associations 
remained despite stratification of the anaiysis by genetic lineage. This was 
demonstrated against a background in which many determ inants were highly 
clonal, as shown in detail for several determinants.
8.4.2 Virulence-associated genes in the community and hospital setting.
Host factors for S. aureus disease are likely to include a genetic 
predisposition via one or more susceptibility genes, and acquired factors such as 
the presence o f intravenous devices, surgical wounds and other events that 
perturb normal host defences. I t  seems plausible to speculate tha t invasive 
disease occurs in two overlapping host populations. Individuals affected in the 
community (where the rate of disease is low) may represent those most 
genetically predisposed to S. aureus infection, while individuals infected in 
hospital (where the burden of disease is higher) may represent a much larger at 
risk group who may or may not carry susceptibility genes. Given this scenario, it 
is possible tha t the pattern or number of bacterial determinants associated with 
disease in the hospitalized host would d iffer from tha t seen in the community. 
However, there was little  difference between strains associated w ith disease in 
the two settings, suggesting that bacterial factors play a role In causing disease 
even in the compromised host. Whether this is the case fo r tru ly  
immunocompromised individuals such as neutropenlcs and those w ith AIDS 
requires further study.
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8.4.3 Function of viruience-associated genes during the disease process.
This study of the presence of bacterial determinants in isoiates associated 
w ith carriage and disease was assumption free w ith respect to the ir presumed 
function and biological effect during infection. Having identified 7 viruience- 
associated genes, the biological plausibility of these findings may now be 
considered. Fibronectin, the host ligand for the adhesin encoded by fnbA, is a 
ubiquitous host protein present in soluble form in the blood and in fib rilla r form 
in cellular matrices, bacterial adhesion to which may be im portant during several 
steps of the disease process (Patti e ta !., 1994a). Likewise, toxins tha t modulate 
the immune response through superantigen activity probably make a significant 
contribution to disease manifestations. However, it is also im portant to be 
somewhat circumspect when ascribing a given function to the pathogenic 
process, for the following reasons. First, many bacterial determ inants are m ulti­
functional (for example, fibronectin binding protein has recently been found to 
be an adhesin for fibrinogen) (Wann e ta !., 2000), and the critical interaction of a 
given factor w ith the host may not yet have been defined. Second, the functions 
ascribed to a determ inant by in vitro  assays may not accurately reflect the ir 
behaviour in vivo. For example, it is possible that fibronectin binding protein is 
more im portant as an evader of the host immune response than as an adhesin 
per se. Bacteria in blood are likely to acquire a surface coat of fibronectin which 
could result In poor adherence to solid surfaces but may, for example, affect the 
efficiency of uptake by phagocytes. The finding tha t the presence of the ica 
operon is more commonly present in disease isoiates is interesting. Biofiim is 
considered to be im portant in adherence to prosthetic material, and in 
persistence as bacteria become enmeshed in an exopoiysaccharide tha t confers 
protection from the host immune system and the effects o f antibiotics. I t  is 
possible tha t exopoiysaccharide also confers protection in the absence of a 
foreign device or devitalised host tissue.
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8.4.4 The role of 'non-virulence-associated' and other determinants in disease.
The study design enriched for the chances of finding virulence-associated 
determ inants by pre-seiecting those previously thought to be involved in 
disease, and excluding those w ith purely housekeeping functions. However, it is 
very unlikely tha t ail o f the genes responsible for disease manifestations have 
been identified in this study, an enterprise well suited to m icro-array analysis. In 
addition, some of the 'non-virulence-associated' determinants as defined here 
may indeed play a role in pathogenesis, but because of the ir essential nature 
were not flagged as viruience-associated by the study design used here. For 
example, genes encoding the fibrinogen binding proteins CifA and CifB were 
ubiquitous, regardless of the origin of the strain.
8.4.5 Viruience and aiieiic variation at a given locus.
Studies of staphylococcal pathogenesis often focus on the presence or 
absence of a given determinant. The results above were analysed on the same 
basis. However, the nature of the methodology used here means tha t it is not 
possible to differentiate between the presence/absence of the entire gene, and 
the presence/absence of an aiieiic variant at a polymorphic locus. Southern 
hybridization may have been more sensitive than PCR in determ ining the 
presence or absence of a given gene. However, aiieiic variation may be 
im portant in defining viruience, and PCR may provide interesting clues. For 
example, bbp and sdrE appear to be allelic variants of each other, yet only sdrE 
was associated w ith viruience.
8.4.6 Effect of viruience-associated genes on bioiogicai fitness.
S. aureus usually behaves as a harmless human commensal as reflected 
by the large proportion of the healthy population who sometimes or usually carry 
this organism, the transition to disease representing the exception rather than 
the rule. So what is the relationship between viruience-associated genes and
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bacterial fitness? The answer to this question is unknown, but is iikeiy to be 
complex and could vary depending on the factor in question. For example, a 
determ inant that confers the ability to invade the host may be associated w ith a 
fitness disadvantage since invasion could lead to bacterial death following 
antib iotic treatm ent or death of the host. Conversely, the presence o f genes that 
enhance the ability to cause conditions such as superficial skin infection could 
lead to enhanced host-to-host transmission. A further consideration is that 
accessory genes tha t are im portant to disease pathogenesis but which are not 
critical to survival may impose a cost to fitness through additional gene 
replication and protein secretion if expressed during periods o f carriage. I t  could 
be postulated, therefore, tha t the proportion of strains circulating in the 
community tha t carry viruience determinants, and the number of viruience- 
associated genes carried per strain, is a product of the interplay between rates of 
gene acquisition, the cost to bioiogicai fitness, and the rate o f decay of strains 
causing human disease.
8.4.7. Horizontal transfer of viruience-associated genes.
The variation in viruience determinants in a given clone (as demonstrated 
for EMRSA-16), together with the widespread nature o f combinations of 
virulence determinants, suggests tha t horizontal transfer of genes Is a common 
event. The preservation of the associations between certain genes and viruience 
after stratification for bacterial lineage is in itself strong evidence fo r e ither loss 
or gain through horizontal transfer of genetic elements. The mechanism of 
transfer can be readily explained for 'mobile' determinants such as sej which is 
plasmid mediated (Zhang e t al., 1998). However, the m ajority of the viruience- 
associated genes are chromosomal, and it is not clear how such genes are being 
transmitted. In addition, not ail 'mobile' elements appeared to undergo frequent 
horizontal transmission. An example of this is ts t which resides on a 
pathogenicity island termed SaPI 1 (Lindsay et al., 1998). This gene was very
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common (>60% ) in two cioseiy related cionai complexes in this study (CC30 and 
CC39), but appeared either very infrequently or not at ail in the remainder.
Although ail the virulence-associated genes have plausible functional 
explanations for the ir involvement in disease genesis, and care has been taken 
to stra tify for the m ajor S. aureus lineages, the above anaiysis cannot exclude 
the possibility tha t one or more of these genes is a marker fo r a viruience gene 
which is either cioseiy linked chromosomaily or which co-segregates on the same 
mobile element.
8.5 Chapter summary.
This study has demonstrated the variable presence o f virulence- 
associated genes in natural populations of S. aureus, providing evidence that 
bacterial factors play a role in determining invasive disease in both community 
and hospital settings. The effect of these genes was cumulative, each 
independently multiplying the odds of disease. There was also evidence of 
considerable horizontal transfer of genes, on a background of clonaiity. This 
study also indicates that it may be an over-simpiification to consider viruience in 
relation to the presence or absence of a given bacterial factor, since allelic 
variants of a polymorphic locus (such as SdrEfbbp) may make different 
contributions to the disease process.
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9. Concluding comments.
This body of work started out examining the processes by which S.
J "
aureus in teract^with human endothelial ceils. The early studies proved fru itfu l 
and exciting, demonstrating that fibronectin-binding proteins are critical for 
bacterial adherence to, and uptake by endothelial cells; later studies developed 
largely as a result of these findings. This discussion will now consider the 
possible relevance of this work to interactions occurring in the human host.
The firs t question one m ight pose is a fundamental one, and tha t Is, how 
do fibronectin-blnding proteins contribute towards the ecological success of S. 
aureus? This question cannot be answered from the pool of current knowledge, 
and can only be addressed by developing postulates based largely on common 
sense. The firs t postulate is that FnBPs and the genes encoding them are 
maintained in the genome because they contribute to human carriage rather 
than to viruience. This is based on the premise tha t human carriage is essential 
for bacterial survival. Approximately 20% of the healthy population persistently 
carry S. aureus, while about 60% of individuals are Interm ittent carriers. The 
nose represents the ecological niche for this organism, and there are no known 
sustainable environmental reservoirs. Survival in this site is likely to involve the 
ability to adhere to the lining of the nose (keratinized squamous epithe lium ); to 
adapt to environmental changes such as cold, moisture and dryness; to evade 
the host immune defences (in particuiar IgA and anti-bacteriai peptides); and 
the capability of transmission between hosts. Furthermore, adaptability and 
rapid response to change are iikeiy to be vital to ecological success. In 
comparison with carriage, invasive disease is a rare event and appears to be of 
little  biological benefit to the bacterium. Affected individuals do not have 
enhanced shedding unless infection involves the skin, they are usually treated 
with anti-staphyiococcal antibiotics (where affordable), and infection may even 
result in death of the host. Thus, one could postulate tha t the presence and
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pattern o f bacterial determinants is driven primarily by the benefit they confer 
during colonisation in the nose.
Fibronectin-binding proteins are almost ubiquitously expressed by S. 
aureus, and as such are iikeiy to fu lfil an im portant role. While the maintenance 
of two fnb genes may be the result of linkage with other beneficial genes and the 
genome, it is also possible tha t two genes are in some way better than one. So 
what role could FnBPs have during colonisation? Possibilities include adherence 
to the squamous epithelium, and evading expulsion by the immune system by 
becoming coated w ith host proteins. Studies o f the interaction between S. 
aureus FnBP and nasal epithelial ceils, mucin and components of the mucosal 
im m unity have not been reported in the literature. The functions served by FnBP 
may be necessary for many pathogens, since FnBPs are expressed by a range of 
bacterial species; defining what these are represents an im portant and ciinicaiiy 
relevant area of research.
So why study determinants such as FnBP in relation to disease 
pathogenesis? One m ight speculate that the presence or absence of fnb  genes or 
polymorphisms in the protein relate to bioiogicai fitness; however, once in vivo 
they could potentially make an Important contribution to the outcome of an 
invasive event. The importance of studying this area is to gain an understanding 
of the interactions between the host and bacterium that may prove amenable to 
interference, such as vaccination against a bacterial epitope tha t is o f central 
importance. Defining the involvement of FnBP in the interaction with 
endothelium could be an important starting point. However, there are many 
more questions to examine. For example, this study should be replicated using 
human dermal endothelial cells. These differ in surface receptors; fo r example, 
human dermal microvascular endothelium but not umbilical vein endothelium 
express CD36 (Sweriick e t a!., 1992), a glycoprotein tha t may bind
thrombospondin (Asch e t a!., 1987) and collagen (Tandon e t ai., 1989). They 
may, therefore, be a better representative of the microvasculature. The model
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should also be expanded to examine factors such as the roie o f piasma proteins, 
the effect of shear flow and endothelial cell stimulation, and the mechanisms by 
which bacteria are taken up by the host celi. However, a more fundamental 
question that this is whether S. aureus is tru ly  an intracellular pathogen. The 
benefits of being taken up by host non-professionai phagocytes include evasion 
from the immune response and the effect of antibiotics. The reality at this 
present time is tha t S. aureus has not been demonstrated to be an intracellular 
pathogen in vivo. This does not mean that it is not, but rather tha t a difficu lt but 
im portant study of fatal human S. aureus disease needs to be conducted.
Studies based on in vitro  systems offer an im portant opportunity to 
examine interactions between determinants at a cellular and molecular level, but 
are easy to criticise when trying to assess the ir relevance to human disease. 
However, the last study in this thesis is sufficiently robust in design to start to 
explore this question. Fibronectin-binding proteins were found to be viruience- 
associated, the effect of the determinants identified being cumulative. However, 
there are several potential contradictions that should be explored. The firs t is 
why carriage isoiates were less iikeiy to have a detectable fnbA in this study if, 
indeed, FnBPs are im portant in colonisation. Second, the study described in 
chapter 5 reported tha t ali S. aureus isoiates had at least one fnb gene by 
Southern dot blot, while the study of adhesins and toxins In chapter 8 found 
them to be very common but variable between carriage and invasive isolates. I t  
is possible that this relates to vagaries in sampling, a possibility tha t could be 
tested by defining the population genetic structure of isolates examined in the 
first study and comparing this with those used in the second study. An 
alternative explanation lies with the difference in technique; the identification of 
a stretch of DNA by PCR relies on conserved sequence at the site of prim er 
annealing. The difference in detection of fnb genes between carriage and disease 
isoiates may be the result of genetic polymorphism which in turn influences
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virulence potential, rather than the presence/absence of the entire gene. Further 
studies are now needed to explore this observation.
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Appendix 1. PGR primers and conditions for ampiification of S. aureus 
adhesin and toxin genes
PCR product Primer sequences Positive control 
& product length
PCR
conditions
fnbA Forward, position 431 (accession J04151) 
5'-CACAACCAGCAAATATAG-3' 
Reverse, position 1792 
5'-CTGTGTGGTAATCAATGTC-3'
8325-4
1362bp
Mg 1.5 
1 min 94°C
1 min 50°C
2 min 72°C
Forward, position 368 (accession Z18852) 
5'-GTAGGTACGTTAATCGGTT-3’ 
Reverse, position 1951 
5'-CTCATCAGGTTGTTCAGG-3'
Nevyman
1584bp
Mg 3.0 
1 min 94°C
1 min 45 °C
2 min 72°C
cljB Forward, position 425 (accession AJ224764) 
5'-TGCAAGATCAAACTGTTCCT-3' 
Reverse, position 1020 
5'-TCGGTCTGTAAATAAAGGTA-3'
Nevraian
596bp
Mg 3.0 
1 min 94°C 
1 min 45°C 
1 min 72°C
cna Forward, position 1719 (accession M81736) 
5'-AGTGGTTACTAATACTG-3'
Reverse, position 3457 
5'-CAGGATAGATTGGTTTA-3’
Phillips
Variable*
Mg 1.5 
1 min 94°C
1 min 55°C
2 min 72°C
spa Forward, position 1 (accession JO 1786) 
5'-TCGAAATAGCGTGATTTTGC-3' 
Reverse, position 1892 
5'-GCACTGAGCAACAAAAGATG-3'
8325-4
1892bp
Mg 1.5 
1 min 94°C
1 min 65°C
2 min 72°C
sdrC Forward, position 481 (accession AJ005645) 
5'-ACGACTATTAAACCAAGAAC-3' 
Reverse, position 1040 
5'-GTACTTGAAATAAGCGGTTG-3’
Newman
560bp
Mg 1.5 
1 min 94°C 
1 min 45°C 
1 min 72°C
sdrD Forward, position 361 (accession AJ005646) 
5’-GGAAATAAAGTTGAAGTTTC-3' 
Reverse, position 860 
5’-ACTTTGTCATCAACTGTAAT-3’
Newman
500bp
Mg 1.5 
1 min 94°C 
1 min 45°C 
1 min 72°C
sdrE Forward, position 650 (accession AJ005647) 
5'-CAGTAAATGTGTCAAAAGA-3' 
Reverse, position 1416 
5'-TTGACTACCAGCTATATC-3’
Isolate 476 
767bp
Mg 3
1 min 94°C 
1 min 45°C
1.5 min 72°C
hhp Forward, position 836 (accession Y18653) 
5'-CAGTAAATGTGTCAAAAGA-3' 
Reverse, position 1890 
5'-TACACCCTGTTGAACTG-3'
Isolate 252 
1055bp
Mg 3
1 min 94°C 
1 min 45°C 
1.5 min 72°C
ebpS Forward, position 175 (accession U48826) 
5'-CAATCGATAGACACAAATTC-3’ 
Reverse, position 700 
5'-CAGTTACATCATCATGTTTA-3'
Isolate 252 
526bp
Mg 4
1 min 94°C
1 min 50°C 
1 min 72°C
map/eap Forward, position 203 (accession AJ243790), 255 
(AJ290973), 257 (AJ245439) and 128 (AJ223806) 
5'-TAACATTTAATAAGAATCAA-3'
Reverse, position 1151, 1203,1199 and 1076, 
respectively
5'-CCATTTACTGCAATTGT-3'
Newman
943-949bp
Mg 3
1 min 94°C 
1 min 45°C 
1.5min72°C
icaA Forward, position 2711 (accession AF086783) 
5'-GATTATGTAATGTGCTTGGA-3'
R Reverse, position 3480 
5'-ACTACTGCTGCGTTAATAAT-3'
Isolate 252 
770bp
Mg 4
1 min 94°C 
1 min 50°C 
1 min 72°C
Fg Forward, position 4 (aceession Y00356) 
5'-TTGTTCTTCGAAACTT-3’
Reverse, position 1553 
5'-GGCTTTGGCTTTATTG-3'
V8
1550bp
Mg 3
1 min 94°C
1 min 50°C
2 min 72°C
agr
subgroup I
Forward, position 2405 (accession X52543) 
5'-ATCGCAGCTTATAGTACTTGT-3' 
Reverse, position 3143 
5'-CTTGATTACGTTTATATTTCATC-3'
Isolate 2 
739bp
Mg 3
1 min 94°C 
1 min 50°C 
1 min 72°C
218
agr
subgroup II
Forward, position 642 (accession AF001782) 
5'-AACGCTTGCAGCAGTTTATTT-3’ 
Reverse, position 1332 
5’-CGACATTATAAGTATTACAACA-3'
Isolate 19 
691 bp
Mg 3
1 min 94°C 
1 min 50°C 
1 min 72°C
agr
subgroup III
Forward, position 642 (accession AF001783) 
5’-TATATAAATTGTGATTTTTTATTG-3' 
Reverse, position 1353 
5'-TTCTTTAAGAGTAAATTGAGAA-3’
Isolate 252 
712bp
Mg 3
1 min 94°C 
1 min 50°C 
1 min 72°C
agr
subgroup rv
Forward, position 1346 (accession AF88215) 
5'-GTTGCTTCTTATAGTACATGTT-3' 
Reverse, position 2028 
5’-CTTAAAAATATAGTGATTCCAATA-3’
Isolate 3049 
683bp
Mg 3
1 min 94°C 
.1 min 50°C 
1 min 72°C
* Variable product size depending on number of B repeats. Multiples of-560 nucleotides
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Appendix 2. BURST diagram demonstrating popuiation genetic structure of S. 
aureus as defined by muitiiocus sequence typing.
The figure (over) was kindly provided by Dr's Ed Feil, Nicholas Day and 
colleagues.
Diagrammatic representation of clonal complexes. Each number represents 
an MLST sequence type (ST). The central circle of each clonal complex contains 
the putative ancestral clone of each clonal complex. Single-locus variants (SLVs) 
of an ancestral clone lie within the next concentric circle, and double-locus 
variants w ithin the outer circle. A solid straight line between two STs denotes a 
single-locus difference between them. Singletons are isolates possessing STs 
which differ from those of all other genotypes at > 2 loci. The clonal complexes 
are named according to the ST of the primary ancestral genotype, but w ith the 
prefix 'CC' (for clonal complex).
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